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Abstract
Dendritic cells play a central role in the control of immune responses. They 
are unique among antigen presenting cells in their ability to stimulate naïve T 
cells and thereby initiate primary immune responses. Polarised T helper cell 
subsets have been implicated in autoimmune and allergic conditions in 
humans and it is important to understand how such immune responses 
develop. Dendritic cells are known to induce IFNy producing cells via their 
secretion of IL12 but little is known of their ability to promote Th2 responses. 
The work presented in this thesis investigated conditions in which dendritic 
cells modulate the cytokine profile of naïve T helper cells. Dendritic cells 
were generated in vitro from cord blood derived CD34^ progenitor cells. They 
were characterised in their immature resting state and following activation by 
lipopolysaccharide or by crosslinking surface CD40 molecules. Mature 
dendritic cells increased their expression of surface co-stimulatory and 
histocompatibility molecules, secreted higher levels of inflammatory 
cytokines and increased their capacity to stimulate CD4^ T cell proliferation. 
Inhibition of NFkB activation prevented lipopolysaccharide-induced 
maturation of dendritic cells. Activated dendritic cells induced IFNy 
production from CD4^ T cells. However, when dendritic cells were treated 
with IL4, the glucocorticoid dexamethasone or house dust mite allergens prior 
to activation, IFNy production by T cells was inhibited. The IL4 or 
glucocorticoid effect could be explained by their inhibition of IL12 production 
by activated dendritic cells. In contrast, IL12 production by activated dendritic 
cells was unaffected by treatment with house dust mite allergens. 
Furthermore, house dust mite allergens did not induce secretion of anti­
inflammatory cytokines such as IL4, ILIO, IL13 or TGFp by dendritic cells. 
Investigations using cDNA arrays did not reveal differential gene expression 
by house dust mite treated-dendritic cells but brought to light expression of 
genes that have not been previously reported in dendritic cells.
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Chapter 1 Introduction
1.1 The Dendritic Cell
1.1.1 Discovery
Low density cells from murine spleens which were adherent to glass on 
isolation but distinctive from spleen macrophages were identified as a 
novel cell type in 1973 by Steinman and Cohn. They had a distinct 
morphology, lacked selective T or B cell surface molecules and were 
termed dendritic cells (DC) (Steinman and Cohn, 1973). DC represented 
<1% of total spleen cells and were thought to derive from thymus- 
independent bone marrow cells (Steinman et aL, 1974). Subsequent 
investigations using scanning electron microscopy showed that freshly 
isolated spleen DC displayed unusual bulbous cytoplasmic prj protrusions.
After 1 day of culture in vitro, they were no longer adherent to glass and 
could be maintained for three days without changing their expression of 
surface molecules or shape. Furthermore, they failed to proliferate in 
response to B or T cell mitogens (lipopolysaccharide and concanavalin A 
respectively) and expressed high levels of histocompatibility molecules 
which indicated a potential role as an accessory cell for T or B cell 
activation (Steinman et ah, 1979).
The theory of DC as accessory cells was vindicated when they were proved 
to be the predominant stimulator cells within primary mixed leukocyte 
reactions. Steinman and Witmer (1978) showed that DC were at least 100 
times more efficient than other antigen presenting cells (APC). 
Furthermore, Ahmann et al. (1979) found that a murine splenic adherent 
cell population expressing the histocompatibility molecule la was 2 0 - 5 0  
times more effective than splenic B cells at stimulating T cells in a primary 
allogeneic mixed leukocyte reaction (MLR). The stimulator cells in these 
experiments were probably a mix of both DC and macrophages.
The role of DC in vivo became clearer following studies of Langerhans 
cells (LC) found in the skin epidermis. It was thought that they were 
involved in contact sensitivity to chemical skin allergens and subsequently 
found to express la molecules and present antigens to T cells. LC displayed 
a similar morphology to splenic DC and further comparisons following the 
isolation and growth of LC in vitro indicated that LC were immature DC 
(Schuler and Steinman, 1985). This led to the idea that immature DC 
resided in non-lymphoid peripheral organs and only matured once they had 
reached the lymphoid organs. Freshly isolated LC were able to present 
antigen to T cells and stimulate sensitized T cells but were weak 
stimulators of primary T cell proliferation in an antigen dependent system 
or within MLR. In contrast, LC cultured for 72 hours in vitro were 100 -  
300 times more effective at stimulating primary T cells. Furthermore, 
cultured LC were able to cluster T cells in an antigen-independent fashion. 
These experiments indicated that primary T cell activation required 
accessory molecules expressed by LC only on maturation (Inaba et al., 
1986).
1.1.2 Antigen uptake and processing
Early studies of DC in vitro demonstrated that these cells were poorly 
phagocytic (Steinman et al., 1979) and that both splenic DC and cultured 
LC were unable to pinocytose soluble horse-radish peroxidase (Schuler 
and Steinman, 1985). However, experiments over a decade later proved 
that not only could DC internalise soluble antigen but that they did so at an 
extraordinary rate compared to other antigen-presenting cells. The 
discovery that large numbers of both human and mouse DC could be 
generated in vitro has rapidly expanded our understanding of DC biology. 
In Chapter 3 of this thesis experiments are described in which DC were 
generated in vitro from human cord blood CD34^ progenitor cells. Their 
groAVth and maintenance are described in addition to their morphology, cell 
surface molecule expression and T cell stimulatory function. Furthermore, 
other methods for the generation of DC in vitro and their subsequent 
phenotypes are discussed in the introduction to Chapter 3.
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Sallusto and Lanzavecchia (1994) generated DC from monocytes with the 
addition of IL4 and GMCSF. Using these cells, they showed that DC could 
present tetanus toxoid (TT) to TT-specific T cells more efficiently than 
even TT-specific B cells. This efficiency was increased by 100 times when 
DC captured immune complexes on their FcyRU molecules. Furthermore, 
only DC and not B cells or peripheral blood mononuclear cells (PBMC) 
were able to stimulate cord blood T cells which are considered to be 
mainly naïve cells, further evidence that DC are the initiators of primary 
immune responses.
Later investigations showed that efficient antigen capture by DC was due 
to fluid phase macropinocytosis and marmose receptor mediated 
endocytosis. Both of these mechanisms deliver antigen to vesicles within 
the DC which contain major histocompatibiliy (MHC) class II molecules, 
the protease cathepsin D and lysosomal-associated membrane protein-1 
(LAMP-1) (Sallusto et a l, 1995; Tan et a l, 1997; Lutz et a l, 1997). 
Mannose receptors are 175-kDa c-type lectins which bind to a broad range 
of sugars including mannosylated glycoproteins and are also expressed by 
macrophages. They are found on the surface of DC in clathrin coated pits 
(Tan et a l, 1997; Engering et a l, 1997) and when bound by antigen, they 
are internalised. However, in contrast to Ig complexes on B cells, the 
internalised mannose receptor is not degraded but yields its bound antigen 
at low pH and returns to the surface of the cell to capture more antigen. 
This may explain why DC are more efficient at antigen capture than B 
cells. In addition, DC are able to internalise high concentrations of soluble 
antigen via macropinocytosis. Unlike cells which micropinocytose small 
vesicles via clathrin-coated pits in the cell membrane, DC are able to 
internalise large vesicles probably because of their extensive cell 
membrane ruffles. Using this mechanism, an individual DC is capable of 
internalising volumes almost equal to the volume of the cell itself. 
Internalised macropiuosomes deliver their contents to large MHC class II-
rich lysosomes within the DC and then return to the surface of the cell to 
fuse back into the cell membrane (Sallusto et al., 1995).
Neither mouse (Pierre et al., 1997) nor human (Celia et al., 1997) DC 
generated in vitro express stable complexes of MHC class II and antigen 
on their cell surface when they are at an immature stage. Both 
constitutively internalise antigen/MHC class II complexes and either store 
them in lysosomes (mice) or recycle them back to the surface of the cell 
(human). However, following maturation mouse DC shut down MHC class 
n  synthesis and internal antigen/MHC complexes are expressed on the 
surface of the cell. Human DC give a short burst of MHC class II synthesis 
following maturation which rapidly ceases and antigen/MHC complexes 
are stably expressed on the cell surface having increased their half life over 
10 times. This mechanism allows DC to retain antigen while they migrate 
to the secondary lymphoid organs where they present the antigen to T cells 
(Pierre et al., 1997; Celia et al., 1997).
Exogenous antigen taken up into endosomes by APC is usually processed 
via the MHC class II pathway which activates CD4^ T helper cells. On the 
other hand, endogenous proteins are hydrolysed by proteosomes in the 
cytosol and carried by transporters associated with antigen processing 
(TAP) proteins into the lumen of the endoplasmic reticulum. Here they are 
associated with MHC class I molecules which move to the surface of the 
cell and present the peptide to CD8^ cytotoxic T cells (CTL) (Janeway and 
Travers, 1994). However, DC have a unique ability to present exogenous 
antigen on MHC class I molecules and prime naïve CTL. This cross­
priming mechanism is important because although virally infected cells 
can present viral antigen to CTL, they cannot provide the necessary co­
stimulatory signal to induce effector action. The mechanism of cross­
priming by DC is not fully understood but it is thought that exogenous 
antigens, in particular those bound in immune complexes to Fc receptors 
are internalised and access the cytosol via specific translocator vesicles 
(Watts, 1999; Rodriguez et al., 1999). Just like the processing of antigen
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associated with MHC class II molecules, cross-presentation is downregulated 
once DC mature (Mitchell et al., 1998). Moreover, immature but not mature DC 
can phagocytose apoptotic cells via avp5 and CD36 receptors on the DC cell 
surface (Albert et ah, 1998b). The effect of phagocytosis of dead or dying cells on 
DC maturation is controversial. One study has shown that apoptotic cells induce 
maturation (Rovere et al., 1998) whereas a later report indicated that only necrotic 
cells could activate DC (Sauter et ah, 2000). The antigens from apoptotic cells are 
associated with both MHC class I and class II molecules and either cross­
presented to CTL (Albert et ah, 1998a; Albert et ah, 1998b) or presented to T 
helper cells (Rovere et al., 1998). DC are 10,000 times more efficient at forming 
peptide/MHC complexes with phagocytosed cells rather than preprocessed 
peptide. This phenomenon is believed to be associated with the ability of DC to 
induce peripheral tolerance to self-peptides (Inaba et a l, 1998), which is 
discussed later on in this chapter
1.1.3 Migration from the periphery to the secondary lymphoid organs 
The function of dendritic cells is dynamic, depending on their maturation status. 
Immature DC in the periphery such as LC take up antigen efficiently but are poor 
T cell stimulators (Inaba e ta l, 1986; Romani e ta l,  1989). However, on receiving 
inflammatory stimuli via microbial products or particular cytokines, DC mature, 
downregulate their antigen uptake capacity (Heuffer et a l, 1988; Sallusto and 
Lanzavecchia, 1994; Sallusto et a l, 1995) and migrate to the secondary lymphoid 
organs where they efficiently present antigen to T cells and induce T cell clonal 
expansion.
In Chapter 4 of this thesis experiments are described in which human DC 
generated in vitro are cultured with maturation stimuli; lipolysaccharide from the 
cell wall of Gram negative bacteria and agents that crosslink CD40 molecules 
expressed on the cell surface of DC. Changes in their morphology, surface 
molecule phenotype, cytokine expression and allogeneic T cell stimulatory 
capacity were examined. In addition, fiirther factors that induce maturation of DC 
in vivo and in vitro and their
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subsequent phenotype and function are discussed in the introduction to 
Chapter 4.
Some DC such as Langerhans cells reside in the peripheral tissues in a 
resting state but during an inflammatory response DC and their precursors 
are mobilised from the blood. These may include CD34^ progenitor cells 
and monocytes both of which can generate DC in vitro. During 
inflammation, endothelial cells upregulate adhesion molecules: P-selectin 
and E-selectin which bind to P-selectin glycoprotein ligand expressed by 
blood dendritic cells (Robert et al., 1999) allowing the cells to extravasate 
from the blood into the inflammatory site. This migration across the 
endothelium also induces the differentiation of blood monocytes into DC 
(Randolph et al., 1998).
DC are attracted to the site of inflammation by a range of chemokines 
which are soluble low molecular weight proteins capable of recruiting cells 
in and out of the tissue via a concentration gradient. There are two main 
families of chemokines; C-C chemokines which have two adjacent 
cysteine residues and C-X-C chemokines which have one amino acid in 
between these two cysteine residues. Chemokines from both families are 
either induced during an inflammatoiy response or constitutively expressed 
(Baggiolini, 1998). Immature DC express chemokine receptors CCRl, 
CCR2, CCR5 and CXCRl and respond to their corresponding ligands; 
macrophage inflammatory protein-la (MIP-la), MIP-lp and regulated on 
activation of normal T cell expressed and secreted (RANTES) (Sozzani et 
al., 1998; Sallusto et al., 1998). In addition, immature DC are attracted to 
the site of inflammation by fMLP (a formyl peptide of bacterial origin), 
C5a (a product of the complement cascade) and monocyte chemotactic 
protein-3 (MCP-3) (Sozzani et al., 1995). CD34^ progenitor-derived DC 
generated in vitro also express CCR6 which binds to MIP-3a, a chemokine 
expressed in inflamed epithelium (Dieu et al., 1998).
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DC not only migrate in response to these inflammatory chemokines but 
they produce them themselves. They are probably induced to do so 
immediately after initial contact with inflammatory stimuli. Following 
treatment with LPS or CD40L monocyte-derived DC cultured in vitro 
rapidly and transiently express M IP-la, MIP-lp and IL8 whereas 
expression of RANTES and interferon-inducible protein-10 (IP-10) is 
more sustained (Sallusto et a l, 1999). Maturing DC express these 
chemokines in order to recruit more DC and other inflammatory cells such 
as neutrophils and monocytes to the site of inflammation. The chemokines 
also downregulate their own receptor. This enables maturing DC to move 
away from the site of inflammation and towards the secondary lymphoid 
organs where they can interact with T cells (Sallusto et a l, 1998).
As DC receptors for inflammatory chemokines are downregulated, 
receptors for constitutive chemokines are upregulated. This enables DC to 
migrate to the secondary lymphoid organs. In response to LPS, ILl, TNFa 
or CD40L, DC upregulate CCR7, the receptor for both secondary 
lymphoid organ chemokine (SLC) and MBP-3p (also known as EBIl ligand 
chemokine). SLC is expressed in high endothelial venules and both 
chemokines are expressed in the T cell regions of lymph nodes 
(Yanagihara et a l, 1998; Sozzani et a l, 1998; Dieu et a l, 1998; Chan et 
a l, 1999). In addition to attracting mature DC to the lymph node, SLC and 
MEP-3p also attract naïve T cells, allowing DC and T cells to co-localise. 
DC themselves amplify the effect by expressing MIP-3P and so recruit T 
cells and CCR7-bearing mature DC into the lymph node T cell region 
(Ngo et a l, 1998; Sallusto et a l, 1999). The importance of SLC in 
recruiting both DC and naïve T cells is shown in mice with a deficiency in 
SLC production in which neither naïve T cells nor DC are able to home to 
the secondary lymphoid organs (Gunn et a l, 1999). In addition, 
macrophage-derived chemokine (MDC) and fractalkine, a unique cell- 
membrane bound chemokine, are expressed by lymphoid-residing DC and
i /
are chemoattractants for activated T cells (Tang and Cyster 1998; 
Kanazawa et al., 1999).
1.1.4 Presentation o f antigen to T cells
1.1.4.1 Induction o f T and B cell activation
Mature DC within the T cell area of secondary lymphoid organs are termed 
interdigitating cells (IDC) and their role is to present antigen to T cells. 
IDC form a network within the T cell regions of peripheral lymphoid 
organs. These areas surround the primary B cell follicles within the deep 
cortex and paracortex of lymph nodes and in the periarterial lymphoid 
sheath (PALS) of the white pulp in the spleen. Naïve and memory T cells 
recirculate through the IDC network until they find presented antigen for 
which they are specific (Steinman et al., 1997). T cells recognise antigen in 
association with MHC molecules expressed by IDC via an antigen receptor 
(TCR) and are induced to proliferate after they receive a second co­
stimulatory signal provided by IDC. The most important co-stimulatory 
signal is given by B7 (CD80 or CD86) molecules on the surface of IDC 
interacting with CD28 on the surface of T cells. Activated T cells either 
become short-lived effector cells or recirculating memory cells. Antigen- 
specific B cells are also present in the T cell areas and they co-localise with 
Th cells and IDC. B cells internalise native antigen bound to surface 
antibodies, process it and present it on the surface of the cell in context 
with MHC class IE molecules. They present the antigen to antigen-specific 
Th cells which deliver a signal via CD40 to the B cell promoting clonal 
proliferation. During these cognate interactions, IDC appear also to deliver 
signals to the B cells. Both human (Dubois et a l, 1997; Fayette et al., 
1997) and mouse studies (Gerloni et al., 1998; Wykes et al., 1998) have 
shown that DC can induce proliferation of CD40-activated B cells and 
modulate Ig class switching. In the presence of ILIO and TGFp, human DC 
induce the synthesis of IgA by naïve CD40-activated B cells (Fayette et al.,
1997) and in mouse primary responses IDC are responsible for the switch 
from IgM to IgG. This was exemplified fiirther by showing that RelB
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deficient mice which cannot generate dendritic cells are unable to switch 
isotype (Gerloni et al., 1998).
Following CD40 activation by T cells, B cells either differentiate 
terminally into IgM producing plasma cells which migrate to the bone 
marrow, or into germinal centre (GC) founding cells which enter the B cell 
follicles of the lymph node or spleen. Inside the follicles, GC founding 
cells become centroblasts which massively proliferate and push small 
resting B cells to the periphery to form a follicular mantle. Centroblasts 
make up the dark zone of the GC and rearrange the variable regions of 
their immunoglobulin genes in a process called somatic hypermutation. 
Following rearrangment, centroblasts cease proliferation and move 
towards the apex of the GC (the light zone) where they become centrocytes 
and express their new surface immunoglobulin. Resident follicular 
dendritic cells (FDC) form a network throughout the light zone and display 
immune complexes bound to Fc and complement receptors. The origins of 
FDC are controversial but it is believed that they are derived from stromal 
cells rather than haematopoietic precursors. It is not clear how FDC pick 
up native antigen. One possibility is that antigen is brought into the 
germinal centre by a specialised CD4^ CDl Ic^CDS" DC subtype (GCDC) 
which carry immune complexes on their cell surface. GCDC are evenly 
distributed throughout the light and dark zone of the GC and are 
surrounded by T cells. They are extremely efficient at stimulating T cells 
and they may be involved in maintaining the activation state of memory T 
cells in the GC (Grouard et al., 1996).
Those centrocytes expressing newly formed immunoglobulin which bind 
with high affinity to the native antigen displayed by FDC are able to 
internalise the antigen. They process it and present it to antigen-specific T 
cells which have migrated into the light zone and receive a survival signal 
probably via CD40. The T cell secretes cytokines which induce Ig class 
switching and centrocytes either become plasma cells secreting high 
affinity antigen or memory B cells. Those centrocytes bearing surface Ig
l y
which binds to self-antigen or with low affinity for the antigen displayed 
by FDC do not receive a survival signal from the T cell and undergo 
apoptosis (MacLennon, 1994; Gordon et al., 1994; Mondino et al., 1996).
Although CTL require CD4^ T cell help for activation it may be given via 
the DC. Activation of CTL is dependent on CD40-CD40L interactions and 
anti-CD40 antibodies can replace CD4^ T cell help (Bennett al., 1998; 
Schoenberger et al., 1998). Ridge et al. (1998) suggest that DC provide a 
temporal bridge between Th cells and CTL. DC present antigen to Th cells 
and induce their activation via co-stimulatory molecules. Activated Th 
cells upregulate CD40L which binds to CD40 on the surface of DC and 
results in an increase in the levels of CD40 expressed by DC. These highly 
activated DC can then present antigen to CTL and provide them with the 
CD40 stimulation requisite for activation.
1.1.4.2 Induction o f peripheral tolerance
DC are pivotal in the control of immunity because of their ability to 
respond to foreign peptides or ‘danger’ signals or induce tolerance to self 
or innocuous antigen (Matzinger 1994; Banchereau and Steinman, 1998). 
Thymic DC are responsible for presenting self-peptide to developing T 
cells in the thymus. Cells which bind too tightly to self-antigen or do not 
recognise self MHC molecules are depleted and the rest are released into 
the blood. However, not all self-peptides can be presented in the thymus 
and some self-reactive T cells exit into the periphery. A putative role of 
migratory DC during steady non-inflammatory states is to bring antigen 
from the periphery to the lymph node. These migratory cells are thought to 
die, probably by apoptosis, and are phagocytosed by resident lymphoid 
DC. These in turn present self-antigens carried by the migratory cells to 
self-reactive CD4^ helper T cells and CD8^ cytotoxic T cells (Inaba et al., 
1997; Inaba et al., 1998). The way in which self-reactive T cells may be 
tolerized remains to be seen. However, a subset of mouse DC expressing 
CD8a on their cell surface and thought to be of lymphoid derivation can 
induce apoptosis in activated allogeneic T cells via Fas/Fas ligand
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interactions (Süss and Shortman, 1996). It has been suggested that these 
DC induce tolerance whereas DC of myeloid origin induce T cell 
activation. However, Lu et al. (1997) showed that mouse DC of a myeloid 
origin also express FasL and were able to induce apoptosis in a T cell line. 
Furthermore, there is increasing evidence, discussed in the introduction to 
Chapter 5 of this thesis, to show that lymphoid-derived DC and myeloid- 
derived DC are equally immunogenic.
It appears to be increasingly likely that DC are able to adapt to their 
environment, responding to the surrounding cytokines or inflammatory 
signals by becoming tolerogenic or immunogenic depending on which 
response is most appropriate. One of the most important influences on the 
development of an immunological response is the balance of T helper cell 
cytokines. As the only APC type which are capable of priming naïve T 
cells, DC are considered the initiators of immune responses. As such, there 
is a great deal of interest in their influence on T helper cell cytokine 
profiles. In chapter 5 of this thesis I discuss the ways in which DC 
influence the development of Thl or Th2 cells and I investigate the effect 
of various treatments on DC and their consequent modulation of cytokine 
expression by primed CD4^ T cells.
1.2 T helper cell differentiation
For a number of years immunologists wondered whether cell-mediated 
immune responses to intracellular pathogens and humoral responses to 
extracellular organisms were differentially regulated. This idea was 
confirmed by Mosmann et al. (1986) who showed that murine T cell 
clones can be classified as Thl cells which produce IFNy, IL2 and TNFp 
or Th2 cells which produce IL4, IL5 and ILl 3. Humans were subsequently 
shown to produce Thl and Th2 cells (Romagnani, 1991) and since then 
there has been a colossal amount of research investigating the mechanisms 
of differentiation from naive T cells to Thl or Th2 cells. Human CD4^ T 
cells express a mixture of Thl and Th2 cytokines unless polarized in a
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disease state. Therefore, it would be more accurate to describe memory 
human CD4^ T helper cells as expressing a Thl-like or Th2-like 
phenotype. Directly following activation, naive T cells become ThO cells 
which may be the precursors for Thl or Th2 cells since they.express both 
Thl- and Th2-type cytokines. ThO cells could also represent a stable subset 
that can regulate immune responses requiring a balance between Thl-type 
and Th2-type cytokines (O’Garra, 1998).
Thl and Th2 cells produce cytokines which act as autocrine growth factors 
and crossregulate each other (Constant and Bottomly, 1997; Abbas et a l, 
1996). IL4 is necessary for the induction and growth of Th2 cells and it 
also prevents the development of Thl cells. On the other hand, IFNy 
induces IL l2 production by macrophages which initiates Thl responses 
(Hsieh et al., 1993) and IL2 promotes the growth of Thl cells. In addition, 
IFNy inhibits the proliferation of Th2 cells (Abbas et al., 1996). Thl 
dominated responses are cell-mediated and involve the production, due to 
IFNy expression, of opsonising antibodies (IgG2a and IgG3 in mice; the 
effect of IFNy on human opsonising antibodies is not clear), the activation 
of macrophages and cytotoxic CD8^ T cells. IL4 is expressed during Th2 
responses and this induces the production of non-complement fixing IgG 
isotypes IgG4 (IgGl and IgG2b in mice) and IgE (Constant and Bottomly, 
1997; Seder and Paul, 1994). Th2 cells also express IL5 which attracts 
eosinophils and IL9 which is involved in the maturation of mast cells. 
Eosinophils and mast cells are the effector cells in helminth infections and 
also in allergic responses (Corry and Kheradmand, 1999; Finkelman et al, 
1996).
1.2.1 Initiation o f Thl or Th2 responses
1.2.1.1 Sources o f  IL4
It has been known for some time that the cytokines produced by each 
helper cell subset can amplify their own expansion. However, it is not 
wholly understood how ThO clones are initially directed down a Thl or a 
Th2 pathway in response to a specific antigen. Since IL4 directs the
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development of Th2 cells and IL l2 is required for Thl cell development, 
the source of these two cytokines in the initiation of immune responses has 
been investigated. Natural Killer (NK) cells produce IFNy following 
activation by IL l2 secreted by macrophages and dendritic cells in response 
to bacterial products such as lipopolysaccharide (LPS). IFNy activates 
macrophages further and ensures a Thl response develops. Therefore, NK 
cells act as a bridge between innate and acquired immunity (Trinchieri, 
1995).
Identifying the source of IL4 has proved more elusive. Mast cells are 
known to express IL4 (Plant et al., 1989) but they are more likely to be the 
effector cell in a secondary Th2 response, releasing soluble mediators 
following antigen induced crosslinking of IgE receptors. However, if 
allergens or helminth antigens were able to directly stimulate mast cells 
they may be able to provide IL4 in a primary immune response. A minor 
subset of CD4^ T cells, N K l.l^ T cells, which recognise antigen in the 
context of non-polymorphic MHC molecules express large amounts of IL4 
in vivo (Scott et al., 1990). However, p2-microglobulin deficient mice 
which cannot produce CD4’*TSfKl.l  ^ T cells are still able to mount Th2 
responses ruling out these cells as providers of the early source of IL4 
(Guery et al., 1996). Most recently it has been shown that the tiny amount 
of IL4 which naïve CD4^ T cells are able to secrete following antigen 
stimulation may be enough to initiate a Th2 response (Schmitz et al., 
1994). An interesting study in mice has shown that IL6 can direct the 
development of Th2 responses by inducing naïve CD4^ T cells to express 
IL4 (Rincon et al., 1997). However, the source of IL6, which is 
presumably secreted by APC has yet to be identified and the results have 
not been repeated with human cells.
1.2.1.2 Role o f co-stimulatory molecules
There is currently much speculation about the role of APC in providing a 
Thl/Th2 differentiation signal to naïve T cells. Clearly, macrophages and 
dendritic cells can induce Thl polarisation by producing IL12 in response
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to bacterial antigens (Trinchieri, 1995; Macatonia et al., 1995) but how do 
APC induce Th2 responses? As described above, IL6 is a possible 
candidate but IL6 is also expressed by DC in response to Thl polarising 
antigens (Verhasselt et al., 1997; Reis e Sousa et al., 1997). Signals 
delivered to the T cell via cognate interactions may play a vital role in 
determining which response ensues. T cell activation requires recognition 
of specific antigen displayed by APC in association with MHC molecules. 
In addition, the interaction between CD28 expressed by T cells and CD80 
or CD86 on the surface of APC is absolutely required for T cell activation. 
Antigen presented to T cells in the absence of co-stimulatory molecules 
results in anergy, a state in which T cells cannot proliferate in response to 
IL2 (McAdam et al., 1998). The role of CD28 in Thl/Th2 cell 
differentiation is complex. It has been shown to be critical for priming of 
both Thl and Th2 cells from naïve murine cells (Seder et al., 1994). 
However, enhanced costimulation of CD28 results in the development of 
Th2 cells from naïve cells. This mechanism is independent of IL2 since 
addition of exogenous IL2 to CD28 deficient T cells failed to induce Th2 
cells (Rulifson et ah, 1997). Furthermore, human memory T cells also 
require CD28 costimulation to produce Th2 cytokines (Schulze-Koops ef 
al., 1998). CD28 deficient mice can mount fimctional DTH responses but 
not humoral responses thus indicating that CD28 plays a preferential role 
in the development of Th2 responses (Shahinian et al., 1993).
The molecules which bind to CD28 have also been implicated in skewing 
naïve T cells towards either a Thl or Th2 phenotype. Kuchroo et al. (1995) 
showed that CD80 (B7.1) promoted Thl development whereas CD86 
(B7.2) influenced the development of Th2 cells. However, this remains 
controversial since others have shown that CD80 can induce Th2 responses 
(Lenschow et al., 1995) and that blocking both molecules affects the 
development of a type 2 response during a helminth infection (Greenwald 
et al., 1997). Other surface molecule interactions implicated in T helper 
cell differentiation include LFA-1 /ICAM-1 and 2 and OX40/OX40L. 
ICAM-1 and ICAM-2 are expressed by APC and bind to LFA-1 expressed
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on the surface of T cells. When APC present antigen to T cells, this pairing 
adheres the cells together and may also provide a co-stimulatory signal to 
the T cells. Salomon and Bluestone (1998) blocked ICAM-1 and LFA-1 
binding during antigen presentation by DC to T cells expressing transgenic 
TCR specific for OVA peptide. They found that although T cell 
proliferation was slightly inhibited, type 2 cytokine expression was greatly 
increased indicating that LFA-1/ICAM-1 may play a role in suppressing 
Th2 responses.
0X40, a member of the TNF receptor superfamily, is expressed by T cells 
and it binds to OX40L on the surface of DC and B cells. Ligation of 0X40 
on human T cells activated by anti-CD3 and anti-B7-l antibodies results in 
the expression of IL4, IL l3, IL5 whilst IFNy is downregulated. 
Furthermore, addition of exogenous ILl2 following 0X40 stimulation fails 
to skew the response towards a Thl phenotype (Ohshima, Y. et al., 1998). 
In vivo studies have also shown that 0X40 ligation during T cell priming 
results in the expression of type 2 cytokines and induces CD4^ T cell 
migration to germinal centres (Flynn et al., 1998; Brocker et al., 1999).
1.2.1.3 Antigen concentration and affinity for MHC molecules 
Early work by Bottomly and co-workers showed that the same antigen 
displayed by different MHC haplotypes could induce either a Thl or a Th2 
response fi*om naïve CD4^ T cells (Murray et al, 1989; Murray et al, 
1992). Subsequent studies using altered peptide ligands which vary in their 
ability to bind to MHC class II molecules indicated that Thl/Th2 
differentiation was due to the strength of signal given to the TCR by the 
MHC/peptide complex. They showed that peptides which bind well to 
MHC molecules send a strong signal to the T cell via its TCR and induce a 
Thl response whereas peptides with a lower affinity for MHC molecules 
influence the development of Th2 cells (Pfeiffer et al., 1995).
Many studies have shown that the concentration of antigen presented to T 
cells can influence whether a Thl or a Th2 response ensues. The majority
of experiments, both in vivo and in vitro, used soluble protein to stimulate 
T cells and indicated that Thl development requires high concentration of 
antigen whereas low antigen concentration results in a Th2 response (for 
review see Constant and Bottomly, 1997). Of particular interest is a study 
by Carballido et al. (1997) who isolated T cell clones from patients allergic 
to bee venom phospholipase A2 and stimulated them in vitro. They 
showed that the clones proliferated in response to anti-CD3 antibodies and 
produced high levels of IL4 and IL5 but very little IFNy. This result also 
occurred when clones were stimulated with low concentrations of the 
allergen. However, when the concentration of allergen was increased the 
clones began to express IFNy and less IL4 and IL5.
In contrast to these studies, a smaller number of reports have shown an 
opposite antigen concentration effect. Using a mouse nematode infection 
model in which disease resolution requires a Th2 response, Bancroft et al. 
(1994) found that low levels of infection polarized the response towards a 
Thl phenotype. Likewise, low levels of Leishmania major infection in a 
mouse model elicited a protective DTK response which disappeared when 
levels of infection increased (Bretscher et al., 1992).
1.2.2 Thl and Th2 cell trafficking
Thl and Th2 cells have also been reported to have different migratory 
properties. Thl cells but not Th2 cells were recruited to inflammatory 
tissues in murine models of cutaneous DTK or antigen-induced arthritis 
(Austrup et al., 1997). On the other hand, the same study showed that Th2 
but not Thl cells migrated to the lung in a model of allergen-induced 
airway inflammation. Differences in trafficking to the skin were related to 
the ability of Thl but not Th2 cells to bind to the endothelial molecules P- 
selectin and E-selectin indicating that T helper subsets selectively express 
adhesion molecules during inflammatory responses. As such, it is likely 
that Thl and Th2 cells respond differentially to chemokines since these are 
the molecules which induce leukocyte migration to sites of inflammation. 
Indeed, both Thl and Th2 cells have recently been shown to selectively
express chemokine receptors. Th2 cells express CCR3, CCR4 and GCR8. 
CCR3 is the receptor for eotaxin which is also a chemoattractant for 
eosinophils (Sallusto et ah, 1997), CCR4 binds to thymus and activation- 
regulated chemokine (TARC) and also macrophage derived chemokine 
(MDC) both of which are expressed by macrophages and dendritic cells 
(Sallusto et al., 1998). MDC production is induced by IL4 and IL13 and 
inhibited by IFNy (Bonnechi et al., 1998). The ligand for CCR8 is TCA-3 
which is produced by both Thl and Th2 cells (Zingoni et al., 1998) and 
both CCR4 and CCR8 are upregulated on activated Th2 cells (D’Ambrosio 
et al., 1998). Thl cells selectively express CCR5 (Loetscher et al., 1998) 
and CXCR3 which binds to the chemokine interferon-inducible protein-10 
(IP-10) (Loetscher et al., 1996).
The complexity of the data describing the expression of chemokines and 
chemokine receptors by T helper cells probably reflects the transience of 
their expression. Most of the reports concentrate on T cells aheady 
polarized towards a Thl or Th2 type phenotype. However, in humans most 
immune responses involve both Thl and Th2 type cytokines expressed by 
a mixture of ThO, Thl-like and Th2-like cells. It is more probable that 
CD4^ T helper cells can express a variety of Thl-type and Th2-type 
chemokine receptors until they are stimulated enough times to become 
polarised and express their selective receptors.
1.2.3 Transcriptional regulation o fT  helper cell differentiation 
A number of transcription factors have been implicated in the 
differentiation of naïve T cells towards a Thl or a Th2 phenotype. Of 
particular importance are the Signal Transducing Activator of 
Transcription (STATs) which exist in the cytoplasm in an inactive form. 
STATs are linked to cytokine receptors which when bound by cytokines 
induce the phosphorylation and activation of STATs by Janus kinases 
(JAKs). Activated STATs translocate to the nucleus where they bind to 
specific gene promotor regions. IL12 activates STAT4 in Thl cells and its 
importance is shown in STAT4 deficient mice which are unable to produce
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IFNy. STAT6 is activated by JAKl and JAK3 following the triggering of 
IL4 receptors. STAT6 is required to induce IL4 expression and naïve T 
cells from STAT6 deficient mice fail to differentiate into Th2 cells (Kuo 
and Leiden, 1999). Furthermore, Thl cells have a dysfunctional ability to 
respond to IL4 probably because of their inability to phosphorylate STAT6 
despite having normal levels of JAK-3 (Huang and Paul, 1998). GATA-3 
is a transcription factor containing a zinc-finger motif which also regulates 
Th2 differentiation. It is selectively upregulated by Th2 cells and inhibition 
of GATA-3 in Th2 clones results in the inhibition of IL4, IL13, IL5 and 
ILIO (Kuo and Leiden, 1999). Other transcription factors which play a role 
in T helper subset regulation are c-maf and NFAT. c-maf is also 
selectively upregulated by Th2 cells (Ho et ah, 1996) and overexpression 
in vivo induces a Th2 response which is dependent on IL4 (Ho et al.,
1998). In contrast, NFAT proteins are expressed by both Thl cells and Th2 
cells. Mouse gene knockout studies have shown that both the isoforms 
NFATc and NFATp are involved in the initiation of IL4 expression in 
activated T cells. Interestingly, NFATp is required for the downregulation 
ofIL4 in the later stages of an immune response (Kuo and Leiden, 1999).
1.2.4. Th2 cells and allergy
The reason why substances such as house dust mite faeces and birch pollen 
induce a Th2 response in some people but not in others is not known but a 
greater understanding of how allergens induce Th2 responses may help in 
designing therapeutic interventions. In Chapter 5 of this thesis, the effect of 
extracts of house dust mite faeces on dendritic cells and their ability to 
modulate the cytokine profile of CD4^ T cells is investigated and reported.
Allergic or hypersensitivity reactions occur when the immune system 
makes a response to a normally innocuous antigen as if it were an 
infectious agent. Hypersensitivity can be subdivided into four types. Types 
n  and m  involve IgG antibodies and complement fixation or phagocytosis 
respectively. Type IV or delayed type hypersensitivity reactions often 
occur in response to chemical allergens (contact allergy) and involve Thl
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cells and cytotoxic T cells rather than antibody. However, most allergens 
induce IgE production which results in type 1 immediate hypersensitivity 
reactions (Janeway and Travers, 1994). These reactions range from mild 
rhinitis in response to certain types of pollen to systemic anaphylaxis and 
possible death in individuals allergic to insect venom or penicillin. In 
individuals who are prone to produce IgE readily (known as atopic), 
allergens induce a polarised Th2 response resulting in the production of IL4 
which is responsible for the induction of IgE (Romagnani, 1998).
Initial contact with an allergen does not induce an allergic reaction but 
sensitizes the individual. Antigen presenting cells take up the allergen, 
process it and present it to allergen specific CD4^ T cells which clonally 
expand and secrete IL4. B cells specific for the same allergen are given 
signals by the T cells to proliferate and produce IgE. CD40L expressed on 
the surface of the T cell delivers the signal to the B cell via CD40 to switch 
antibody isotype and IL4 induces the switch specifically to IgE. IL4, acting 
via its receptor on B cells, leads ultimately to changes in the conformation 
of chromatin in the gene encoding the constant region of the 
immunoglobulin, that determines its isotype and effector function. The 
consequence of IL4-induced changes in the chromatin structure is that 
specific transcription factors are able to bind to the switch region upstream 
of the epsilon constant region, leading to synthesis of fimctional allergen- 
specific IgE molecules. The transcription factors that promote 
transcription of the epsilon region may include NFkB and STAT6, 
activated by CD40 and IL4 respectively (Correy and Kheradmand, 1999).
An atopic individual becomes sensitized once allergen-specific I ^  
molecules bind to FcsRl molecules on the surface of mast cells. Following 
re-exposure the allergen binds to the IgE molecules attached to the mast 
cell, crosslinking the Fes receptors and inducing mast cell degranulation. In 
allergic conditions such as asthma, this initiates the acute phase of the 
allergic response. Mast cells secrete histamine, leukotrienes and
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prostaglandins which all contribute to the acute inflammation by inducing 
vasodilation and vasopermeation, and bronchoconstriction in asthma. In 
addition, mast cells secrete chemokines and cytokines which attract other 
leukocytes to the site of inflammation. The late or chronic phase of asthma 
occurs several hours after the acute phase and involves infiltration of 
monocytes, T cells and eosinophils to the site of inflammation. Eosinophils 
are drawn out of the bone marrow and into the blood by IL5 secreted by 
Th2 cells and they are recruited to the site of inflammation by eotaxin and 
related chemokines. The contribution of eosinophils to the pathology of 
asthma is not frilly understood but probably involves their production of 
toxic proteins such as major basic protein, peroxidase and cationic proteins 
(Desreumaux and Capron, 1996). The principal features of the late phase 
of the allergic response, that is thought to be T cell-rather than mast cell- 
mediated, are recruitment of inflammatory cells and associated tissue 
swelling (Holgate, 1999; Holt ef a/., 1999).
1.3 Aims o f  this project
Generation and characterisation of human DC in vitro (Chapter 3)
Two types of human dendritic cells derived from either cord blood CD34^ 
haematopoietic precursor cells (HPC-DC) or peripheral blood adherent 
mononuclear cells (Mo-DC) will be cultured and maintained in vitro. The 
aim is to characterise and compare the two types of immature DC in terms 
of their cell morphology, capacity to stimulate allogeneic naïve CD4^ T 
cells and their surface molecule phenotype.
Maturation and activation of human DC in vitro (Chapter 4)
Dendritic cells derived from HPC will be matured and activated by EPS or 
mouse fibroblast L cells encoding the CD40L gene. The aim is to study the 
consequences of such activation on DC morphology and expression of co­
stimulatory and adhesion surface molecules, production of inflammatory 
cytokines and nitric oxide. In addition, the effect of maturation on the 
ability of DC to stimulate allogeneic T cells will be examined.
Modulation of T helper cell phenotype by DC in vitro (Chapter 5)
The aim of the studies reported in this chapter is to characterise the effect 
of DC stimulation on the cytokine profile of allogeneic T cells. DC are 
known to produce ELI 2 in response to inflammatory stimuli and 
subsequently induce Thl responses. However, DC are the only APC able 
to activate naïve T cells so they must also be able to initiate primary Th2 
responses. HPC-DC will be treated with compounds associated with either 
anti-inflammation or Th2 immune responses. DC will be cultured with 
IL4, ELIO, the glucocorticoid dexamethasone and extracts from house dust 
mite. The effect of treated DC on the production of IFNy or EL4 by 
stimulated CD4^ T cells will be examined. In addition the effect of the 
treatments on the phenotype of DC will be studied. The effect of house 
dust mite allergens on DC will be investigated further using cDNA array 
technology to examine whether house dust mite allergens induce changes 
in the inflammatory genes expressed by DC.
NFkB signal transduction during maturation of human DC (Chapter 
6)
The aim of this chapter is to examine the role of transcription factor 
nuclear factor k B (NFkB) in intracellular signalling in DC. DC derived 
from adherent peripheral blood mononuclear cells will be treated with 
LPS to see if  NFkB is activated. NFkB activation will be inhibited using a 
known NFkB inhibitor. The effect of inhibition on LPS-induced 
inflammatory cytokine production and co-stimulatory surface molecule 
upregulation by DC will be studied. Furthermore, the effect of inhibiting 
NFkB signalling in DC will be examined in relation to the ability of LPS- 
treated DC to induce naïve T cell proliferation and IFNy expression.
Chapter 2 Materials and Methods
31
Chapter 2 Materials and Methods
2.1 In vitro dendritic cell (DC) culture
Human dendritic cells were grown in vitro from either CD34^ 
haematopoietic precursor cells isolated from cord blood (HPC-DC) or 
adherent peripheral blood mononuclear cells (Mo-DC).
2.1.1 CD34^ HPC-derived DC
Cord blood was collected from placentas of elective Caesarian sections (St 
George’s Hospital, Tooting, London, UK) according to institutional 
guidelines. Blood was prevented from clotting by mixing 10  ^ units of 
heparin (Monoparin, CP Pharmaceuticals, UK) to 25 ml of blood. Blood 
was diluted 1:1 with phosphate-buffered saline (PBS) (Sigma Chemical 
Co., UK), layered over 9 ml of Lymphoprep (Nycomed Pharma, Oslo, 
Norway) and centrifuged at 300 g  for 30 min. Mononuclear cells at the 
interface were removed using a plastic pipette and washed twice in PBS.
2.1.1.1 CD34^ cell isolation
CD34^ cells were isolated using a VarioMACS and CD34^ isolation kit 
(Miltenyi Biotech, Germany). Mononuclear cells were resuspended in ice- 
cold MACS buffer (PBS containing 0.5% BSA (Sigma Chemical Co.)) and 
2 mM EDTA (Sigma Chemical Co.). They were incubated at 4°C for 15 
min with non-specific human IgG and a mouse IgGl hapten-conjugated 
anti-human CD34 monoclonal antibody. Cells were washed once in MACS 
buffer and incubated for a firrther 15 min at 4°C with magnetic microbeads 
recognizing the hapten conjugated anti-CD34 antibody. The cell 
suspension was passed over a magnetised RS^ column (Miltenyi Biotech, 
Germany) on which CD34^ cells were retained and CD34" cells passed 
through. The column was removed from the magnet and CD34^ cells were 
eluted with MACS buffer. Cells were passed over a second column to 
increase purity. The purity of isolation was assessed by flow cytometry.
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2.1.1.2 HPC-DC culture
1+     i n 4CD34 cells were resuspended at 2 x 10 /ml in RPMI-1640 supplemented 
with 2 mM L-glutamine, 25 mM Hepes (Gibco, UK) and 10% heat- 
inactivated (56°C for 30 min) fetal calf serum (complete medium). Cell 
suspension was added to 12-well plates (Costar Corporation, Cambridge, 
MA) at 2 ml/well. GMCSF (25 ng/ml) (R&D Systems Europe Ltd., UK) 
and TNFa (2.5 ng/ml) (Serotec Ltd, UK) were added to each well. Plates 
were incubated at 37°C in 5% CO2 . Cells were split on day 5 or 6 by 
removing 1 ml from each well and adding it to a fresh well. 1 ml of new 
medium containing 12.5 ng/ml GMCSF but no TNFa was added to each 
well. DC were used in experiments after 10 -12  days of culture. Adherent 
cells were removed using 10 mM EDTA in PBS.
2.1.2 Adherent peripheral blood mononuclear cell-derived DC (Mo-DC) 
Peripheral blood from healthy volunteers was collected, mixed with 
heparin (500 units/25 ml of blood) and diluted 1:1 in PBS. Mononuclear 
cells were isolated as above. PBMC were resuspended in complete 
medium. Cells were resuspended at 3 x 10  ^/ml and 2 ml of suspension 
were seeded into 6-well Falcon plates (Becton Dickinson, NJ, US). Plates 
were incubated at 37°C in 5% CO2 . After 2 h, non-adherent cells were 
removed by gently pipetting the suspension up and down in each well. 
Adherent cells were washed once with 1 ml of HBSS (Sigma Chemical 
Co.). Fresh complete medium containing 25 ng/ml GMCSF and 10 ng/ml 
IL4 (Serotec Ltd) were added to the adherent cells.
2.1.2.1 Removal o fT  and B cells
After three or four days, contaminating T and B cells were removed from 
the DC culture. Cells were washed once with HBSS and resuspended in 1 
ml complete medium. Mouse anti-human CD 19, CD20, CD2 and CD3 
mabs (Becton Dickinson) were added at 200 pl/ml and cells were 
incubated on ice for 30 min. Cells were washed once in HBSS and 
resuspended in complete medium with washed Dynabeads coated with 
sheep anti-mouse IgG (Dynal, Oslo, Norway) (lOpl per 10  ^contaminating
cells). Cells were rotated at 8°C for 30 min and then washed once with 
HBSS. Labelled cells were removed using the Dynal magnet. DC purity of 
90 -  94%, judged microscopically by size, was achieved after three rounds 
of depletion. DC were replated in complete medium containing 25 ng/ml 
GMCSF and 10 ng/ml IL4. DC were used in experiments after 5 - 7  days 
of culture.
DC were counted on a Neubauer haemocytometer (Marienfeld, Germany) 
and viability measured by Trypan blue exclusion. Cytospins were 
performed using a Shandon Cytospin 3. DC were fixed and stained in Diff- 
Quik (Dade). Cells in culture were photographed using an Axiovert 100 
inverted photomicroscope.
2.2 DC treatments
Human recombinant IL4, ILIO, ELI2, IFNy and IL6 were purchased from 
Serotec Ltd (UK). Human recombinant ILlp was purchased from R&D 
Systems Europe Ltd. Dexamethasone (DEX), bacterial lipopolysaccharide 
(LPS, Salmonella typhosa) and pyrrolidine dithiocarbamate (PDTC) were 
purchased from Sigma Chemical Co. House dust mite (HDM) extract was 
purchased from Allergopharma Reinbek, Germany. Mouse fibroblast L 
cells tranfected with the gene encoding human CD40L or CD32 were 
kindly supplied by Dr S. Ingvarrson from Lund University, Sweden. L cells 
were cultured at 10^/ml in 5 ml complete medium in 25 cm^ flasks (Nalgo 
Nunc International, Denmark). Cells were removed from the flasks using 
10 mM EDTA in PBS. Cultures were split every three days and the cells 
resuspended in fresh medium to maintain viability.
2.3 Measurement o f  nitric oxide
Nitric oxide (NO) production by activated DC was measured using the 
Griess assay. This indicates the level of nitric oxide expressed by 
measuring the amount of nitrite (NO^ ) in the cell supernatant. Nitric oxide 
in solution rapidly forms nitrite when it binds with molecular oxygen. 
NaNOi standards were diluted in the range 0 -100 pM. Standards and
samples were added in 100 pi duplicates to a 96 well plate (Costar 
Corporation). Griess reagent (0.5% sulfanimide and 0.05% N-(l- 
napthyl)ethylenediamine dihydrochloride in 45% ethanoic acid) was added 
to the plates at 100 pl/well and incubated at rt for 10 min. Absorbance was 
read at 570 nm and background absorbance at 630 nm subtracted. The 
concentration of nitrite in the samples was calculated from the standard 
curve.
2.4 Flow Cytometric Analysis
2.4.1 Antibody labelling
Cells were resuspended in ice-cold PBS at 5 -  10 x 10  ^cells/ml. Aliquots 
of 100 pi of cell suspension were incubated for 30 min at 4°C in the dark 
with 10 pi of mouse anti-human monoclonal antibodies conjugated to a 
fluorochrome. Cells were washed twice in ice-cold PBS and resuspended 
in 400 pi PBS containing 4% paraformaldehyde. If the primary antibody 
was unconjugated, the cells were incubated with a secondary goat anti­
mouse IgG (heavy and light chain) F(ab)2  fragment conjugated to 
phycoerythrin (Pe) (Immunotech, Coulter Corporation, France) for 30 min 
at 4°C in the dark, washed twice in PBS and resuspended in 4% 
paraformaldehyde in PBS.
2.4.2 Monoclonal antibodies
Mouse IgGl isotype control unconjugated or conjugated to FITC, 
phycoerythrin (PE) and Cy5 (Opticlone). Mouse anti-human monoclonal 
antibodies: CDlaPE (IgGl), CD14FITC(IgG2a), CD50FITC(IgGl), 
CD40PE(IgGl), HLA DRFITC(IgGl), CD54FITC(IgGl), 
CD64FITC(IgGl), CD83PE(IgG2a), HLA ABCFITC(IgG2a), 
CDllaFITC(IgGl), CDllbFITC(IgGl), CDllcPE(IgGl), CD58(IgG2a) 
unconjugated, CD34(IgGl)PE, CD102(IgGl) unconjugated, 
CD3PE/aCD19(IgGl)FITC, CD44(IgGl)FITC (Immunotech, Coulter 
Corporation, France), CD86 unconjugated (The Binding Site, Birmingham,
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UK), CD4(IgGl)Cy-chrome, CD45RA(IgGl)PE, CD45RO(IgG2a)FITC 
(Pharmingen, Beckton Dickinson, NJ, US).
Labelled cell suspensions were analysed on a Coulter XL Flow Cytometer. 
DC and T cells were gated on forward and side scatter dot plots.
2.5 DC and T cell co-cultures
2.5.1 CD4^ T cell isolation
CD4^ T cells were isolated using a VarioMacs and CD4^ isolation kit 
(Miltenyi Biotech). Mononuclear cells from cord blood or adult peripheral 
blood were isolated as described above. Cells were resuspended in ice-cold 
MACS buffer and incubated with a cocktail of hapten-conjugated mabs 
against CDS, C D llb, CD16, CD36 and CD56 for 15 min at 4°C. Cells 
were washed twice then incubated with magnetic microbeads coupled to an 
anti-hapten mab for 10 min at 4°C. Cells were washed and then passed 
over a magnetised VS"^  column and eluted. CD45RA^ cells were negatively 
selected from purified CD4^ cell suspensions using CD45RO beads 
(Miltenyi Biotech). Cells were incubated with beads for 10 min at 4°C, 
washed and then passed over a VarioMacs magnetised RS^ column. The 
isolation purity was analysed by flow cytometry.
2.5.2 T helper cell proliferation assay
DC were incubated with mitomycin C (25 pg/ml) (Sigma Chemical Co.) 
for 1 h on ice and washed three times in PBS. Cells were resuspended at 
10^/ml in complete medium. DC suspensions were serially diluted from 
lO^ /^well to 312/well in 100 pl/well (96 flat bottom well plate. Coming 
Incorporated). Each dilution was performed in triplicate. CD4^CD45RA^ T 
cells were resuspended in complete medium at 10^/ml. T cells were added 
at 100 pl/well. Cells were incubated at 37°C in 5% CO2 . In some 
experiments, L cells were treated with mitomycin C (50 pg/ml) for 1 h on 
ice, washed 3 times with PBS and resuspended in complete medium at 2 x
JO
lO' /^ml. L cell suspension was added at 50 pi to each appropriate well. 
After 5 days, 1 pCi of [methyl-^H]-thymidine (Amersham International, 
UK) was added to each well. Cells were harvested 20 h later (Skatron Cell 
Harvester 11025) and counted on a 2300TR Tri-carb liquid scintillation 
analyser (Canbera Packard).
2.5.5 T helper cell cytokine assay
DC were resuspended at lO^cells/ml in complete medium and 100 pi of 
cell suspension was added to each well of a 96 flat bottom well plate 
(Coming Incorporated). CD4^CD45RA^ T cells were resuspended at 
lO^cells/ml in complete medium and 100 pi of cell suspension was added 
to each well. In some experiments, 10  ^mitomycin C-treated L cells in 50 
pi of complete medium were added. Plates were incubated at 37°C in 5% 
CO2 . After 5 days T cells were removed by gentle pipetting, counted and 
replated in a 96 round bottom well plate (Coming Incorporated). They 
were restimulated with 1.5 pg/ml ionomycin (Sigma Chemical Co.) and 25 
ng/ml PMA (Sigma Chemical Co.) and incubated at 37°C in 5% CO2 for a 
further 48 h. Plates were centrifuged at 200 g, supematants removed and 
stored at -20°C.
2.6 Enzyme-linked immunosorbant assay (ELISA)
ELISA for human IL6 were performed using an IL6 Duoset kit from 
Genzyme Diagnostics. ELISA for human IL12p40, IL4, IFNy, IL ip were 
performed using matched antibody pairs and human recombinant cytokines 
as standards purchased from R&D Systems Europe Ltd. Capture antibodies 
diluted in PBS were coated onto 96 well plates (Maxisorp, Nalgo Nunc 
Intemational), covered and incubated ovemight at 4°C. Plates were washed 
4 times with wash buffer (0.05% Triton-X 100 in PBS), blotted and 
blocked with 4% BSA (Sigma Chemical Co.) in PBS for 2 h at 37°C. 
Human recombinant IL12p40, ILlp, IL4, IL6 and IFNy were diluted in 
complete medium to make standards in the following ranges: IFNy, 0 -  
1000 pg/ml, IL4, 0 -  2000 pg/ml, IL6, 0 -  1000 pg/ml, IL12p40, 0 -  2000
3 /
pg/ml, ILip, 0- 250 pg/ml. Blocking buffer was removed by blotting and 
100 pi of sample or standard was added to the plates in duplicate. Plates 
were incubated for 1 h at 37°C and then washed 4 times in wash buffer. 
Biotin-labelled detection antibodies (R&D Systems Europe Ltd) were 
diluted in PBS, added to the plates and incubated for 1 h at 37°C. Plates 
were washed 4 times with wash buffer. To each well, 100 pi of horseradish 
peroxidase conjugated to streptavidin (Sigma Chemical Co.) diluted in 
PBS were added and incubated at 37°C for 15 min. Plates were washed 4 
times with washing buffer and 100 pi of 3,3’,5,5’-tetramethylbenzidine 
liquid substrate solution (Sigma Chemical Co.) were added to each well. 
Reactions were stopped by 1 M H2SO4 (50pl/well). Absorbances were read 
at 450 nm, no longer than 30 min after the addition of stopping solution 
and the cytokine concentration of samples calculated from the standard 
curve.
ILIO, ELI 3 and EL5 ELISA were performed using Quantikine kits from 
R&D Systems Europe Intemational. Standards were diluted in culture 
medium in the following ranges: EL5, 0 -  250 pg/ml, ILIO, 0 -  500 pg/ml, 
ELI3, 0 -  4000 pg/ml. Standards and samples were added to the plates in 
200 pi duplicates and incubated at rt for 2 h. Plates were washed 4 times 
with wash buffer and 200 pi of conjugate was added to each well. Plates 
were incubated at rt for 2 h and then washed 4 times with wash buffer. 
Substrate solution was added to the plate at 200 pl/well and left at rt for 20 
min. Finally, 50 pi of stop solution was added to each well and 
absorbances read at 450 nm within 30 min Wave correction was set at 540 
nm.
2.7 Reverse transcriptase polymerase chain reaction
2.7.1 Experimental methods used at GlaxoWellcome
2.7.1.1 RNA extraction
Cells were washed in ice-cold PBS and centrifuged at 2300 rpm (Biofuge 
13, Heraeus) for 5 min and PBS removed. Cell pellets were stored at -80°C
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until use. Cells were lysed at 5 -10^ cells/ml of TRI REAGENT™ (Sigma 
Chemical Co.) by repeated pipetting! and then left to stand for 5 min at rt. 
Chloroform (Sigma Chemical Co.) was added (0.2 ml) and samples shaken 
vigorously for 15 sec and allowed to stand for 5 min at rt. Samples were 
centrifuged at 12,000 rpm for 15 min at 4°C. The resulting aqueous phase 
was transferred to a ftesh tube and 0.5 ml isopropanol (Sigma Chemical 
Co.) was added. Samples were left to stand for 10 min at rt and then 
centrifuged at 12,000 rpm for 10 min at 4°C. The supernatant was removed 
and 1 ml of 75% ethanol was added to the RNA pellet, vortexed and spun 
at 12,000 rpm for 5 min at 4°C. Most of the supernatant was removed and 
the pellet was left to air dry for 2 min. RNA was dissolved in water (Sigma 
Chemical Co.) and quantified by absorption at 260 nm (GeneQuant H, 
Pharmacia Biotech). The integrity of the samples was measured by 
running 1 pg of RNA mixed with 2 volumes of RNA loading buffer 
(Sigma Chemical Co.) and denatured at 65°C for 3 mins on a 1% agarose 
gel containing 5% formalin and 10% 10 x MOPS in water (Sigma 
Chemical Co.). Samples were run with RNA Molecular Weight Marker II 
(Boehringer Mannheim). The gel was stained with SYBR Green for 30 
min and then scanned on a Vistra fluoroimager. RNA pellets were stored at 
-80°C under 100% ethanol until use.
2.7.1.2 Reverse transcriptase reaction
RNA samples were precipitated from 100% ethanol by adding 2 pi of 3 M 
sodium acetate (pH 5.2) followed by centrifugation at 12,000 rpm for 15 
min at 4°C. Samples were washed in 75% ethanol and air dried for 2 min. 
Pellets were resuspended in water (Sigma Chemical Co.) at 0.33 pg 
RNA/pl. First strand cDNA was synthesised using a SMART PCR cDNA 
Synthesis Kit from Clontech UK Ltd. SMART (Switch Mechanism At the 
5’ end of RNA Templates) PCR generates high yields of double stranded 
cDNA from small amounts of RNA template. A modified oligo-(dT) 
primer anneals to the junction between the polyA tail and the mRNA, 
cutting out reverse transcription of long polyA stretches. The SMART
oligonucleotide annealed to the 5’ end of the mRNA prompts reverse 
transcriptase to switch templates and continue synthesis to copy the 
SMART oligo.. This generates single stranded cDNA containing the 
complementary sequence to the SMART oligonucleotide which is used as 
the template in PCR to generate double stranded DNA. The protocol for 
first strand synthesis is as follows: 1 pi of 10 pM oligo-(dT) primer and 1 
pi of 10 pM SMART n  oligonucleotide were mixed with 1 pg of total 
RNA and incubated at 70°C for 2 min. The reaction was left to stand at rt 
for 5 min. First strand buffer (2 pi), 1 pi of 20 mM DTT, 1 pi of 10 mM 
dNTP mix and 1 pi of Superscript II were added to the reaction and 
incubated at 42°C for 1 h. TRIS-HCL (40 pi of 10 mM) (pH 7.6) plus 1 
mM EDTA were added to the mix and incubated at 72°C for 7 min. cDNA 
samples were stored at -80°C until use.
2.7.1.3 Polymerase chain reaction
PCR were performed using an Advantage 2 PCR kit (Clontech UK Ltd). 
For 50 pi reactions the following were added; 40 pi of water (Sigma 
Chemical Co.), 5 pi of 10 x Advantage 2 polymerase buffer, 1 pi of 10 
mM dNTP mix, 1 pi of cDNA template, 1 pi of 3’ primer, 1 pi of 5’ 
primer and 1 pi of Advantage 2 polymerase mix. Reactions were 
performed on either a PTC 200 Peltier Thermal Cycler or on a Stratagene 
Robocycler. Products were mixed with a bromophenyl blue loading buffer 
and run on a 1.3% agarose gel containing ethidium bromide. A 1 Kb or 
100 Kb DNA marker (Boehringer Mannheim) was run with the products. 
The bands were visualised under UV light and photographed.
2.7.2 Experimental methods used at BIBRA/TNO
2.7.2.1 RNA extraction
RNA from up to 3 X 10  ^cells was isolated in the following way: cells were 
resuspended in 0.5 ml Solution D (25 g guanidinium thiocyanate dissolved 
in 29.3 ml of DEPC-treated water plus 1.76 ml of 0.75 M sodium citrate 
and 2.64 ml of 10% sarkosyl. 2-mercaptoethanol (7.2 pl/ml) was added
just prior to use.). The cell suspension was homogenised for 10 sec using 
an Omni 1000 homogeniser. 50 pi of 2 M sodium acetate, 0.5 ml of phenol 
and 100 pi of 2% isoamyl alcohol in chloroform were added to the 
homogenised cells, vortexed well and left on ice for 15 min. After 20 min 
centrifugation at 13,000 rpm, the aqueous phase containing RNA was 
removed. Isopropanol (0.5 ml) was added and the solution left at -20°c for 
1 h. The solution was centrifuged at 13,000rpm for 20 min and the 
supernatant discarded. Solution D (150 pi) and 150 pi of isopropanol were 
added and mixed well. The solution was left at -20°C for 1 h and then 
centrifuged at 13,000 rpm for 20 min. The supernatant was discarded and 
the samples were air dried in ethanol. Samples were resuspended in diethyl 
pyrodicarbonate (DEPC)-treated water (Sigma Chemical Co.) and kept at - 
70°C until use.
2.7.22 Reverse transcriptase reaction
First strand DNA was generated using a Reverse Transcription kit 
(Promega,UK). RNA (1 pg) was dissolved in 9.9 pi of DEPC-treated water 
and the following were added: 4 pi MgCb, 2 pi RT 10 x buffer, 2 pi dNTP 
mix, 0.5 pi RNAsin, 0.6 pi AMV reverse transcriptase and 1 pi Oligo-(dT) 
primer. The mix was incubated at 42°C for 15 min followed by 99°C for 5 
min and then left on ice for 5 min. Samples were kept at -70°C until use.
2.7.2.5 Polymerase chain reaction
For a 100 pi reaction volume, the following were mixed together: 10 pi 10 
X polymerase buffer (Promega), 6 pi MgCli (Promega), 0.8 pi dNTP mix 
(Pharmacia Biotech), 1 pi 3’ primer, 1 pi 5’ primer, 60.7 pi DEPC-treated 
water and 0.5 pi Taq polymerase (Promega). Products were amplified 
using a Hybaid Omnigene Thermocycler. Products were mixed with 
bromophenyl blue and run at 75 volts on a 2% agarose gel containing 
ethidium bromide. Bands were visualised under U.V light and 
photographed.
2.7.3 Primers 
(Sigma-Genosys Ltd, UK):
TGFBl
Forward, 5 -GCG AAG GCA TTA CAA AG-3’
Reverse, 5’-TTG GAG CAC AAC AAG G-3’
TGFB3
Forward, 5’-ACA AGC AAC AAA C C I C-3’
Reverse, 5’-TTT CCA CCC TFT CTT C-3’
PARI
Forward, 5’-GCG CAG AGC CCG GGA CAATG-3 
Reverse, 5’-TTA CAG TAA AAT GCT GCA GTG ACG-3’.
PAR2
Forward, 5’-CAG AGG TAT TGG GTC ATC GTG-3’
Reverse, 5 ’-TCA ATA GGA GGT CTT AAC AGT GG-3 ’.
PAR3
Forward, 5’-TGG ACT GGT GTG GGC AAC AG-3’
Reverse, 5’-TGT GAT GGC TGT CCT TGT TC-3’
PAR4
Forward, 5 -GCG CCT GGC CCT TGG ACT C-3’
Reverse, 5’-TGT GTC ACT GGA GCA AAG AGG AG-3’
Glyceraldehyde - 3- phosphate dehydrogenase (GAPDH) (Oswell Research 
Products)
Forward, 5’-ACC ACA GTC CAT GCC ATC AC-3’
Reverse, 5’-TCC ACC ACC CTG TTG CTG TA-3’
Primers from Pharmacia Biotech:
GAPDH
Forward, 5 -ACC ACA GTC CAT GCC ATC ACT-3 ’
Reverse, 5’-CAC CCT GTT GCT GTA GCC ATA-3’
IL6
Forward, 5’-TCA ATG AGG AGA CTT GCC TG-3’
Reverse, 5’-GCA GGA CAT GAC AAC TCA TCT C-3’
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IL12p40
Forward, 5 -ATT GAG GTC ATG GTG GAT GC-3’
Reverse, 5’AAT GCT GGC ATT TTT GCG GC-3’
2.7.4 PCR conditions 
TGFBl
94”C for 1 min followed by 35 cycles of 94”C for 30 sec, 52°C for 30 sec 
and 72°C for 90 sec.
TGFB3
94”C for 1 min followed by 35 cycles of 94°C for 30 sec, 54°C for 30 sec 
and IT C  for 90 sec 
Protease Activated Receptors
94“C for 1 min followed by 35 cycles of 94°C for 30 sec, 50“C for 1 minute 
and 72”C for 90 sec.
GAPDH (Oswell Research Products)
94”C for 1 min followed by 30 cycles of 94°C for 10 sec, 65°C for 30 sec 
and 72°C for 2.5 min 
n.6, TL12 and GAPDH
30 cycles of 95°C for 10 sec, 54“C for 15 sec and 72°C for 1 min followed 
by 1 cycle of 72°C for 5 min and 35°C for 30 min
2.8 Analysis o f mRNA expression using cDNA array technology 
cDNA array technology has developed from previous methods of gene 
expression analysis which depend on the natural ability of complementary 
strands of nucleotides to bind to one another. Similar to Northern and 
Southern blots, arrays are based on nucleotides attached to a solid support 
and a labelled probe in fluid phase. However, in array technology, the probe 
is the labelled sample of interest and the solid support can carry cDNA 
representative of many thousands of genes. A^ays can be made of 
nitrocellulose or nylon membranes or glass slides or ‘chips’ which are
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referred to as microarrays and can be as small as 2 cm^. Regardless of 
solid support, any combination of genes can be represented on the array 
from those specifically involved in inflammation or development to whole 
genomes. Arrays can carry whole length cDNA clones or partial length 
expressed sequence tag cDNA clones (ESTs) or oligonucleotides. They are 
spotted onto the array using a robotic arrayer which typically dispenses 5 nl 
of cDNA in a position which can be identified during data analysis by 
overlaying a grid indicating which genes the spots represent. The arrays 
used in the experiments of Chapter 5 in this thesis were kindly donated by 
the Genomics Unit at GlaxoWellcome, Stevenage, UK. They were nylon 
membrane arrays which were spotted with whole cDNA clones from a 
subtraction library of inflammatory gene products chosen by the Genomics 
Unit at GlaxoWellcome, Stevenage.
Arrays are heat treated to denature the attached cDNA so that the majority 
of DNA on each spot is single stranded. Reverse transcription of mRNA 
extracted from cells of interest generates cDNA which is also denatured 
and mixed with nucleotides and a radioisotope so that the complementary 
strand is radiolabelled. Alternatively, fluorescent labels improve accuracy 
when comparing gene expression between two samples. Each sample can 
be labelled with a different fluorochrome and hybridised onto the same 
array. Each fluorochrome will fluoresce at a different wavelenth enabling 
the samples to be distinguished. Arrays hybridised with radiolabelled 
probes are placed on a phosphoimage screen and enclosed within a 
cassette. The density of each spot on the array can then be determined 
using a phosphoimager and the information analysed by computer. (Schena 
et al, 1998; Ermolaeva et al., 1998; Duggan et al., 1999; Southern et al., 
1999)
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Fig. 2.1 Analysing gene expression by cDNA arrays. Clones are chosen 
jfrom cDNA subtraction libraries, purified and amplified by PCR. A robotic arrayer picks 
up the cDNA from a plate and prints it onto a nylon membrane in the same orientation as 
the plate. cDNA is denatured on the array to give single strands. mRNA is extracted from 
test samples, reverse transcribed and then amplified using SMART PCR. cDNA test 
samples are denatured and radiolabelled. Probes are hybridised to the array which is later 
exposed to a phosphoimager screen. The image is read on a scanner and the information is 
downloaded into specialized software for data analysis.
2.8.1 Amplification o f cDNA for probes
cDNA was generated and amplified using a SMART PCR amplification 
kit. First strand cDNA was generated as above (2.7.1.2). Only single 
stranded cDNA containing the SMART sequence at the 5’ end and the 
oligo (dT) sequence at the 3’ end was amplified by long distance PCR 
using the primer provided in the kit. For a 100 pi reaction mix the 
following were added: 1 pi of cDNA template, 81 pi of water (Sigma 
Chemical Co.), 10 pi lOx Advantage 2 Polymerase buffer, 2 pi lOmM 
dNTPs, 4 pi 10 pM SMART PCR primer and 2 pi 50 x Advantage 2 
Polymerase mix. A Peltier 200 Thermocycler was used for amplifying 
reactions under the following conditions: 95°C for 1 min followed by 25 
cycles of 95°C for 10 sec, 65°C for 15 sec and 68°C for 6 min. After 15, 
17, 19, 21, 23 and 25 cycles, 25 pi samples were removed. DNA loading 
buffer (Sigma Chemical Co.) was mixed with 10 pi of sample and
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electrophoresed on a 1.3% agarose gel which was stained with SYBR 
green for 30 min. The gel was scanned and the volume of the bands was 
analysed by ImageQuant. The proportion of cDNA amplified at each cycle 
was determined by ImageQuant data imported into an Excel spreadsheet.
2.8.2 Radioabelling cDNA for Probes
Overcycling cDNA generated by SMART PCR can lead to a lower quality 
product, therefore, cDNA samples were selected according to their 
appropriate PCR cycle number. The number of cycles was chosen on the 
basis of the maximum proportion of DNA amplified from the previous 
cycle. Samples were diluted in water (Sigma Chemical Co.) at 100 ng 
cDNA/45 pi and purified using a High Pure PCR Product Purification Kit 
(Boehringer Mannheim). The purified sample was denatured at 95°C for 5 
min and then incubated on ice for 5 min. Samples were added to 
Rediprime DNA labelling system vials (Amersham Pharmacia Biotech UK 
LtD) which contained dTTP, dATP and dGTP. To each vial, 5 pi of [^^P]- 
dCTP (Amersham) were added, mixed and left to incubate at 37°C for 30 
min. Sample radioactivity was counted and then unincorporated dNTPs 
were removed by passing the sample over a ProbeQuant G-50 
microcolumn (Amersham Pharmacia Biotech). Samples were counted 
again to determine the percentage of radiolabel incorporated. 
Approximately 60% of [^^-P]-dCTP was incorporated into the cDNA 
samples.
2.8.3 Probing the cDNA array
Membranes were placed in individual bottles with 50 ml of EasyHyb 
(Boehringer Mannheim) and pre-hybridised at 45°C for 30 min in a Techne 
Hybridiser HB-ID oven (Jencons PLS). Labelled samples were mixed with 
a quench solution (500 ml of EasyHyb, 10 ml of Cot-1 DNA (Boehringer 
Mannheim) and 5 ml of Poly dA.dT (Pharmacia Biotech)) for 5 min at 
100°C followed by 90 min at 45°C. Pre-hybridisation solution was 
removed fi*om the bottles and replaced with 10 ml of fi*esh EasyHyb. 
Quenched samples were added to each bottle (one sample per membrane).
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Membranes and samples were incubated at 45°C for 48 h. Following 
hybridisation, membranes were washed three times for 15 min at 68°C 
with 0.1% SDS and 0.5x SSC (NaCl and sodium citrate) (GibcoBRL)) in 
water. Membranes were removed from their bottles, kept wet and placed 
on plastic and covered with plastic film. They were placed in a cassette, 
covered with an activated phosphoscreen (Molecular Dynamics) and left at 
rt to expose for two weeks. Screens were scanned on a phosphoimager 
(Molecular Dynamics) and data analysed using Glaxowellcome in-house 
software.
2.9 Immunofluorescence
Cells resuspended in PBS at 5 x 10  ^were cytospun (500 rpm) on to glass 
slides. Cells were air dried and then fixed at rt for 15 min in 3.7% 
formaldehyde in PBS. Slides were gently washed with Tris buffered saline 
(TBS). Cells were permeabilised and non-specific sites were blocked by
0.25% BSA and 0.2% Triton-X 100 in TBS (buffer A) for 30 min at rt. 
Cells were stained for 1 h at rt with a rabbit polyclonal anti-human NFkB 
p65 primary antibody (Santa Cruz Biotechnology) diluted in 0.25% BSA 
and 0.05% Triton-X 100 in PBS (buffer B). Slides were washed 3 times for 
5 min in buffer B. Cells were incubated in the dark at rt for 1 h with goat 
anti-rabbit IgG (H+L chain) Alexa™ conjugate (Molecular Probes) diluted 
in buffer B. Slides were washed 3 times for 5 min in buffer B. Nuclei were 
stained with 1 pg/ml propidium iodide and 2% RNAse in PBS for 30 min 
at 37°C in the dark. Slides were washed 3 times for 5 min in PBS, mounted 
with Citifluor and a coverslip which was sealed around the edges with nail 
varnish. Slides were examined under a Nikon fluorescence microscope and 
photographed using a 1600 ASA, 36 exposure colour film.
Chapter 3 Summary
Introduction
The study of dendritic cells has been enhanced over recent years by the
ability to grow large numbers of DC in vitro. DC can be generated from
CD34" HPC in the presence of GMCSF and TNFa. In addition, peripheral
blood monocytes can be driven towards a DC phenotype when grown with
GMCSF and IL4. The results in this chapter attempt to characterise both
monocyte derived DC and HPC derived DC in terms of their morphology,
surface molecule phenotype and ability to induce allogeneic T cell 
proliferation.
Methods
CD34 HPC were isolated from cord blood using magnetic beads. DC were
generated after 12 days in the presence of GMCSF and TNFa. Monocytes
were isolated by density gradient medium from adult peripheral blood. DC
were generated after 5 days in the presence of GMCSF and IL4; Residual T
and B cells were removed from DC cultures using magnetic beads. Levels
of surface molecules were determined using flow cytometiy and the ability
to induce T cell proliferation was measured in allogeneic mixed leucocyte 
reactions.
Results and discussion
Light microscopy showed that both HPC derived DC and monocyte derived !
DC displayed characteristic surface membrane dendrites. HPC derived DC !
required the constant presence of GMCSF in the culture medium but could :
be maintained in the absence of TNFa. Both types of DC expressed MHC '
class I, MHC class II, costimulatory molecules CD80, CD86 and adhesion
molecules CD54 and CD44. However, HPC derived DC were able to
induce higher levels of allogeneic naïve T cell proliferation in an MLR than
monocyte derived DC. As a result, DC of HPC derivation were used in ' 
subsequent experiments.
Chapter 3 in vitro Generation and 
Characterization of Human Dendritic 
Cells from Precursor Cells
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Chapter 3 in vitro Generation and Characterization of Human Dendritic 
Cells from Precursor Cells
3.1 Introduction
Two important methods have been developed over recent years that have enabled 
the growth of large numbers of dendritic cells in vitro. Caux et a l,  (1992) isolated 
CD34^ progenitor cells from cord blood and cultured them with GMCSF and 
TNFa. Two populations of cells arose after 5 days: one subset expressed both 
CD14 and CDla, whilst the other expressed CD14but not CDla. A further 7 days 
culture resulted in the loss of CD14 and upregulation of CDla in all cells but the 
two subsets remained functionally distinct. Both were equally able to stimulate 
allogeneic naive CD4"^  T cells but only the CD14^ CDla precursor-derived DC 
were able to induce IgM production by B cells in the presence of IL2 (Caux et al., 
1997). DC derived from CDla^ precursors seemed to be akin to DC found in the 
epidermis since they contained Birbeck granules and expressed the Langerhans cell 
markers E cadherin and the lag antigen. DC derived from CD14^CDla' precursor 
cells resembled dermal DC in their expression of CD2, CD9, CD68 and factor 
Xnia. The addition of M-CSF could induce the latter cells to become 
macrophages (Caux et a l,  1996). The culture system described above utilises fetal 
calf serum (FCS), however even greater numbers of DC can be generated in FCS- 
free media supplemented with TGFpi which acts to protect cells from apoptosis 
rather than enhance proliferation (Strobl et a l,  1996; Riedl et a l ,  1997).
An alternative pathway for the differentiation of DC from CD34^ progenitors has 
been demonstrated in vitro (Flores-Romo et a l ,  1997). In the absence of GMCSF 
and TNFa, CD40 molecules on the surface of progenitor cells were crosslinked to 
induce the development of cells with DC morphology, surface phenotype 
(although they lacked CDla and were low in CD40) and ability to stimulate 
allogeneic T cells. This alternative pathway to DC development may explain why
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GMCSF receptor deficient mice exhibit normal levels of DC (Nishinakamura et al., 
1995). The signalling cascade initiated by CD40 crosslinking activates protein 
kinase C which has been shown to be involved in the differentiation of DC fi-om 
CD34^ progenitors (Davis et al., 1998).
Dendritic cells can also be generated fi’om precursor cells in peripheral blood. 
Romani et al. (1994) identified proliferating DC precursor cells in peripheral blood 
by culturing mononuclear cells with GMCSF and IL4 for 5 - 7  days. The resulting 
cells formed characteristic large aggregates and expressed high levels of MHC 
class n  and co-stimulatory molecules. They were also able to stimulate allogeneic 
naive T cells. Sallusto and Lanzavecchia (1994) characterized these cells further by 
showing that the layer of peripheral blood mononuclear cells that adhere to plastic 
give rise to dendritic cells in the presence of GMCSF and IL4. They described 
these cells as immature DC, similar to Langerhans cells in vivo in that they were 
able to take up soluble antigen and present it to T cells. TNFa downregulated the 
capacity of these cells to take up antigen and concomitantly induced high levels of 
surface MHC class II molecules, CD40 and B7; molecules requisite for efficient T 
cell activation.
Other studies have shown that purified CD 14  ^peripheral blood monocytes acquire 
DC characteristics and functions when cultured with GMCSF and IL4 (Zhou and 
Tedder, 1996; Pickl et a l,  1996). Since these cells are non-proliferative it has been 
assumed that all blood monocytes and not just a subset of DC precursor cells are 
capable of differentiating to DC given the appropriate signals. Monocytes have 
been shown to derive from the same progenitor cell which gives rise to neutrophil- 
granulocytes (Medcalf et a l,  1991). The myeloid origin of at least a subset of 
dendritic cells has been illustrated in experiments in which neutrophil-committed 
cells have been driven to acquire dendritic cell characteristics (Oehler et a l ,  1998).
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The myeloid lineage of some DC types appears to be established but a certain 
subset of DC may derive from lymphoid precursor cells. Precursor cells from the 
thymus expressing low levels of CD4 can develop into T cells, B cells, NK cells 
and dendritic cells (Ardavin et a l,  1993). A further downstream precursor, having 
lost the ability to become a B cell or NK cell can still differentiate into either a T 
cell or dendritic cell bearing the murine thymic DC marker CD8a (Wu et a l,  
1995). CD8a DC have been identified in the peripheral lymphoid organs and may 
play a role in regulating CD4 T cells via Fas/Fas-ligand mediated apoptosis (Suss 
and Shortman, 1996). DC can be cultured from CD4^“'^  thymic precursor cells in 
vitro using a cocktail of cytokines which doesn’t include GMCSF, further 
indication that a subset of dendritic cells which may have a specialised role in 
regulation derive from lymphoid origins (Saunders et a l,  1996). More recently, 
Bjork and Kincade (1998) have shown that dendritic cells which do not express 
CD8a can be generated in vitro from murine CD 19  ^ pro-B cells cultured with 
ILlp, IL7, IL3, SCF, TNFa and Flt3L.
Murine DC can be identified by the expression of the C D llc leukocyte integrin 
and the DEC205 multilectin receptor for antigen capture (Bell et a l ,  1999) but, at 
present, there is no surface molecule solely restricted to human dendritic cells 
which makes their identification more difficult. However, there are a number of 
criteria which can be used to characterise human DC:
1. Morphology
DC have a distinctive morphology, usually displaying long dendritic processes 
useful for sampling their surroundings for antigen. Sometimes, as when they are 
travelling with antigen through the lymph vessels, their cell membrane ruffles up 
into ‘veils’.
2. Surface molecule phenotype
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DC express surface molecules which are requisite for antigen presentation and co­
stimulation of T cells including MHC class I and II, CD80 (B7.1), CD86 (B7.2), 
CD40 and CD54 (ICAM-1), adhesion molecules including C D lla, CD lib , CD44 
and chemokine receptors. Most DC generated in vitro also express CDla, a 
Langerhans cell (a type of DC in the epidermis of the skin) marker and they are 
negative for T cell, B cell and NK cell markers.
3. T cell stimulation
DC initiate T cell-dependent immune responses and are therefore alone in their 
ability to activate naïve T cells. This may be due to very high levels of co­
stimulatory molecules upregulated on the surface of DC when they undergo 
maturation (see Chapter 4 of this thesis). Although the other professional antigen 
presenting cells (B cells and macrophages) are able to present antigen to T cells 
and activate resting memory cells, it is DC which induce the most “potent 
proliferative response from these cells.
The results presented in Chapter 3 detail the in vitro generation and 
characterisation of a) dendritic cells derived from CD34^ haematopoietic precursor 
cells isolated from cord blood (HPC-DC) and b) dendritic cells derived from 
adherent peripheral blood mononuclear cells (Mo-DC).
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3.2 Results
S. 2.1 Morphology
Figure 3.1 shows the morphological changes that developed when CD34^ 
haematopoietic precursor cells (HPC) were cultured with 25 ng/ml GMCSF and
2.5 ng/ml TNFa. After 3 - 4  days, the small, round HPC began to change shape, 
developing elongated, pseudopodic-like processes (fig. 3.1 A). Cells were 
replicating at this stage (fig. 3.2) but by day 8, mitotic cells were no longer evident 
(fig. 3.3). Between days 6 and 8, some cells began to adhere to the bottom of the 
wells and develop long dendritic processes (fig. 3.IB) but most cells were still non­
adherent with short, irregular surface membrane processes. At day 8, cells 
displayed large nuclei with prominent nucleoli surrounded by quite densely stained 
cytoplasm (fig. 3.3). By day 12 DC had formed large, adherent aggregates 
(fig.3.1C). Cytospin preparations showed the cells exhibited ruffled cell 
membranes and short dendrites (fig. 3.3). These Giemsa stained preparations also 
identified larger cells with a different morphology; a lightly stained nucleus and 
cytoplasm without the membrane processes characteristic of dendritic cells. These 
cells may have diverged during development along the macrophage pathway.
In this culture system, GMCSF and TNFa were both requisite for the in vitro 
development of CD34^ HPC derived DC (fig. 3.4). In the absence of either one of 
these cytokines at the start of culture, HPC failed to develop into DC and died 
(figs. 3.5 and 3.6). GMCSF was required for the maintenance as well as the 
generation of DC in culture. Cells were cultured in medium containing GMCSF 
and TNFa and after ten days they were washed and replated in medium containing 
TNFa but no GMCSF. Within one day these cells lost their adherence to the wells 
and died (fig. 3.7). However, as long as GMCSF remained in the medium, the
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removal of TNFa at day 10 failed to have any effect on mature DC survival (fig.
3 8).
Dendritic cells were also generated in vitro fi-om adherent peripheral blood 
mononuclear cells by adding 25 ng/ml GMCSF and 10 ng/ml IL4 to the culture 
medium. After 4 - 5  days DC became elongated and displayed irregular dendrites 
(fig. 3.9). They also lost their adherence to plastic and clustered into large 
aggregates.
2.2.2 Cell surface phenotype
Haematopoietic precursor cells were isolated from cord blood on the basis of 
CD34 expression with a purity of 95 - 97% (fig. 3.10). After 4 days of culture with 
GMCSF and TNFa, HPC were still expressing high levels of CD34 along with 
HLA DR and CD40. At this stage the cells were not expressing CDla, CD14 or 
CD80. Between day 4 and day 8, HPC-derived DC began to express CDla and 
lost CD34. CD80 expression increased between day 8 and day 12 and 10 - 20% of 
cells started to express low levels of CD 14 (fig. 3.11 A and B). Cells were used in 
experiments at day 12 when levels of co-stimulatory surface molecules were at 
their highest although CD40 and HLA DR expression was slightly lower than 
levels expressed by cells in the initial culture (Fig. 3.11 A).
Human dendritic cells cultured in vitro do not express a cell specific marker but 
they display a characteristic surface molecule profile of co-stimulatory molecules 
and HLA antigens. Neither Mo-DC (Table 3.1) nor HPC-DC (Table 3.2) 
expressed CD83 which is a marker characteristic of immature dendritic cells found 
in peripheral blood. Both types of DC were negative for CD 19 and CD3 and 
expressed high levels of MHC class I (HLA ABC), HLA DR and CD40. On 
average, only half of resting Mo-DC derived DC expressed CD80 whereas most 
expressed CD86. The opposite was found with HPC-DC which expressed more 
CD80 than CD86. HPC-derived DC also expressed CD58 which binds to CD2 on
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T cells and may play a role in T cell co-stimulation. The adhesion molecule, 
ICAM-1 (CD54) was highly expressed by both DC types and over half of HCP- 
derived DC expressed ICAM-3 (CD50) but no ICAM-2 (CD102). Other adhesion 
molecules expressed were CD44 and the LFA-1 integrins CD 11b and CD llc. 
HPC-derived DC expressed C D lla  but Mo-DC were negative for this molecule. 
After 12 days of culture, 40-70% of HPC-derived DC expressed CDla, a molecule 
expressed by Langerhans cells in the skin.
3.2.3 Allogeneic CD4^ T cell stimulation
CD4^ T cells were isolated from cord blood by negative depletion, achieving a 
purity of 90-98% CD3^CD4^cells (fig. 3.12). The majority of CD4^ T cells in cord 
blood expressed the naïve T cell marker CD45RA (96%) (fig. 3.13A). However, in 
addition to CD45RA molecules, 21% of these cells also expressed CD45RO, 
indicating that this proportion may have been activated (fig. 3.13B). In contrast, 
almost half of the CD4^ T cells isolated from peripheral blood using the same 
method expressed CD45RO (fig. 3.14).
In allogeneic MLRs, DC were able to stimulate CD4^ T cell proliferation strongly, 
whereas peripheral blood mononuclear cells did not induce proliferation (fig. 3.15). 
Results shown in figure 3.16 indicated that DC derived from CD34^ HPC were 
more potent stimulators of allogeneic T cell proliferation than DC derived from 
adherent PBMC.
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3.3 Discussion
The dendritic cells generated from both adherent PBMC and cord blood stem 
cells displayed a characteristic DC morphology and surface phenotype. Cells 
expressed MHC class II for antigen presentation, molecules for co-stimulation 
of T cells and molecules for adhesion. However, a proportion of the cells did 
not express CDla, a marker associated with human DC generated in vitro. 
Some of the progenitor cells may have diverged along the macrophage pathway 
although the 15 - 27% of HPC-DC expressing CD 14, a monocyte marker, were 
also expressing CDla, unlike the cells described by Caux et al. (1996) which 
lose CD 14 expression by day 12. The rest of the cells were negative for both 
CDla and CD 14. The populations of CDla CD14', CDla CD14^ and CDla’ 
CD 14’ cells may represent different subsets of DC which grow in vitro from 
progenitor cells. This heterogeneity may be as a result of cord blood CD34^ 
stem cells having already committed themselves to a particular myloid pathway. 
The small population of CD 14  ^cells in the Mo-DC cultures did not co-express 
CDla and were most likely to be monocytes which did not differentiate into DC 
or had diverged along the macrophage pathway.
IL4 required for Mo-DC generation could be replaced by IL13 (data not 
shown) to obtain the same results but either cytokine was absolutely necessary 
for DC growth as cells failed to differentiate to DC in GMCSF alone. It is 
believed that IL4 acts on the cells by preventing them from differentiating into 
macrophages (Sallusto and Lanzavecchia, 1994). Unlike murine bone marrow 
CD34^ stem cells (Bell et al., 1999), human HPC were also unable to 
differentiate into DC in the presence of GMCSF alone. TNFa is necessary at 
the beginning of culture because it is thought to induce GMCSF receptors on 
HPC (Caux and Banchereau, 1996).
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However, once DC were frilly differentiated they could be maintained in the 
absence of TNFa but the continual presence of GMCSF was obligatory for 
survival.
Dendritic cells are known to be the major inducer of T cell proliferation in an 
allogeneic MLR (Ahmann et a l,  1979). This is due to their high expression of 
MHC class II and co-stimulatory molecules. Compared to PBMC which include 
B cells and monocytes as antigen presenting cells, DC generated in vitro were 
able to induce much higher levels of allogeneic CD4^ T cell proliferation. The 
CD4^ T cells used as responder cells were isolated from cord blood because 
they are predominantly naïve cells. In comparison, approximately half of all the 
CD4^ T cells isolated from adult peripheral blood were expressing CD45RO 
which is considered a marker of memory T cells (Young et a i,  1997). The low 
level of T cell proliferation induced by PBMC shown in these results may be 
because B cells and monocytes are unable to stimulate naïve CD4^ T cells due 
to their lower levels of co-stimulatory molecules compared to DC.
These experiments showed that HPC-DC induced greater T cell proliferation 
than Mo-DC although the reason for this is unclear since both types of resting 
DC expressed similar levels of MHC class H, CD80, CD86 and CD54. DC 
derived from monocytes are thought to represent immature DC in vivo in that 
they are competent at antigen uptake but inefficient at stimulating T cells 
(Sallusto and Lanzavecchia, 1994). After maturation by TNFa they lose the 
ability to take up antigen but become potent T cell stimulators, reflecting the in 
vivo changes in DC as they migrate to the draining lymph node. This has been 
attributed to the increase in MHC class II and co-stimulatory molecules. 
Although the levels of these molecules were similar on resting HPC-DC and 
Mo-DC, the addition of TNFa to HPC-DC cultures may have resulted in the 
production of other factors, such as inflammatory cytokines, which may 
enhance their T cell proliferative ability.
56
0
A
%
W
0 ,
? %)<&\
c y \ '
j i ‘ .
 ^ , - ,^ ™
-73':.
sJLJ
/ W
. . . ' i-^
B
Q W .
Fig. 3.1 HPC-DC in culture at day 4 (A), day 8 (B) and day 12 (C). 
To generate dendritic cells, CD34^ HPC isolated from cord blood 
were cultured in media containing 25 ng/ml GMCSF and 2.5 ng/ml 
TNFa for 12 days. Light microscope. Magnification; x400
57
Mitotic cells
Fig. 3.2 Cytospin preparation of HPC-DC at day 4. 
Dividing cells with visible condensed chromosomes 
are evident. Cells were stained with Giemsa.
Light microscope. Magnification: x 400
Fig. 3.3 Cytospin preparation of HPC-DC at day 8.
Mitotic cells are no longer present. Cells were stained with 
Giemsa. Light microscope. Magnification: x 400
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Fig. 3.4 Day 9 HPC-DC cultured in medium containing 
25 ng/ml GMCSF and 2.5 ng/ml TNFa. Light microscope. 
Magnification; x 400
Fig. 3.5 Day 9 HPC-DC cultured in medium containing 25 ng/ml 
GMCSF but not TNFa. Light microscope. Magnification; x 400
Fig. 3.6 Day 9 HPC-DC cultured in medium containing 2.5 ng/ml 
TNFa but not GMCSF. Light microscope. Magnification; x 400
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3
Fig. 3.7 HPC-DC were cultured in complete medium supplemented 
with 25 ng/ml GMCSF and 2.5 ng/ml TNFa. After 10 days cells were 
removed from medium, washed and replaced with fresh medium 
containing 2.5 ng/ml TNFa but not GMCSF. Cells were photographed in 
culture on day 12. Light microscope. Magnification: x 400
.< f  *  '
Fig. 3.8 HPC-DC were cultured in complete medium supplemented 
with 25 ng/ml GMCSF and 2.5 ng/ml TNFa. After 10 days cells were 
removed from the medium, washed and replaced with fresh medium 
containing 25 ng/ml GMCSF but not TNFa. Cells were photographed in 
culture on day 10. Light microscope. Magnification : x 400
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Fig. 3.9 Peripheral blood mononuclear cell-derived DC cultured 
in complete medium supplemented with 10 ng/ml IL4 and 25 ng/ml 
GMCSF. Cells were photographed in culture on day 5. Light microscope. 
Magnification; x 400
A
Histogram profiles of CDla expression by HPC derived DC but not 
monocyte derived DC were bimodular indicating that there was a CDla^ 
population and a CDla^° population. However, when gating on either 
population, the levels of other surface molecules including CD 14 were 
comparable.
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SURFACE
MOLECULE
CD1A
4
CD14 HLA DR CD40 CD80 CD86 CD54 CD11
A
HLA
ABC
%  p o s i tiv e 73 10 98 99 46 86 83 3 84
±SEM 8 7 2 1 22 15 13 2 5
SURFACE
MOLECULE
C D llc GD19 CDS CD4 CD64 CD72 CD44 CD5B CD83
%  p o s itiv e 96 0 0 55 1 57 99 83 0
+ SEM 3 0 0 21 1 35 1 13 0
Table 3.1 Surface molecules expressed by resting Mo-DC at 
day 5. Surface molecule expression by DC was analysed by 
flow cytometry. Background fluorescence was detected using 
a non-specific isotype matched control antibody. The 
percentage of positive cells shown for each molecule is the 
mean of flve separate experiments ± SEM.
SURFACE
MOLECULE
CD1A CD14 HLA DR CD40 CD80 CD86 CD54 CD11A CD11C
% positive 56 21 91 90 65 56 88 62 66 83
±SEM 14 6 8 5 13 13 3 31 * 4
SURFACE
MOLECULE
CD19 CDS CD4 CD64 CD44 CD102 CD34 HLA ABC CD8S
% positive 0 0 58 8 94 0 58 0 82 0
±SEM 0 0 25 1 7 0 19 0 21 0
Table 3.2 Surface molecule expression by resting HPC-DC at day 
12. Surface molecule expression by DC was analysed by flow 
cytometry. Background fluorescence was detected using a non­
specific isotype matched control antibody. The percentage of positive 
cells shown for each molecule is the mean of flve separate 
experiments ± SEM. *only one experiment performed.
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% positive = 97%
1 0 ® 1 0 ’  10
Fluorescence
Fig. 3.10 CD34 expression by freshly isolated HPC. HPC 
were isolated from cord blood by positive selection using 
magnetic beads. CD34 expression was analysed by flow 
cytometry. A non-specific isotype matched antibody was used 
as a negative control. The percentage of positive cells is 
indicated.
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Fig. 3.11 Changes in surface mol ecule expression during HPC-DC 
devdopment from day 4 to day 12. Surface expression of CD80,
HLADR, CD40 (A) and CD34, CDla, CD 14 (B) were analysed on day 4, 
day 8 and day 12 by flow cytometry. Background fluorescence was 
detected using a non-specifrc isotype mat died control antibody.
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Fig. 3.12 Surface expression of CD4 by T cells isolated from 
cord blood. CD4^ T cells were negatively selected from cord 
blood, doubled stained for CD4 and CD3 expression and 
analysed by flow cytometry.A non-specific isotype matched 
antibody was used as a negative control.
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Fig. 3.13 Surface expression of CD45RO and CD45RA by CD4^ T 
cells isolated from cord blood. T cells were analysed by flow 
cytometry for expression of CD45RA and CD4 (A) and dual 
expression of CD45RA and CD45RO (B). A non-specific matched 
isotype antibody was used as a negative control.
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Fig. 3.14 Surface expression of CD45RO by CD4^ T cells 
isolated from peripheral blood. CD4^ T cells were negatively 
selected from adult peripheral blood and analysed by flow 
cytometry for CD4 and CD45RO expression. A non-specific 
isotype matched antibody was used as a negative control.
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Fig 3.15 HPC-DC and PBMC as stimulator cells in an allogeneic 
MLR. Freshly isolated PBMC and day 12 DC were treated with 
mitomycin C, washed thoroughly and cultured with 10^  allogeneic naive 
T cells/well. After 5 days, 1 p.Ci pH]-thymidine was added to each well. 
Cells were harvested 20 h later. The mean ± SEM of triplicate wells is 
shown for each point.
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Fig. 3.16 HPC-DC and Mo-DC as stimulator cells in an allogeneic 
MLR. Day 12 HPC-DC and day 5 Mo-DC were treated with 
mitomycin C, washed thoroughly and cultured with 10  ^allogeneic 
naïve CD4^ T cells/well. After 5 days, 1 |aCi [^H]-thymidine was added 
to each well. Cells were harvested 20 h later. Each point is the mean 
±SEM of triplicate wells.
Chapter 4 Summary
Introduction
Immature DC in the periphery take up antigen and are induced to migrate 
by maturation factors. These include bacterial products and inflammatory 
cytokines which shut down DC antigen uptake mechanisms and enable 
them to induce T cell proliferation in secondary lymphoid organs. The 
results in this chapter describe the characterisation of DC stimulated via 
CD40 or by bacterial lipopolysaccharide.
Methods
DC generated using methods described in the previous chapter were treated 
with lOpg/ml LPS for 24 h or cultured with L cells transfected with the 
gene encoding human CD40L for 24 h. Changes in cell morphology were 
observed using light microscopy and DC surface molecule expression was 
monitored using flow cytometry. The production of cytokines was 
measured either by ELISA (protein) or RTPCR (mRNA). The ability of DC 
to induce T cell proliferation was measured in MLR.
Results and discussion
DC were activated by LPS and via CD40 stimulation. Morphological 
changes included cell elongation and prominent dendrite formation. Both 
methods of maturation increased the level of costimulatory molecules and 
adhesion molecules on the surface of DC. Thus, DC upregulated their 
ability to stimulate naïve T cell proliferation. In addition, DC treated with 
LPS expressed higher levels of inflammatory cytokines; IL12p40, IL6 and 
ILip. In contrast, CD40 stimulated DC expressed elevated levels of 
IL12p40 and ILIP but did not express IL6.
Chapter 4 Maturation and Activation 
of Human Dendritic Cells in vitro
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Chapter 4 Maturation and Activation of Human Dendritic Cells in vitro
4.1 Introduction
Following the generation and maintenance of dendritic cells in vitro, changes in their 
phenotype as a result of inflammatory stimuli were investigated in this chapter. 
When DC are resting in the interstitium it is important that they do not constitutively 
express inflammatory products which might initiate a cell-mediated immune 
response and put self tissue in danger. The dendritic cell’s response to inflammatory 
stimuli is to move away fi’om the site of infection and enter the draining lymph node 
to activate antigen-specific T cells. Microbial products, inflammatory cytokines and 
cognate interactions with antigen-specific T cells all serve to activate dendritic cells 
(fig. 4.1) and in response, mature dendritic cells upregulate the surface molecules 
and cytokines which are needed to initiate and maximize the T cell response.
Microbial Stimulation
Dendritic cells are considered the sentinels of the immune system and rapidly 
respond to danger signals in the form of microbes and their products. Resting DC 
can be activated by lipolysaccharide (LPS), a cell wall component of Gram negative 
bacteria. Systemic administration of LPS in mice results in the depletion of 
Langerhans cells fi*om the epidermis of the skin and DC fi*om the heart and kidneys 
(Roake et al., 1995). Within the spleen, LPS induces the movement of DC from the 
marginal zone to the T cell area of the periarteriole lymphoid sheath (PALS) (De 
Smedt et ah, 1996; Reis e Sousa et ah, 1997). At the same time, these cells change 
phenotypically into mature DC expressing high levels of MHC class 1 and n, co­
stimulatory molecules: CD80, CD86, CD40, CD58 and the adhesion molecule, 
CD54 (Verhasselt et ah, 1997; De Smedt et ah, 1996; Sallusto et ah, 1995). LPS 
also induces DC to express inflammatory cytokines including 1L6, 1L8, TNFa and 
1L12 (Verhasselt et ah, 1997; Reis e Sousa et ah, 1997) and enhances the ability of 
DC to stimulate naïve and memory allogeneic CD4^ T cells (Verhasselt et ah, 1997;
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De Smedt et al., 1996). A further feature of DC maturation is the downregulation of 
antigen uptake and processing. LPS has been shown to diminish DC 
macropinocytosis, a process by which DC accumulate soluble antigen within MHC 
class n-rich intracellular vesicles. DC capture native antigen using mannose 
receptors and these are also downregulated in the presence of LPS (Sallusto et al.,
1995). Celia et al. (1997) showed that DC expressed large amounts of MHC class II 
molecules but that only a small percentage of this was expressed on the surface of 
the cells. However, surface MHC class n  expression increased dramatically 
following LPS treatment. There was an initial upregulation of synthesis but after 40 
hours, when ftuid-phase pinocytosis and receptor mediated endocytosis decreased, 
intracellular MHC class n  molecules disappeared and the half-life of the remaining 
molecules on the cell surface increased fi’om approximately 10 hours to 100 hours.
In addition to LPS, other microbial products and whole microorganisms themselves 
can induce DC maturation. Administration of soluble antigen from Toxoplasma 
gondii to mice has the same effect as LPS m driving DC from the marginal zone of 
the spleen to the PALS (Reis e Sousa et al., 1997). These activated cells were also 
induced to express lL12p40. DC have also been shown to express 1L12 following 
phagocytosis of Leishmania donovani amastigotes (Gorak et al., 199S) or 
Leishmania major promastigotes (Konecny et al., 1999) or Mycobacterium 
tuberculosis (Henderson et ah, 1997). M.tuberculosis also induced the expression 
of TNFa and DLl, upregulated CD54, CD40, CD80, MHC class I and diminished 
DC phagocytic ability. L. donovani induced the movement of DC from the marginal 
zone of the spleen to the PALS and L.major upregulated MHC class 1 and H, CD80, 
CD86, CDlla,b,c, CD44 and CD54 and enhanced the ability of DC to stimulate 
naïve T cells. When Ghanekar et ah (1996) stimulated human peripheral blood DC 
with mV-1 and herpes simplex virus (HSV), they saw an upregulation of mRNA 
for ILl, 1L6, ILIO, 1L12, GMCSF, TNFa, and IFNy after 4 hours. However, 
cytokine protein levels were only detectable for ILip after HSV stimulation and 
IFNy and 1L6 after HlV-1 stimulation. There was also no change in the level of co­
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stimulatory cell surface molecules. In contrast, other reports have shown that 
microorganisms can inhibit DC activation. HSV infected DC fail to respond to LPS 
maturation (Salio et al., 1999) and measle virus infection inhibits DC allostimulatory 
properties and downregulates IL12 production by DC (Grosjean et a l, 1997; 
Fugier-Vivier et a l, 1997). In addition, erythrocytes infected with the protozoan 
Plasmodium falciparum modulate DC by downregulating their ability to stimulate 
allogeneic T cells (Urban et a l, 1999). In these experiments, DC were cultured with 
P falciparum infected erythrocytes which were removed prior to stimulation of DC 
by LPS. Under these conditions, LPS failed to upregulate MHC and co-stimulatory 
molecules and both primary and secondary allostimulation were inhibited. The 
mechanism for this inhibitory effect is at present unknown but it is another example 
of the way microbes have evolved methods of immune avoidance.
DC can also recognise other microbial ‘danger signals’ which include DNA 
immunostimulatory sequences (ISS) and double stranded RNA. ISS contain two 5’ 
purines, an unmethylated CpG motif and two 3’ pyrimidines which occur at a higher 
frequency in bacterial DNA than mammalian DNA. These sequences have an 
adjuvant effect which has been utihsed in DNA vaccination development. Jakob et 
al (1998) showed that synthetic ohgodeoxynucleotides containing an ISS motif can 
directly activate murine cutaneous DC in vitro by upregulating surface MHC class 
II, CD40 and CD86 and inducing the production of high levels of IL12. Synthetic 
double stranded RNA (polyriboinosinic polyribocytidylic acid) can also induce the 
stable maturation of DC by upregulating MHC class II molecules and co-stimulatory 
molecules and downregulating pinocytosis. These cells also produced high levels of 
IL12 and low levels of ILIO and had an enhanced capacity to stimulate allogeneic T 
cells and present antigen to specific cytotoxic T cells (Verdijk et a l, 1999). Double 
stranded RNA or influenza virus, in addition to inducing DC maturation, protected 
DC from the cytopathic effect of the virus. Double stranded RNA induced the 
expression of IFNa which acts in an autocrine fashion to induce MxA. This protein
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is known to confer cellular resistance to several viruses and is abundantly expressed 
by LPS matured DC as well (Celia et al., 1999).
Activation hy cytokines
Langerhans cell maturation and migration can also be initiated by TNFa and ILlp. 
Systemic administration of anti-TNFa and anti-ILlp prevented the migration of LC 
from the skin in response to a contact allergen (Cumberbatch et ah, 1997). TNFa 
and IL la  both had the same effect as LPS in downregulating MHC class II rich 
compartments but only TNFa treated DC upregulated surface MHC class I and II 
and co-stimulatory molecules (Sallusto et ah, 1995). TNFa also induced the 
migration of DC from the skin, heart and kidneys whereas IL la  only affected renal 
DC (Roake et ah, 1995). These results indicate that some of the effects of LPS on 
DC maturation may be due to its ability to induce TNFa and ILL Roake et ah 
(1995) showed that mice produce serum TNFa in response to LPS and whilst the 
administration of blocking antibodies against the cytokine had no effect on migration 
from the heart or kidney, they were able to inhibit the loss of LC from the skin. 
TNFa has also been shown to synergise with prostaglandin E2 (PGE2) in inducing 
human DC activation in vitro. Cells treated with TNFa alone did not produce IL12 
whilst those treated with PGE2 only expressed small amounts. However, in 
combination, IL12 levels increased dramatically along with an increase in co­
stimulatory molecules and the downregulation of endocytosis. Conversely, PGE2 
had an inhibitory effect on IL12 expression by LPS treated cells indicating that 
PGE2 can play either an enhancing or a diminishing role in inflammation (Rieser et 
ah, 1997).
Crosslinking DC surface molecules
The initial activation signal must be given to DC in the periphery in order for them 
to move into the lymphoid organs and present antigen to T cells. Cognate 
interactions with T cells provide DC with further signals which may maintain their
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mature phenotype. Of particular importance is the receptor-ligand pairing between 
CD40 on the surface of DC and CD40L (CD 154) which is expressed by activated T 
cells. CD40 is a 50kDa glycoprotein belonging to the TNF receptor superfamily. It 
was first identified on B cells and carcinomas but has since been shown to be 
expressed by thymic epithelial cells, monocytes and dendritic cells. CD40 is ligated 
and crosslinked by CD40L, a 39 kDa glycoprotein which is a member of the TNF 
superfamily and expressed by activated T cells. Crosslinking CD40 on B cells is 
essential for T cell dependent B cell activation resulting in proliferation and 
immunoglobulin isotype switching in the presence of different cytokines (Gordon et 
al., 1994). The importance of this receptor-ligand pair is illustrated by sufferers of 
X-linked hyper IgM syndrome who have a mutation in the gene encoding CD40L. 
They make elevated levels of low afihnity IgM antibodies but critically lack 
circulating IgG or IgA and fail to develop germinal centres (Aruffo et al., 1993).
In addition to its role in B cell activation, CD40 crosshnking has been shown to 
stimulate dendritic cells. Caux et al (1994a) crosslinked CD40 on the surface of DC 
generated from CD3 4  ^ progenitor cells using CD40L transfected L cells. This 
induced morphological changes, enhanced DC survival and upregulated cell surface 
MHC class n, CD80, CD86, CD58, CD40. However, from a wide panel of 
cytokines tested CD40 stimulation only induced TNFa and the chemokines IL8 and 
MBP-la. Freshly isolated human epidermal Langerhans cells (LC) spontaneously 
upregulate MHC class H, co-stimulatory and adhesion molecules after two days in 
vitro culture with GMCSF (Péguet-Navarro et al., 1995). Triggering CD40 on the 
surface of these cells resulted in the upregulation of CD54 and CD86 but not MHC 
class II molecules or CD80. This was still enough to enhance the ability of LC to 
stimulate allogeneic T cells and the addition of CD54 and CD86 blocking antibodies 
resulted in the inhibition of LC allostimulatory properties. Anti-CD40 and anti- 
CD40L also had an inhibitory effect in the MLR.
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Kitajima et al. (1996) showed that T cells were able to induce the maturation of DC 
but only in the presence of antigen. They indicated the role of IFNy in the ability of 
T cells to downregulate the phagocytic and adhesive properties of DC whilst 
Macatonia et al. (1995) showed that dendritic cells expressed DL12 when co­
cultured with naïve antigen specific CD4^ T cells and that this directed the 
development of IFNy producing T cells. The mechanisms by which DC are induced 
to express IL12 which ultimately leads to the production of IFNy by T cells was 
elucidated by Koch et al. (1996) and Celia et al. (1996). The latter showed that 
ligation of CD40 on the surface of DC induced high levels of IL12 secretion in 
addition to upregulating surface co-stimulatory molecules. Furthermore, in co­
cultures of DC and T cell clones, IL12 was only detected when specific antigen was 
added. Koch and co-workers found that DC expressed high levels of IL12 when co­
cultured with naïve T cells in an oxidative mitogenesis assay but only after 72 hours. 
The delayed onset of IL12 expression indicated that it is only induced once T cells 
are activated and express a particular surfece molecule. This was proved by adding 
CD40L blocking antibodies which greatly reduced IL12 expression. In the absence 
of T cells, DC responded to anti-CD40 antibodies by producing IL12. Anti-MHC 
class II antibodies were also able to induce DC DL12 production albeit to a lesser 
extent than anti-CD40 but the effect of the two antibodies together was additive. 
This may explain why blocking CD40L in DC-T cell cultures only resulted in partial 
IL12 inhibition, particularly during antigen specific interactions.
Other surface molecules can also induce the maturation of DC when Hgated or 
crosslinked. CD43 is the major sialoglycoprotein expressed on the surfece of DC. 
Its ligand is unknown at present but when CD43 was crosslinked on human 
monocyte derived DC it resulted in the upregulation of HLADR, CD40, ÇÇ^54, 
CD80, CD86 and CD83. ILip, IL6, TNFa, ILIO and ELI2 were also induced and 
DC endocytic activity was downregulated (Corinti et al., 1999). The same effect 
was seen when OX40L was stimulated on the surface of DC using anti-OX40L 
antibodies, although the expression of MHC class I or II was unaffected. OX40L is
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another member of the TNF receptor superfamily and its expression was induced 
when DC were stimulated via CD40 (Ohshima et ah, 1997) 0X40 is the 
physiological ligand for OX40L and is expressed by T cells. OX40L is also 
expressed by activated B cells and its ligation by T cell 0X40 molecules induces 
large amounts of immunoglobulin (Stüber et ah, 1995). Receptor Activator of 
NFkB (RANK) is another member of the TNF receptor superfamily which is 
expressed by DC and upregulated after CD40 stimulation. DC cultured with soluble 
human RANK ligand formed large aggregates, upregulated co-stimulatory 
molecules and increased their allostimulatory capacity by three to ten fold 
(Anderson et ah, 1997). The physiological ligand for RANK is tumour necrosis 
factor related activation-induced cytokine (TRANCE) which is expressed by T cells 
(Wong a/., 1999).
Aims o f chapter 4
In the previous chapter dendritic cells were generated from CD34^ haematopoietic 
precursor cells and phenotypically characterised. This chapter seeks to show that 
these DC can be activated by LPS or via CD40 stimulation in order to enhance their 
capacity to stimulate allogeneic naïve CD4^ T cells. After maturation treatment, 
changes in DC morphology will be observed and the cells examined by flow 
cytometry for changes in surface MHC class I and II and co-stimulatory molecules. 
In addition, the expression of inflammatory cytokines will be analysed by RT-PCR 
and ELISA and the production of nitric oxide, an inflammatory mediator known to 
be expressed by activated macrophages (Stuehr et ah, 1987) and murine dendritic 
cells (Lu et ah, 1996) will be investigated.
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Fig. 4.1 A summary of DC maturation and activation. Immature DC in the periphery are 
activated by microbial products and cytokines. They upregulate co-stimulatory molecules 
and inflammatory cytokines and downregulate antigen uptake and processing. They migrate 
to lymphoid organs and present antigen to T cells where they receive further maturation signals 
via T cell cognate interactions.
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4.2 Results
4.2.1 Morphology o f activated DC
HPC-derived DC were cultured for 11 days and then treated with 1 pg/ml LPS 
for 24 h. LPS-treated cells formed larger clumps than untreated cells (figs. 4.2 
and 4.3). Most clumps adhered to the bottom of plastic plates whilst other 
large aggregates remained non-adherent in culture. DC stimulated with LPS 
became elongated and exhibited stretched dendrites. DC were also activated 
via CD40 using mouse fibroblast L cells that were transfected with the human 
gene encoding CD40L. L cells transfected with the human gene encoding 
CD32 (FcyRl) were used as controls. DC and L cells were cultured together at 
a ratio of 10:1 for 24 h. L cells were incubated with 50 pg/ml mitomycin C for 
one h which inhibited mitotic spindle formation thus preventing the cells from 
proliferating. The morphology of DC co-cultured with CD32 L cells remained 
unchanged (fig. 4.4) whilst DC that formed cognate interactions with CD40L 
L cells were induced to change shape and adhere to the bottom of the plate 
(fig. 4.5). Unlike LPS-activated DC, CD40 activated cells did not become 
elongated but displayed many branched dendrites which extended in a radial 
fashion from the cell bodies.
4.2.2 Allogeneic naïve T cell proliferation induced by activated DC
Naïve (CD45RA^CD45R0 ) CD4^ T cells were isolated from cord blood and 
co-cultured with 12 day old allogeneic DC. Prior treatment with 25 pg/ml 
mitomycin C for 1 h prevented DC proliferation in culture. Cells were co- 
cultured for 5 days and T cell proliferation was measured by tritiated 
thymidine uptake. LPS-treated DC (1 pg/ml) were able to induce greater T cell 
proliferation than untreated DC (fig. 4.6). T cell proliferation peaked when 
LPS-treated DC were at a ratio of 40:1. This was a consistent finding when 
proliferation reached a high level (in this example 45000cpm) and may reflect 
an increase in T cell death as nutrients in the media become exhausted.
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DC activated via CD40 were also able to stimulate T cells to a greater extent 
than DC alone or cells co-cultured with CD32 L cells (fig. 4.7). L cells, treated 
with mitomycin C and seeded at 10^/well, were present throughout the DC-T 
cell co-culture period.
4.2.3 Expression o f surface molecules by activated DC 
Changes in expression of surface molecules by activated DC were analysed 
using flow cytometry. The results are presented as the percentage of cells in 
the suspension which expressed the marker and the level of expression by 
positive cells which is indicated by the median fluorescent intensity. DC at 
day 12 were either stimulated with 1 pg/ml LPS and analysed 24 h later or co- 
cultured for 24 h with CD32 or CD40L L cells. Cells were co-cultured with 
CD32 L cells to ensure that any effect seen by cells cultured with CD40L L 
cells was due to the presence of human CD40L rather than any bystander 
effect.
All the surface molecules associated with T cell activation and proliferation 
were upregulated by DC stimulated by CD40L L cells; the percentage of cells 
expressing CD80 increased from 35% to 57% however, the level of expression 
was low (MFI = 7) and remained unchanged after activation (fig. 4.8A and B). 
Most of the cells expressed CD86 before activation although there appeared to 
be a CD86^' population and a CD86*° population. Following activation the 
CD86^° population diminished whilst the fluorescence intensity of CD86^‘ 
cells increased (fig. 4.8C and D). Similarly, LPS induced the upregulation of 
both CD80 and CD86 (fig. 4.9C, D, E and F). The resting cells in these 
experiments expressed low levels of CD86 and whilst the number of cells 
expressing these molecules increased following LPS activation, the level of 
expression stayed fairly low. LPS treatment increased DC expression of CD80 
by two to fourfold.
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CD40 expression was high on resting DC and although stimulation via CD40 
itself slightly decreased the percentage of cells expressing the molecule (fig. 
4.10A), the intensity of fluorescence doubled (fig. 4.1 OB). LPS activation also 
resulted in a slight decrease in percentage of cells expressing CD40 (fig. 4.9A 
and B) however, levels of expression increased in all experiments. The 
majority of resting DC expressed HLA DR (80 to 94%) (figs. 4.IOC and 
4.11 A) and DC cultured with CD40L L cells showed a marked increase in the 
level of HLA DR although the percentage of positive cells decreased slightly 
after activation (fig. 4.IOC and D). In contrast, the level of HLA DR 
expression by cells treated with LPS gave inconsistent results (fig. 4.11 A and 
B). The majority of experiments resulted in a decrease in both the total 
number of cells expressing HLA DR as well as a decrease in the levels of 
expression by positive cells after LPS treatment. Only one experiment shows 
an increase in the levels of surface expression (fig 4.1 IB). However, it is 
known that DC require high levels of MHC class II molecules on their surface 
after activation in order to present antigen to T cells and if HLA DR levels are 
not increased after LPS activation perhaps other MHC products are just as 
important. For this reason, the effect of LPS on HLA DQ expression was 
examined. It was found in all experiments that the percentage of cells 
expressing this molecule increased by up to threefold (fig. 4.11C) and that the 
level of expression, which is much lower than HLA DR on resting cells, also 
increases (fig. 4.1 ID). However, LPS only upregulated HLA DQ molecules to 
the same levels as HLA DR expression by resting DC.
Both CD40L and LPS stimulation upregulated CD54 expression (fig. 4.12A 
and B and fig. 4.13C and D). The number of positive resting cells was high 
and activation increased this number and the intensity of fluorescence even 
further. LPS also upregulated the adhesion molecule CD44 which was 
expressed by 85 to 100% of resting cells (fig. 4.13E and F). MHC class I
78
molecules (HLA ABC) were expressed by 90 - 97% of resting cells and levels 
of expression doubled when cells were stimulated by CD40L L cells (fig. 
4.12C and D). Between 20 and 50 % of resting DC expressed very low levels 
of CD4 whose fimction on these cells is unknown. Following LPS stimulation 
the number of cells expressing CD4 decreased by over half in each experiment 
(fig. 4.13A) whilst levels of expression by positive cells remained very low 
(fig.4.13B).
Other changes induced by LPS included the upregulation of CD 14. In the 
experiments shown, 20 - 30 % of resting cells expressed CD 14 but this 
percentage was increased by three to fourfold after LPS treatment (fig. 4.14A). 
Levels of CD 14 expression by positive cells also consistently increased, 
dramatically in two of the experiments shown (fig. 4.14B). At the same time, 
the level of CD la  expression by positive cells was unaffected by LPS (fig. 
4.14C) and the percentage of cells positive for the molecule after activation 
was inconsistent; increasing slightly in some experiments and decreasing in 
others (fig. 4.14D). Stimulation of DC via CD40 however, had no effect on 
the expression of either CD14 (fig. 4.15A and B) or CDla (fig. 4.15C and D).
4.2.4 Cytokine expression hy activated DC
DC at day 11 were either stimulated with 1 pg/ml LPS and left for 24 h or co- 
cultured for 24 h with mitomycin C-treated CD32 or CD40L L cells. 
Supernatants were removed and analysed for cytokines by ELISA. RNA from 
DC stimulated with LPS was also extracted and cytokine message analysed by 
RTPCR. DC stimulated with LPS or via CD40 resulted in the upregulation of 
IL12p40 at the protein level (figs. 4.16A and 4.17A) measured by ELISA. LPS 
treatment also upregulated the production of IL6 (fig. 4.16B) and IL ip (fig. 
4.16C) whereas CD40L stimulation upregulated ILip (fig. 4.17B) but failed to 
induce IL6 (data not shown). Resting cells produced only negligible amounts 
of each of these cytokines.
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Reflecting the changes in expression of cytokine protein, LPS also upregulated 
cytokine mRNA. RTPCR reactions were performed at BIBRA according to 
the methods described in Chapter 2 (2.7.2). The housekeeping gene, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was used as a control 
to show that uniform amounts of total RNA were reverse transcribed in each 
experiment. cDNA from a selection of samples was amplified with G3PDH 
primers at different cycle numbers to show that the final cycle number used 
(30) lay on the linear part of the DNA amplification curve (fig. 4.18). IL12p40 
mRNA was undetected in resting cells (fig. 4.19) whereas two out of four 
experiments showed that mRNA for IL6 was present in resting cells (fig. 
4.2GB and D). LPS treatment resulted in the upregulation of both IL6 (fig. 
4.20) and IL12p40 message in all experiments (fig. 4.19).
4.2.5 Nitric oxide production by DC
Mouse macrophages produce nitric oxide (NO) in response to inflammatory 
stimuli which aids them in their microbial-killing activity (Nathan, 1992). 
Mouse DC are known to produce NO under certain conditions including LPS 
and IFNy treatment (Lu et a l, 1996). For these reasons, the ability of activated 
human DC to produce NO was investigated. However, under the conditions 
used in these experiments, human DC were unable to produce significant 
amounts of NO. DC were treated with either 10 ng/ml ELlp or 1 pg/ml LPS or 
10 ng/ml IFNy for 24 h or co-cultured with CD40L L cells for 24 h. The 
supernatants from each experiment were analysed for the presence of nitrite 
(NO^ ), a product of NO, using the Griess assay. Resting DC produced less 
than 1 pM NO2 (below the lowest standard dilution) and none of the above 
treatments were able to induce further N0^‘ production (data not shown).
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4.3 Discussion
Dendritic cells derived from HPC were activated by LPS and via CD40 
stimulation. Although only LPS-treated cells are illustrated here, both 
activation treatments consistently resulted in the formation of large adherent 
clusters which is probably related to the upregulation of the adhesion 
molecules CD54 and CD44 on the DC cell surface. Clustering may be a 
mechanism which gives a large number of DC greater access to a pathogen or 
its products resulting in an increase in endocytosis or pinocytosis. In relation 
to CD40L stimulation which occurs in the T cell areas of the secondary 
lymphoid organs, DC may be induced to cluster in order for T cells to sample 
antigen presented by as many DC as possible. Although both LPS and CD40L 
induced DC clustering, they changed individual cell morphology in different 
ways. LPS induced very long thin dendrites with many branches extending 
from an elongated cell body. In contrast, DC stimulated via CD40 expressed 
larger numbers of shorter dendrites, mainly unbranched and extending radially 
from a round cell body. The differences in morphology may reflect the effect 
of each type of activation stimuli in vivo. LPS induces DC to migrate from the 
periphery to the secondary lymphoid organs and this may require long, 
stretched out dendrites to sensitively and quickly sample the surrounding 
milieu for chemokine gradients. However, CD40 stimulation by T cells 
probably only takes place once DC have arrived in the lymph node and, as 
they are thought to remain there until death, their rounded morphology and 
large numbers of short dendrites are perhaps more suited to non-migration and 
efficient antigen presentation to T cells.
Both LPS and CD40-activated DC were able to stimulate allogeneic naïve T 
cell proliferation to a greater extent than untreated cells or cells co-cultured 
with CD32L cells. Their enhanced allostimulatory capacity may have been due 
to the upregulation of MHC and co-stimulatory molecules on the surface of
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the cells. CD40L activated DC upregulated both MHC class I (HLA ABC) and 
class n  (HT .A DR) molecules. In contrast to published data on monocyte- 
derived DC (Sallusto et al., 1995; Verhasselt et al., 1997), LPS treatment not 
only failed to increase HLA DR expression but actually slightly diminished it. 
The reason for this is unclear but may be due to shedding of molecules either 
during the culture period or perhaps during flo^v cytometry staining. However, 
the failure to upregulate HLA DR did not effect enhanced allostimulatory 
capacity probably because of compensation by HLA DQ which was 
upregulated by LPS.
DC activated with CD40L or LPS upregulated CD80 (B7.1) and CD86 (B7.2), 
both important co-stimulatory molecules which bind to CD28 and CTLA-4 
(cytotoxic T lymphocyte antigen-4) expressed by T cells. When the T cell 
receptor is engaged, B7 molecules bind to CD28 which results in the 
expression of IL2, upregulation of IL2 receptors and consequent T cell 
proliferation. Activated T cells upregulate CTLA-4 which has a higher affinity 
than CD28 for CD80 and CD86 and downregulates the response and can also 
induce anergy (McAdam et al., 1998). LPS and CD40L also upregulated 
ICAM-1 (CD54) which binds to leukocyte fimction antigen-1 (LFA-1); an 
integrin expressed by T cells, monocytes and dendritic cells. The interaction 
between LFA-1 expressed by T cells and ICAM-1 expressed on vascular 
endothelium is essential for lymphocyte homing. The interaction may also be 
important in the clustering of DC and T cells in the T zones of secondary 
lymphoid organs. However, in addition to its role in adhesion, ICAM-1 
expressed by DC may play a part in co-stimulation. Péguet-Navarro et al. 
(1995) showed that the addition of anti-CD54 blocking antibodies to an 
allogeneic MLR inhibited T cell proliferation. This may be because blocking 
ICAM-1 :LFA-1 prevents the necessary cellular contact between DC and T 
cells or it may be because it stops CD54 delivering a co-stimulatory signal to 
T cells.
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In addition to co-stimulatory molecule upregulation, LPS stimulation also 
induced other changes in DC surface phenotype. In contrast to the data 
published by Caux et al. (1994a) the expression of CDla, the Langerhans cell 
marker was unaffected by CD40L stimulation but downregulated by LPS 
treatment. LC have been reported to lose CDla expression when they mature 
in vitro (Teunissen et al., 1990) and the results observed herein may reflect the 
changes in Langerhans cells in vivo as they migrate from the periphery in 
response to inflammatory stimuli and lose their immature phenotype. Whilst 
CD40L stimulation had no effect on the low level of CD 14 expressed by 
resting DC, LPS treatment upregulated it. LPS binds to a protein in serum and 
the complex then binds to CD 14 (Ulevitch, 1995). This membrane receptor is 
expressed by monocytes and macrophages (Ulevitch, 1995) and not reported 
to be present on the surface of mature dendritic cells whether they are derived 
from peripheral blood monocytes or CD34^ HPC (Caux and Banchereau, 
1996) . As discussed in the previous chapter, some of the cells used in the 
experiments reported here may have diverged along the macrophage pathway 
after differentiation with GMCSF and TNFa which may explain the presence 
of CD 14 on the surface of a small percentage of cells. However, after 
stimulation with LPS, the majority of the cells upregulated the molecule. This 
may be a positive feedback mechanism whereby LPS stimulates the 
expression of its own receptor. If dendritic cells do not express CD 14, the 
question is how does LPS activate them? P2 integrins (CD11/CD18) have 
been reported as LPS receptors (Flaherty et al., 1997) and these are expressed 
on the surface of DC. Alternatively, Verhasselt et al. (1997) reported that 
CD 14 exists as a soluble form in plasma and is crucial for mediating the 
effects of LPS on DC. However, these experiments used monocyte-derived 
DC and not those derived from CD34^ HPC which may explain the 
differences between their results and those reported here, although CD 14
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shedding may occur at a later time point than the 24 hours after LPS treatment 
shown in the results of this chapter.
Resting DC aheady expressed high levels of surface CD40 but LPS and 
CD40L treatment upregulated the molecule further. This may be in order to 
potentiate IL12 expression. Since both LPS and CD40L induced high levels of 
IL12p40, it could be argued that the cytokine is required both in the initial 
response to inflammatory stimuli and then later on during T cell activation. 
LPS in the periphery may induce the expression of XL 12 by DC in order to 
activate other inflammatory players such as natural killer cells. They respond 
to IL12 by producing IFNy which activates macrophages, inducing nitric oxide 
and further IL12 production (Trinchieri, 1995). Mature DC expressing high 
levels of CD40 arriving in the T zone are given a fiirther signal to produce 
IL12 via CD40L on activated T cells. The IL12 expressed at this stage plays a 
role in developing a Thl response (Macatonia et al., 1995). It is also now 
emerging that ELI2 acts on DC in an autocrine fashion, stimulating further 
IL12 expression (Grohmann et al., 1998) and acting as an adjuvant for the 
presentation of tumour peptides (Bianchi et al., 1999).
Both LPS and CD40L were able to stimulate ILip expression fi*om DC but 
only LPS could induce EL6 expression. These two cytokines are central to 
inflammatory responses, influence B and T cell function and, in the case of 
IL6, direct haematopoiesis (Salmon et al., 1996). In accordance with other 
studies (Zhou et ah, 1995; de Saint-Vis g/ al., 1998) EL6 mRNA could be 
detected in resting cells. Since LPS but not CD40 stimulation is able to 
upregulate IL6, it is likely that this cytokine plays a role in the initial stages of 
the immune response rather than during DC-T cell interactions.
Nitric oxide (NO) is an important inflammatory mediator expressed by 
activated mouse macrophages and possibly human macrophages/monocytes
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(Nathan, 1992; Dugas et al., 1995). It is also known to be expressed by mouse 
dendritic cells in response to IFNy, LPS and allogeneic T cells (Lu et al.,
1996) and has been indicated in T helper cell differentiation (Liew et a l, 
1991). In contrast to Huang et al. (1999) the results reported here show that 
neither LPS, IFNy, ILip or CD40L stimulation can induce NO expression by 
human DC. However, Huang et al. (1999) isolated DC from peripheral blood 
rather than generating them in vitro which may explain the differences. They 
showed that DC expressed inducible NO synthase (the enzyme which converts 
L-arginine to NO and L-citrilline) and that they spontaneously produced large 
amounts of NO. Others have shown that NO is only expressed by human DC 
in disease states such as primary biliary cirrhosis (Yamamoto et al., 1998) and 
hepatocellular carcinoma (Ninomiya et al., 1999). It may be that some DC 
subtypes are capable of expressing NO at different stages of maturation or 
under certain conditions which could contribute to an inflammatory response.
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Fig. 4.2 Day 12 HPC-DC in culture medium containing 
50 ng/ml GMCSF and 10 ng/ml TNFa. Light microscope. 
Magnification; x 200
Fig. 4.3 Day 12 HPC-DC in culture medium containing 
50 ng/ml GMCSF and 10 ng/ml TNFa. DC were treated 
with 1 pg/ml LPS for 24 h. Light microscope. 
Magnification: x 100
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Fig. 4.4 HPC-DC and CD32 L cells in culture medium containing 
50 ng/ml GMCSF and 10 ng/ml TNFa. On day 12, 10^  DC were 
mixed with 10"^  mitomycin C-treated CD32 L cells in each well. 
Cells were cultured together for 24 h. Light microscope. 
Magnification: x 400
Fig. 4.5 HPC-DC and CD40L L cells in culture medium containing 
50 ng/ml GMCSF and 10 ng/ml TNFa. On day 12, 10  ^DC were 
mixed with 10"^  mitomycin C-treated CD40L L cells in each well. 
Cells were co-cultured for 24 h. Light microscope. Magnification: x 
400.
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Fig. 4.6 Allogeneic T cell stimulation by LPS activated DC. Untreated DC 
or DC treated with 1 jig/ml LPS for 24 hours were cultured with 10^  
allogeneic naïve CD4^ T cells/well. After 5 days, 1 |iCi [^H]-thymidine 
was added to each well and cells harvested 20 h later. Each point 
represents the mean of triplicate wells ± SEM.
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Fig. 4.7 Allogeneic T cell stimulation by CD40 activated DC. DC were 
either cultured alone (blue) or with 10^  CD40L L cells/well(red) or CD32 L 
cells/well (green). To each well, 10^  allogeneic naïve CD4 T cells were 
added. After 5 days, 1 pCi pH]-thymidine was added to each well and cells 
harvested 20 h later. Each point represents the mean of triplicate wells ± 
SEM.
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Fig. 4.8 Expression of surface CD80 (A and B) and CD86 (C and D) by DC at day 12. 
DC were cultured at 10  ^/well plus 10^  L cells/well for 24 h. DC were cultured with 
either CD32 L cells (red) (A and C) or CD40L L cells (green) (B and D). DC cultured 
in the absence of L cells are represented by blue histograms. Surface expression was 
analysed by flow cytometry. The percentage of positive cells and their median 
fluorescent intensity (MFI) are indicated. Background fluorescence was measured 
using a non-specific isotype matched antibody was used as a negative control (black).
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Fig. 4.9 Surface expression of CD40 (A and B), CD80 (C and D) and CD86 
(E and F) by DC on day 12. DC were either untreated (blue) or treated with 
1 pg LPS for 24 h (red). The percentage of positive cells (A, C and E) and 
the median fluorescent intensity (MFI) (B, D and F) were analysed by flow 
cytometry. Three separate experiments are shown.
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Fig. 4.10 Expression of surface CD40 (A and B) and HLADR (C and D) by 
DC at day 12. DC were cultured at 10  ^/well for 24 h with 10  ^L cells/well.
Blue histograms represent DC cultured without L cells. Red histograms represent 
DC cultured with CD32 L cells (A and C) and DC cultured with CD40L L cells 
are shown in green (B and D). Surface expression was analysed by flow 
cytometry. The percentage of positive cells and their median fluorescent intensity 
(MFI) is indicated. A non-specific isotype matched antibody was used as a 
negative control (black).
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Fig. 4.11 Surface expression of HLADR (A and B) and HLADQ (C and D) 
by DC on day 12. DC were either untreated (blue) or treated with 1 |ag LPS 
for 24 h (red). The percentage of positive cells (A and C) and the median 
fluorescent intensity (MFI) (B and D) were analysed by flow cytometry. 
Three separate experiments are shown.
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Fig. 4.12 Expression of surface CD54 (A and B) and HLAABC (C and D) by DC 
at day 12. DC were cultured at 10  ^/well with 10  ^L cells/well for 24 h. DC were cultured 
with either CD32 L cells (red histograms) (A and C) or CD40L L cells (green 
histograms) (B and D). DC cultured without L cells are represented by blue histograms. 
Surface expression was analysed by flow cytometry. The percentage of positive cells and 
the median fluorescent intensity (MFI) are indicated A non-specific isotype matched 
antibody was used as a negative control (black).
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Fig. 4.13 Surface expression of CD4 (A and B), CD54 (C and D) and CD44 
(E and F) by DC on day 12. DC were either untreated (blue) or treated with 
1 |ig LPS for 24 h (red). The percentage of positive cells (A, C and E) and 
the median fluorescent intensity (MFI) (B, D and F) were analysed by flow 
cytometry. Three separate experiments are shown.
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Fig. 4.14 Surface expression of CD14 (A and B) and CDla (C and D) by DC 
on day 12. DC were either untreated (blue) or treated with 1 pg LPS for 24 h 
(red). The percentage of positive cells (A and C) and the median fluorescent 
intensity (MFI) (B and D) were analysed by flow cytometry. Three separate 
experiments are shown.
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Fig. 4.15 Expression of surface CD 14 (A and B) and CDla (C and D) by DC on day 12 
DC were cultured at 10  ^/well with either lOVwell CD32 L cells (red) (A and C) or 
10^/well CD40L L cells (green) (B and D) for 24 h. Blue histograms represent DC 
cultured without L cells. Surface expression was analysed by flow cytometry. The 
percentage of positive cells and the median fluorescent intensity (MFI) are indicated. A 
non-specific isotype matched antibody was used as a negative control (black).
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Fig. 4.16 Cytokine expression by LPS-activated DC. DC were either 
untreated or treated with 1 (xg/ml LPS for 24 h. Supernatants were 
analysed by ELISA for IL12p40 (A), IL6 (B) and IL1(3 (C). Results are 
shown as the mean of four separate experiments ± SEM.
ND = not detected.
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Fig. 4.17 Cytokine expression by CD40 activated DC. DC were either 
cultured alone or cultured with CD40L L cells or CD32 L cells for 24 
h. Supernatants were analysed by ELISA for IL12p40 (A) or 
ILip (B). Bars represent the mean of three separate experiments ± SEM. 
ND = not detected.
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Fig. 4.18 G3PDH cDNA was amplified at 20, 25, 30, 35 
and 40 cycles. G3PDH primers gave a cDNA product of 
452bp.
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Lane Product
1. IL 12p40 (untreated DC)
2. IL12p40 (LPS-treated DC)
3. G3PDH (untreated DC)
4. G3PDH(andIL6)
(LPS-treated DC)
B
1.
2.
3.
4.
IL12p40 (untreated DC) 
IL12p40 (LPS-treated DC) 
G3PDH (untreated DC) 
G3PDH (LPS-treated DC)
SOObp
300bp
1. IL12p40 (untreated DC)
2. IL12p40 (LPS-treated DC)
3. G3PDH (untreated DC)
4. G3PDH (LP S-treated DC)
SOObp
300bp
Fig. 4.19 Expression of IL12p40 mRNA measured by RTPCR. RNAwas extracted 
at day 12 from untreated DC or DC treated with 1 pg/ml LPS for 24 h. G3PDH 
primeis were used as a quantitative control giving a cDNA product of 452 base pairs. 
IL12p40 primers gave a cDNA product of 296 base pairs. All products were amplified 
to 30 cydes and electrophoresed on an agarose gel with a 100 base pair DNA ladder. 
Three separate experimmts are shown (A, B and Q .
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Lane Product A
1. IL6 (untreated DC)
2. IL6 (LPS-treated DC)
3. IL6 (+ control)
4. G3PDH (untreated DC)
S. G3PDH (LPS-treated DC - - M
B
1. IL6 (untreated DC)
2. IL6 (LPS-treated DC)
3. IL6 (+ control)
4. G3PDH (untreated DC)
5. G3PDH (LP S-treated DC
SOObp
lOObp
1. IL6 (untreated DC)
2. IL6 (LPS-treated DC)
3. G3PDH (untreated DC)
4. G3PDH (LP S-treated DC)
5. IL6 (+ control)
SOObp
lOObp
1. IL6 (untreated DC)
2. IL6 (LPSTreated DC)
3. IL6 (+ control)
4. G3PDH (untreated DC)
5. G3PDH (LP S-treated DC)
Fig. 4.20 Expression ofIL6 mRNA measured by RTPCR. RNA was extracted at day 12 
from untreated DC and DC treated with 1 pig/ml LPS for 24 h. G3PDHprimers were 
used as a quantitative control giving a cDNA product of 452 base pairs. IL6 primers gave 
a cDNA product of260 base pairs. All products were amplified to 30 cycles and 
electrophoresed on an agarose gel with a 100 base pair DNA ladder. Four separate 
expQ-iments are shown (A, B, C, and D).
Chapter 5 Summary
Introduction
A well known feature of mature DC is their ability to drive the development 
of Thl responses. This is due to the high levels of IL12 they express in 
response to maturation factors such as bacterial or viral products. However, 
since DC are the only antigen presenting cells capable of initiating primary 
immune responses, there is great interest in the factors which may induce 
DC to direct Th2 responses. The results in this chapter describe treatments 
of DC which modulate their effect on CD4^ T cell cytokine expression. 
Methods
DC were treated with EL4, dexamethasone or house dust mite extract for 
24h. Cytokine expression was analysed by ELISA or RTPCR. The effect of 
house dust mite extracts on DC gene expression were examined using a 
cDNA array. To study the effect of DC treatments on T cell cytokine 
profiles, DC were washed and then incubated with naïve CD4^ T cells with 
or without CD40L L cells. After 5 days, T cells were removed and 
restimulated with ionomycin and PMA. After 24h, supernatants were 
analysed for the presence of cytokines by ELISA.
Results and discussion
CD40-activated DC treated with IL4 and dexamethasone were unable to 
induce the same levels of IFNy expression from CD4^ T cells as untreated 
DC. This was probably due to the inhibitory effect of IL4 and 
dexamethasone on CD40-induced IL12 expression by treated DC. Neither 
treatments affected the ability of DC to stimulate naïve T cell proliferation. 
However, HDM-treated DC were also unable to induce high T cell IFNy 
expression but their ability to express IL12 following CD40 stimulation 
remained unaffected. HDM failed to change expression of surface 
molecules or inhibit T cell proliferation. HDM did not induce DC 
expression of anti-inflammatory cytokines such as ILIO, IL13, IL4 or 
TGF(3. cDNA array analysis did not detect differential gene expression 
between HDM treated DC or untreated DC. However, the expression of 
some genes were detected on the arrays which have not been previously 
described in dendritic cells.
Chapter 5 Modulation of T Helper 
Cell Phenotype by Dendritic Cells
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Chapter 5 Modulation of T Helper Cell Phenotype by Dendritic Cells
5.1 Introduction
Since dendritic cells initiate primary immune responses, it is necessary that 
they make a response that is appropriate for the elimination of different types 
of invading pathogens. They are predominantly known for their ability to 
induce type 1 cytokines in inflammatory responses but little is known of their 
ability to induce the Th2 differentiation that is required for anti-inflammatory 
responses and protection against helminths.
DC express IL12 and influence the development o f Thl cells 
Ellis et al. (1991) in human in vitro studies and Ronchese et al. (1994) in 
mouse in vivo studies showed that DC could prime T cells for the expression 
of both 1L4 and IFNy. However, Macatonia and colleagues (1995) were the 
first to show that dendritic cells produce IL12 when cultured with antigen- 
specific T cells and that this cytokine was responsible for the induction of 
IFNy expression by CD4^ naive T cells. In the absence of T cells DC 
expressed very little IL12, an observation also made by Koch et al. (1996) and 
Ria et al. (1998). Koch et al. showed that crosslinking of CD40 molecules was 
required for IL12 production by DC and that simultaneously crosslinking 
MHC class n  molecules synergistically enhanced IL12 production although 
crosslinking MHC molecules alone had little effect. Ria et al. (1998) observed 
the necessity for antigen to induce IL12 expression by DC and consequent 
IFNy secretion by T cells. In keeping with the results of Celia et al. (1997), 
Hilkens et al. (1997) observed IL12 expression from LPS-treated DC. 
However, unlike Koch et al. and Macatonia et al. they were unable to detect 
high IFNy expression from antigen-specific naive T cells when presented with 
antigen by untreated DC unless the T cells has been previously activated by 
superantigen (Staphylococcal enterotoxin A). Their DC induced low but equal
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amounts of IL4 and IFNy from responding CD4^ T cells and they concluded 
that in the absence of inflammatory stimuli, DC require T cell derived IFNy in 
order to secrete IL12. Hov^ever, Hilkens et al. were unable to induce IL12 
secretion from their DC by CD40 stimulation alone, an observation which has 
subsequently been shown many times and may account for the differences 
between their results and those of other researchers. Numbers of stimulating 
DC may also have an effect on responding T cell phenotype. Ohshima et al. 
(1997) found that DC at low density induced ThO cells expressing small 
amounts of hoth IL4 and IFNy whereas higher DC numbers induced a 
polarised Thl response which could be abrogated with the addition of anti- 
CD40L antibodies and CTLA-4Ig, a fusion protein which blocks interactions 
of CTLA4 with B7 molecules (CD80 and CD86). Blocking CD80 expression 
has also been shown to inhibit Thl differentiation induced by Langerhans cells 
(Ozawa et a l, 1996). This fits with the observations by Kuchroo et al. (1995) 
that CD80 is required for driving Thl responses whereas CD86 induces Th2 
cells, and De Becker et al. (1998) who showed that blocking CD86 on 
stimulating DC inhibited IL4 and enhanced IFNy expression by responding T 
cells.
Cytokines modulate DC function: effects on T helper cell differentiation 
The ability of DC to drive T helper cell differentiation may be influenced by 
the cytokines present during DC maturation in the periphery or in the T zones 
of secondary lymphoid organs where DC present antigen to T cells and where 
Thl or Th2 phenotypes are thought to develop (Toellner et a l, 1998). ILIO is 
expressed by Th2 cells and is known to have anti-inflammatory properties 
probably due to its ability to downregulate IL12 production by dendritic cells 
(Koch et a l, 1996; De Smedt et a l, 1997; Liu et a/., 1998). DC treated with 
ILIO stimulated naive T cells to express IL4 and ILIO but little IFNy or IL2 
and the addition of recombinant IL12 or neutralising anti-CD86 antibodies to 
these cultures blocked IL4 and enhanced IFNy expression hy T cells (Liu et
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a l, 1998). De Smedt et a l  (1997) also showed that ILIO treated DC induced 
Th2 polarisation. In contrast, Steinbrink et a l  (1997) found that immature DC 
treated with ILIO subsequently induced T cell anergy rather than a Th2 
response. However, following maturation with ILip, IL6 and TNFa, DC were 
no longer able to respond to ILIO to induce T cell anergy. Th2 cells have been 
shown to inhibit IL12 expression by DC but not because of the ILIO they 
secrete; addition of neutralising anti-ILlO antibodies to DC-Th2 cultures failed 
to increase IL12 secretion by DC (Ria et a l, 1998). Other factors produced by 
Th2 cells may be responsible including IL4 which has been shown to inhibit 
IL12 secretion by DC stimulated by anti-CD40 antibodies or allogeneic T cells 
(Koch et a l, 1996). Also, EL12 expression by mouse bone marrow derived DC 
generated in the presence of IL4 was diminished following LPS and IFNy 
stimulation. Compared to DC generated in the absence of IL4, these cells 
induced lower levels of IFNy and higher levels of IL4 and IL5 from 
responding T cells (Sato et a l, 1999). Other soluble mediators capable of 
inhibiting IL12 production by DC include prostaglandin Ei (PGEi) which 
induced DC to promote T cells that secreted high levels of IL4 and IL5 and 
lower levels of IFNy. PGE2 treated DC also expressed ILIO after stimulation 
with LPS or SAC (Staphylococcus aureas Cowan strain 1) which may account 
for their ability to induce Th2 cells (Kalinski et a l, 1997). Type 1 interferons 
are expressed by leukocytes and fibroblasts and are involved in anti-viral 
responses (Janeway and Travers, 1994). When DC were cultured with IFNp 
during maturation (Bartholomé et a l, 1999) or within T cell stimulation 
assays (McRae et a l, 1998) they failed to upregulate IL12 expression and 
induced T cells to produce more ILIO (McRae et a l, 1998) and less IFNy.
Residential site o f  DC influences the development o f  Thl or Th2 cells 
DC influence on Th2 development may be regulated by factors other than 
those which inhibit IL12 expression by DC. DC themselves have recently been 
shown to express low levels of IL4 when infected with the retrovirus Rauscher
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leukaemia virus (RLV) but the effect of IL4 secreted by DC on developing T 
helper cell phenotypes was not examined (Kelleher et al., 1999). Certain DC 
subtypes have also been reported to express IL13 mRNA following PMA- 
ionomycin stimulation (de Saint-Vis et al., 1998) but neither the IL13 protein 
nor the mRNA have been detected in more physiological conditions.
A number of different subtypes of DC have been identified over recent years 
and the specific tissue in which they reside may play a role in influencing 
whether they direct a Thl or a Th2 response. Immune responses at mucosal 
sites are known to be Th2 dominated which may account for oral tolerance in 
the gut and tolerance to non-pathogenic airhome antigen in the respiratory 
tract (Stumbles, 1999). DC which reside in these particular sites are pre­
disposed to induce Th2 responses (Stumbles et al., 1998). Freshly isolated rat 
lung DC expressed low levels of MHC class II and co-stimulatory molecules 
and were highly endocytic. They expressed ILIO mRNA and were able to 
induce IL4 producing T cells and IgGl but not IgG2b. Following maturation 
of DC by GMCSF, surface co-stimulatory molecules were upregulated, 
endocytosis was downregulated and production of high levels of EFNy from 
responding T cells and production of both IgGl and IgG2b were induced. 
Mature DC also expressed less ILIO mRNA and more IL12p35 mRNA. The 
IL12p40 subunit, however, was niore highly expressed in freshly isolated DC 
than mature DC and was actually downregulated on exposure to GMCSF. It 
would be interesting to know how this relates to the expression of biologically 
active IL12p70 by resting and mature lung DC. DC from Peyer’s patches in 
the gut also induce Th2 differentiation. T helper cell responses to antigen 
presented by DC freshly isolated from mouse Peyer’s patches (PP) or the 
spleen were compared. PP DC were able to induce IL4, ILIO and low levels of 
IFNy from responding T cells whereas spleen DC induced much higher levels 
of IFNy, lower levels of IL4 and no ILIO. The cytokine profile of each of these 
DC types may be responsible for their different T cell activating properties.
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Higher levels of TGFp mRNA could be detected in PP DC than in spleen DC 
and the addition of anti-TGFp antibodies to PP DC-T cell cultures resulted in 
enhanced IFNy production. Neutralising ILIO within these cultures brought 
IFNy levels back up to those induced by spleen cells and CD40L stimulation 
induced ILIO expression by PP DC but not by DC from the spleen (Iwasaki et 
a l, 1999).
DC o f different lineage direct the development o f distinct T cell subsets 
In addition to the site of residence influencing the decision of DC to skew T 
helper cell responses, DC lineage may also play a role. It is known that DC 
can be generated in vitro from myloid progenitor cells under the influence of 
GMCSF and mouse DC with a myloid heritage expressing CDl lb  and CDl Ic 
have been shown to reside in the marginal zones of the spleen (Pulendran et 
a l, 1997). In mice, a subset of cells which reside in the T zones of secondary 
lymphoid organs have been identified as lymphoid DC and express C D llc, 
low levels of CDl lb  and the pre-TCR homodimer CD8a. These cells are 
thought to develop in the thymus from a T cell precursor (Ardavin et a l, 
1993) and have been indicated in deletional tolerance due to their ability to 
kill T cells via CD95L (Suss et a l, 1996). Recently, mouse myeloid and 
lymphoid-related DC have heen shown to differ in their capacity to induce 
Thl or Th2 responses. Maldonado-Lopez et a l  (1999) showed that myeloid- 
derived CD8a DC and lymphoid-derived CD8a^ DC from the spleen were 
equally able to induce T cell proliferation but that CD8a DC induced T cells 
to express high levels of IL4, IL5 and ELIO, and low levels of IL2 and EFNy. 
On the other hand, CD8a^ DC induced a Thl response. These differences 
were related to IL12 expression as CD8a^ DC produced much larger amounts 
than CD8a" DC following stimulation hy pansorbin, EFNy and GMCSF. 
CD8a^ DC isolated from ELI2 deficient mice also failed to induce high levels 
of EFNy from responding T cells. Similarly, Pulendran et a l  (1999) found that 
only myeloid-derived DC were able to induce EL4 and ELIO production from T
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cells but they observed comparable levels of IFNy and IL2 induced by the two 
subtypes. They also injected Flt3L into mice which expands the lymphoid- 
derived DC population or GMCSF which expands myeloid-derived DC. Flt3L 
treatment induced high IgG2a and low IgGl production indicating a Thl 
response whereas GMCSF led to a Th2 response with the production of high 
IgGl and weak IgG2a levels. In addition to expressing IL12, Ohteki et al 
(1999) observed that CD8a^ DC cultured for 3 days with IL12 could produce 
IFNy thus amplifying the Thl response induced by these cells. However, a 
subsequent report showed that antigen-pulsed CD8a^ DC injected into mice 
do not migrate to the draining lymph node despite their ability to induce the 
same level of T cell proliferation as CD8a’ DC (Smith et al., 1999). Reasons 
for their absence are unclear but they may transfer their antigen to other host 
or donor CD8a DC, a phenomenon which has heen observed between 
allogeneic DC in vitro (Bedford et al.,1999) and may also account for the 
ability of DC to cross-present MHC class I antigens (Inaba et al., 1997 ).
DC also derive from another cell type found in human blood and tonsils. This 
is the CD4^CD3"CD 11c" plasmacytoid T cell which develops into dendritic 
cells following treatment with IL3 (Grouard et al., 1997). These DC have 
recently been identified as interferon type 1 producing cells (IPC) in the blood 
(Siegal et al., 1999) and play a dual role in the immune system in that they 
bridge innate and adaptive immunity depending on their maturation state. 
Following stimulation with CD40L, IPC/DC downregulate their type 1 
interferon expression and develop into DC which can stimulate T cells to 
proliferate and express type 2 cytokines (Rissoan et al., 1999). These cells 
have been designated DC2 and in comparison with monocyte-derived DC 
cultured in GMCSF and EL4 and designated DCl, they failed to express 
elevated IL12 levels following CD40 stimulation. Th2 induction by DC2 
appears to be independent of IL4 since blocking IL4 in DC-T cells cultures 
fails to affect T cell IL4 expression. Addition of recombinant IL12 induces
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IFNy expression but, again, has no effect on IL4 levels. The ability to induce 
IL4 was not shown to be a default position in the absence of EL 12 because T 
cells stimulated by anti-CD3 and anti-CD28 antibodies failed to express IL4. 
The Th2 inducing properties of DC2 are unclear but may be due to other 
cytokines or particular cell surface molecules selectively expressed by DC2 
but not DCl.
Aims o f  Chapter 5
In the previous chapter DC generated from HPC were stimulated by CD40L 
and LPS and shown to express elevated levels of certain co-stimulatory 
molecules, inflammatory cytokines and enhance allogeneic naive CD4^ T cell 
proliferation. In this chapter, the ability of DC to direct a Thl or Th2 response 
will be examined. Firstly, the cytokine profile of naive allogeneic CD4^ T 
cells stimulated by DC activated either with LPS or with L cells transfected 
with the gene encoding CD40L will be studied. Secondly, the effects of IL4, 
ILIO, the synthetic glucocorticoid dexamethasone or house dust mite extract 
on expression by DC of cytokines and surface molecules, particularly those 
which downregulate inflammatory responses and/or influence Th2 
development, will be examined. IL4 and ILIO are both expressed by Th2 
cells. ELIO is known to have anti-inflammatory properties and IL4 is the major 
Th2 polarising cytokine. Dexamethasone is an immunosuppressive drug used 
to treat skin inflammation and rheumatoid arthritis. Furthermore, the response 
of dendritic cells will be examined in relation to allergens that cause asthma. 
Since little is known about how allergens disrupt immune regulation in atopic 
individuals and induce a polarised Th2 response, the effects of treating DC 
with house dust mite (Dermatophagoides sp.) and the effect of the DC on 
responding allogeneic naive CD4^ T cell cytokine expression will be 
investigated. The effect of these treatments on the ability of DC to stimulate 
allogeneic T cell proliferation will be studied and any changes in DC surface 
molecules or cytokine expression will be examined. Further investigation of
108
the effect of house dust mite extract on DC function will be performed using a 
cDNA gridded array. This will enable a comparison of inflammatory gene 
expression between untreated DC and DC treated with house dust mite 
extract.
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5.2 Results
5.2.1 Effects o f  LPS and CD40-activated DC on cytokine production by CD4^
T cells
In the previous chapter DC exposed to 1 pg/ml LPS for 24 h were shown to be 
activated. The data in fig. 5.1 shows that the outcome of this activation was 
the production of IFNy by allogeneic naive CD4^ T cells. Resting DC induced 
very little IFNy or IL4 release from naive T cells and LPS-treated DC induced 
the upregulation of IFNy but not IL4 by T cells (fig. 5.1). DC stimulated by 
CD40L L cells also induced T cells to release IFNy (fig. 5.2) but their effect 
on IL4 production by T cells was variable with one experiment out of three 
showing that CD40 activated cells inhibited T cell IL4 production (fig. 5.3).
5.2.2 The effect o f  IL4 on the ability o f CD40-activated DC to upregulate 
IFNy production by CD4^ cells
DC treated with 10 ng/ml IL4 for 24 h were thoroughly washed before 
addition to naïve T cell cultures. Upon restimulation with PMA and 
ionomycin, T cells which had been cultured with EL4-treated DC and CD40L 
L cells failed to upregulate IFNy production (fig. 5.2) and this effect was 
shown to be dependent on the IL4 concentration (fig. 5.4). T cells stimulated 
by IL4-treated DC or untreated DC in the absence of L cells produced little or 
no IFNy. As shown in figure 5.3, the effect of IL4-treated DC on IL4 
production by T cells was inconsistent. In two out of three experiments IL4- 
treated DC inhibited IL4 production by T cells both in the presence or absence 
of CD40L L cells whereas one experiment (no. 2) failed to show any effect. 
Since treating DC with IL4 before CD40 activation appeared to prevent them 
from inducing T cell IFNy production, the effect of IL4 treatment on IL12 
expression hy activated DC was examined. DC were cultured with 10 ng/ml 
IL4 for 24 h and then stimulated with CD40L L cells for a further 24 h. The 
ability to upregulate IL12p40 production following CD40 stimulation was
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inhibited in cells treated with IL4 (fig. 5.5). Furthermore, this inhibition was 
concentration dependent showing that IL4 at 10 ng/ml could inhibit but not 
abrogate the induction Of IL12p40 by CD40L activated DC (fig. 5.6). This 
might account for the inhibition but not the abrogation of IFNy production by 
responding T cells. Very little or no IL12p40 was detected in the supernatants 
of cultures containing DC treated without CD40L L cells or DC cultured with 
CD32L cells as negative controls for the CD40L L cells. Any effects on EL4- 
treated DC surface molecule expression which may be responsible for the 
above effects on T helper cell cytokine expression was examined by flow 
cytometry. IL4 treatment had a slightly inhibitory effect on CD40, CD86 and 
CD54 expression and slightly enhanced CD80 expression. However, the only 
appreciable change was the upregulation of HLA DR expression. 
Approximately 90% of both untreated and IL4-treated DC expressed fairly 
low levels of HLA DR but following IL4 treatment, the intensity of expression 
increased almost four-fold (fig. 5.7). In order to rule out the possibility that 
IL4 had a toxic effect on DC thereby reducing their ability to stimulate T cell 
IFNy (and possibly IL4) production, T cell proliferation was examined. 
Following treatment with EL4, DC were shown to be alive by trypan blue 
exclusion. Furthermore, their ability to stimulate allogeneic naive CD4^ T 
cells to proliferate was unaffected by IL4 (fig. 5.8), demonstrating that the 
cytokine did not act by inducing anergy in the responding T cells.
5.2.3 The effect o f  ILIO on the ability o f CD40-activated DC to upregulate 
IFNy production by CD4^ T cells 
ELIO has also shown to be an inhibitor of DC maturation and skews T helper 
cells towards a Th2 phenotype but it failed to have any effect on T cell 
cytokine profiles in these experiments. Both untreated DC and those treated 
with 10 ng/ml ILIO for 24 h induced limited amounts of IFNy from responding 
naive T cells. In addition, ILIO did not inhibit upregulation of 
IFNy production induced by CD40-activated DC. ELIO also failed to induce
I l l
IL4 production to detectable levels (fig. 5.9). In both experiments, ILIO 
treatment did not inhibit IL12 upregulation by CD40-activated DC (fig. 5.10).
5.2.4 The effect o f dexamethasone on the ability o f CD40-activated DC to 
upregulate IFNy production by CD4^ T cells
DC treated with 2.5 x 10'  ^M dexamethasone (DEX) for 24 h were washed 
thoroughly and co-cultured with naive allogeneic CD4^ T cells. In the two 
experiments shown, IFNy expression was upregulated by T cells stimulated 
with CD40 activated DC and this effect was inhibited by pretreating DC with 
DEX. The effect was more pronounced in experiment 2 (fig. 5.11). IL4 
expression by T cells in the same experiments was inconsistent; in one 
experiment DEX-treated DC induced IL4 upregulation following CD40L 
stimulation whereas in the other DEX exacted no effect (fig. 5.12). Following 
the effect of DEX on IFNy production, IL12p40 expression by DEX-treated 
DC was investigated. Fig. 5.13 shows that DEX, like IL4, inhibited IL12p40 
secretion firom DC activated via CD40. This effect also appears to be 
concentration dependent, although DEX didn’t begin to inhibit IL12p40 until 
concentrations had reached 2.5 pM and even the highest concentration of 25 
pM only halved IL12p40 expression (fig. 5.14). DEX treatment slightly 
inhibited CD86 and CD54 expression (fig. 5.15) but failed to have any effect 
on the capacity of DC to stimulate allogeneic naive T cell proliferation (fig. 
5.16).
5.2.5 The effect o f house dust mite extract on the ability o f CD40-activated 
DC to upregulate IFNy production by CD4^ T cells
DC were treated with 10 pg/ml house dust mite (HDM) extract for 24 h, 
washed thoroughly and then co-cultured with naive CD4^ T cells. HDM had 
no effect on the limited amount of IFNy that resting DC and DC cultured with 
CD32 L cells were able to induce from responding T cells with the exception 
of experiment 1 in which HDM had the same effect as CD40L. However, in
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all four experiments, DC that had been exposed to HDM were unable to 
induce the same levels of IFNy as untreated DC following CD40 activation. 
IFNy expression was brought down to the same levels or lower than those 
induced by resting DC untreated with HDM (fig. 5.17). In these experiments, 
HDM appeared to have no consistent effect on the expression of IL4 by 
responding T cells. Two out of four experiments (exp. 1 and 2) indicated that 
IL4 might be slightly downregulated by HDM-treated DC but this effect was 
not observed in the other two experiments (fig. 5.18). In experiment 4 shown 
in both fig. 5.17 and fig. 5.18, cells were cultured in duplicate under each 
experimental condition and each well tested separately in the ELISA. The 
difference between the duplicate wells was less than 2% of the mean values. 
The previous experiments were performed in quadruplicate wells but the 
supernatants from each well were mixed together in order to provide enough 
material for each ELISA.
Treatment of DC with HDM had the same effect as treatment with IL4 or 
dexamethasone in inhibiting IFNy expression by responding T cells. As HDM 
treatment appeared to have no effect on T cell IL4 secretion, the expression of 
other type 2 cytokines was examined. No IL5 production by T cells was 
detected by ELISA following stimulation with HDM-treated DC (data not 
shown). In two out three experiments HDM-treated resting DC induced a 
slight increase in IL13 expression by responding T cells compared to untreated 
DC but this effect was not replicated by HDM-treated DC cultured with CD32 
L cells. Similarly, in two out of three experiments DC stimulated by CD40L 
upregulated T cell ELI 3 expression. However, this may he due to activated DC 
inducing greater T cell proliferation than resting DC, rather than the T cells 
upregulating ELI 3 synthesis. In both experiment 1 and 2, HDM slightly 
decreased IL13 expression induced by CD40-activated DC but not to any great 
extent (fig. 5.19). The effect of HDM on ILIO expression by T cells was also 
inconsistent. All three experiments showed a slight decrease in ELIO
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expression by T cells responding to HDM-treated DC stimulated with CD40L 
but a variable response overall (fig. 5.20).
Like IL4 or DEX, HDM treatment did not affect the ability of DC to stimulate 
T cell proliferation (fig. 5.21) and the extract did not have any effect on 
expression of CD40, HLA DR, CD80, CD86 or CD54 (fig. 5.22). However, 
unlike BL4 and DEX, HDM-treated DC were able to upregulate IL12p40 
following CD40L stimulation to the same extent as untreated DC (fig. 5.23). 
Since IL12p40 expression by DC was unaffected by HDM and HDM-treated 
DC did not induce T cell IL4, ILIO or IL13 upregulation, other soluble factors 
expressed by DC which may influence IFNy expression by T helper cells were 
investigated. Supernatants fi*om cultures of DC treated with either 2.5 x 10'  ^
M DEX or 10 ng/ml IL4 or 10 pg/ml HDM for 24 h (3 independent 
experiments per treatment) were analysed for IL4, ILIO and IL13 production. 
Release of all of these cytokines was below detectable limits (<31.25 pg/ml 
EL4, <7.8 pg/ml ELIO, <62.5pg/ml ELI3). TGFp is an anti-inflammatory 
cytokine which may bias responses towards Th2 differentiation and for this 
reason its potential upregulation by HDM-treated DC was examined (fig. 
5.24). DC were generated from three independent donors and treated with 10 
pg/ml HDM for 24 h. RNA was extracted firom these samples, quantified and 
equalised. G3PDH message was compared in all samples (fig. 5.24A). The 
optimum annealing temperature of each set of primers was calculated in PCR 
reactions using human spleen cDNA as a template. Fig. 5.24B shows that, 
using these primers to amplify a product, none of the DC, treated or untreated, 
expressed mRNA for TGFpl. However, TGFp3 message was detectable in all 
the samples but HDM treatment failed to have any effect on its expression 
(fig. 5.24C). In all RT-PCR the number of cycles was selected such that the 
product intensity was related linearly to the starting amounts of cDNA for both 
the target and house-keeping genes.
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5.2.6 Expression o f  protease activated receptors hy HPC-derived DC 
Protease activated receptors (PAR) are seven transmembrane receptors which 
are cleaved at the amino terminal by serine proteases. The newly exposed 
amino terminal then binds to a site within the receptor which is subsequently 
internalised. At present, there are four known PAR expressed by a variety of 
cell types which are known to be involved m events such as clotting and the 
release of chemokines (Hollenberg, 1999). Since the HDM extract used to 
treat DC contained allergenic cysteine and serine proteases, the presence of 
PAR expressed by DC was investigated. To begin, the optimal cDNA product 
annealing and extension time and temperature for each primer (PARI - 4) was 
determined using human spleen cDNA as a template. The primers for PAR2 
and PAR3 were abandoned because they consistently amplified non-specific 
bands despite adjusting the PCR conditions. Low levels of PARI mRNA were 
detected in DC treated with or without HDM whereas PAR4 mRNA was not 
expressed by treated or untreated cells However, treatment of DC with HDM 
had no effect on PARI mRNA expression (Fig. 5.25)
It was interesting to find that DC expressed mRNA for PARI and although 
HDM did not upregulate the mRNA, the effect of HDM or any other serine 
protease on this receptor at a cellular level remains unknown. However, to 
investigate further the effect of HDM on DC, a cDNA array displaying a large 
range of genes was employed.
5.2.6 cDNA array technology: analysis o f genes expressed hy DC treated 
with or without house dust mite extract
HDM inhibited the ability of activated dendritic cells to induce high levels of 
IFNy from T helper cells. The results of experiments in this chapter show that 
HDM did not exert its effects by diminishing corstimulatory molecules or
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MHC class n  molecules. Neither did it inhibit the increased production of 
IL12 by DC following CD40 stimulation. Furthermore, HDM did not induce 
BL4, IL13 or ILIO secretion by DC, neither did it promote TGFp mRNA 
upregulation. It was therefore decided to extract RNA from HDM-treated DC 
and use it to probe an array of cDNA products representing hundreds of genes 
that may be involved in immune responses. This was a blanket attempt to find 
genes whose expression might be influenced by substances within the HDM 
extract. The cDNA arrays were kindly donated by the Genomics Unit at 
GlaxoWellcome, Stevenage and were originally designed for a different field 
of research. This meant that a number of the genes represented on the array 
were not particularly relevent to an investigation on the effect of HDM on DC 
gene expression. On the other hand, some of the genes that we subsequently 
discovered to be expressed by DC would not have been unearthed if we had 
designed a more ‘appropriate’ array.
Each cDNA clone was spotted onto one nylon membrane array five times and 
their position was recorded using a computer grid. RNA was extracted from 
untreated DC or DC cultured with HDM extracts for 24 h. RNA was reversed 
transcribed and the resulting cDNA was radiolabelled. Each sample was used 
to probe a separate array spotted with the same cDNA clones. Both the sample 
and the cDNA on the arrays had been treated and denatured to allow single 
complementary strands to hybridise. Following hybridisation of the prohes to 
the array, the density of each spot was detected by a phosphoimage screen and 
analysed by computer. The density of each spot reported in these results 
represents the mean of five spots.
Table 5.1 displays a range of cDNA products spotted onto the arrays and the 
density of each spot following probe hybridisation. The background threshold 
of each array was <2 so that any spot with a density of more than 2 
represented a gene expressed by DC. cDNA froip HPC-DC generated from
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two different donors was used to probe the arrays. Both experiments showed 
that resting DC do not express IL4, IL5, IL6, ILIO or the chemokine EL8. 
Furthermore, treatment of the cells with HDM did not induce expression of 
any of these cytokines. In the first experiment HDM induced upregulation of a 
number of genes including those encoding HLA DR, p2 microglohulin, 
metallomatrix proteinase 2 and the intermediate filament vimentin. However, 
this effect was not repeated in the second experiment. The results in table 5.1 
show that resting DC expressed higher levels of mRNA for HLA DRa than 
HLA DRp and that they expressed high levels of mRNA for endothelial 
differentiation protein and the cytoskeletal protein, vimentin. In addition, DC 
in their resting state expressed metallomatrix proteinase 2, a type IV 
collegenase, thymosin and 5-lipoxygenase activating protein (FLAP).
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5.3 Discussion
DC stimulated with LPS or by CD40L expressed IL12 and upregulated IFNy 
expression by responding naive CD4^ T cells. IL4 treatment of DC inhibited IFNy 
expression by T cells probably by inhibiting IL12 secretion from CD40 activated 
DC This result is in accordance with the observations of Koch et al. (1996) who 
showed that IL4-treated murine DC failed to express IL12 after stimulation by 
anti-CD40 antibodies or CD4^ T cells. LPS-induced expression of IL12 by 
macrophages is also inhibited by IL4 (Skeen et al., 1996; Levings and Schrader, 
1999). In the results of this chapter, IL4 upregulated the expression of HLA DR 
on DC which is also one of its effects on macrophages (Crawford et al., 1988). 
However, the upregulation of HLA DR on DC did not have an enhancing effect 
on their capacity to induce allogeneic T cell proliferation. EL4 also upregulated 
CD80 expression on DC and downregulated CD86 to a small extent although 
these effects may not have been significant. These two isoforms of the B7 
molecules are of interest because their expression has been shown to influence the 
differentiation of T helper cells (Kuchroo et ah, 1995; De Becker et al., 1998). A 
number of studies have shown the effect of various cytokines on the expression of 
CD80 and CD86. Langerhans cells cultured in EL4 upregulated both CD80 and 
CD86 (Kawamura and Fume, 1995). Similar to the results in this chapter, CD86 
expression on the surface of human monocytes was downregulated by both IL4 
and ILIO whereas CD80 was slightly upregulated (Creery et al., 1996). In the 
present study, the observed effect on DC of BL4 to inhibit subsequent IFNy 
expression by T cells co-cultured with the DC plus CD40L L cells is less likely to 
be due to differences in DC surface molecules than the inhibition of IL12 
expression by DC. However, an additional experiment would be needed to clarify 
this, such as the addition of recombinant IL12 to cultures containing activated 
BL4 treated DC and T cells. This might bring IFNy back up to control levels 
showing that inhibition of IL12 is indeed responsible for the inhibition of IFNy.
The mechanism by which IL4 is able to inhibit the induction of EL 12 is unclear, 
although in murine macrophages under certain activating conditions, it appears to
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involve the transcription factor STAT6 (Levings and Schrader, 1999). IL4 
induces the tyrosine phosphorylation of STAT6 which allows it to translocate 
from the cytoplasm to the nucleus and bind to a DNA ST AT binding element 
(SEE) (Lamer et a l,  1993). IL4 had no effect on BL12 expression by 
macrophages from STAT6 null mice when they were stimulated with LPS 
whereas wildtype cells treated with IL4 were unable to upregulate IL12 
expression following LPS treatment. However, IL12 inhibition may also be 
STAT6 independent since EL4 inhibited IL12 expression by STAT6 null cells 
when they were stimulated with IFNy in addition to LPS. How STAT6 activation 
blocks the induction of IL12 is unknown. However, IL4 has previously been 
shown to inhibit ILl-induced IL6 expression from human monocytes by blocking 
NFkB activation (Donnelly et a l,  1993). IL4 also blocks E selectin transcription 
in TNFa stimulated human endothelial cells. STAT6 binds to an SEE which 
overlaps with the NFkE binding site in the E selectin promoter region thereby 
preventing NFkE from binding (Eennett et a l,  1997). Furthermore, EL4 
suppression of TNFa expression by IFNy and IL2 stimulated murine 
macrophages was blocked by cycloheximide, indicating that de novo synthesis of 
an intermediate protein was required (Gautam et a l,  1992). Stimulation via 
CD40 activates NFkE and results in the expression of pro-inflammatory 
cytokines including IL12 (Yoshimoto et a l,  1997). IL4 suppression of IL12 
expression by CD40-activated DC may be due to its effect on NFkE. STAT6 may 
compete for the NFkE binding site on the IL12 promotor region or perhaps block 
NFkE nuclear translocation by upregulating iKE expression or activating a 
phosphatase which prevents the dissociation ofixE.
ILlO-treated DC failed to inhibit IFNy production by responding T cells and ILIO
1
had no effect on ELI2 expression by CD40-activated DC. Reports showing that 
ILIO downregulates DL12 expression by DC and induces Th2 cells have used 
murine DC which may behave differently to the human cells used in these 
experiments (Koch et a l, 1996, De Smedt et a l,  1997; Liu et al., 1998). Human 
DC treated with ILIO havp not been shown to induce Th2 development. They 
respond to ILIO when they are ill an immature state by inhibiting allogeneic T cell
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proliferation (Caux et al., 1994b) probably because they induce T cell anergy 
(Steinbrink e/a/. 1997).
The effect of dexamethasone on DC was similar to the effect of IL4 although the 
inhibition of IFNy expression by T cells was not as pronounced. This inhibition 
may have been due to the inhibitory effect of DEX on IL l2 expression by CD40L 
stimulated DC. Previous reports have shown that DEX and other glucocorticoids 
have a modulatory effect on monocyte-derived DC including the inhibition of 
IL12 expression following stimulation by CD40L (Visser et al., 1998) and LPS 
(Viera etal., 1998; Vanderheyde etal., 1999). However, Piemonti and colleagues 
(1999a) found that IL12p70 expression by DEX-treated DC was inhibited 
following LPS and TNFa stimulation but not CD40L. In the present study, DEX 
treatment had little effect on DC surface molecules although CD86 was slightly 
downregulated. Piemonti et al (1999a) also reported a decrease in CD86 
expression by DC following TNFa maturation as well as lower CD40 levels. DC 
generated from monocytes with IL4, GMCSF and DEX expressed lower levels of 
CD86 but higher levels of CD40, CD80 and MHC class I and II molecules than 
control DC (Piemonti et al., 1999b). DEX also inhibited CD86 expression by an 
LPS treated DC cell line (Kitajima et al., 1996). Glucocorticoids have been 
shown to prevent the maturation of DC and thereby inhibit their T cell 
stimulatory capacity, possibly by downregulating co-stimulatory surface 
molecules (Moser et al., 1995; Piemonti et al., 1999a; Vanderheyde et al., 1999) 
and maintain their endocytic ability following maturation stimuli (Piemonti et al., 
1999a and b). However, the experiments in this chapter show that DEX does not 
inhibit allogeneic naive T cell proliferation despite a slight decrease in CD86 
expression. Viera et al. (1998) also reported that DEX has no effect on the ability 
of monocyte-derived DC to upregulate co-stimulatory and MHC molecules 
following maturation and that they maintain their high T cell stimulatory capacity 
following treatment with DEX. They also report that T helper cells express lower 
levels of IFNy and higher levels of ILIO and IL5 when stimulated by DEX-treated 
DC and superantigen compared to untreated DC and superantigen. This effect 
was reversed with the addition of recombinant IL12p70.
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The ability of glucocorticoids to influence T helper cell cytokine profiles may be 
due to the downregulation of IL l2 expression by DC and also the inhibition of 
the IL l2 receptors on T cells (Wu et ah, 1998). However, their 
immunosuppressive effects, in the skin at least, may also be due to the inhibition 
of Langerhans cell migration by blocking TNFa expression by epidermal cells 
(Cumberbatch et al., 1999). Glucocorticoids exert an immunosuppressive effect 
either by inhibiting NFkB or via a NFkB independent mechanism. Growing 
evidence is pointing to multifactorial mechanisms of immunosuppression which 
may be dependent on cell type. DEX inhibits NFkB activation in HeLa or Jurkat 
cells by upregulating iKBa synthesis which prevents NFkB from dissociating and 
translocating to the nucleus (Scheinman et al., 1995; Auphan et al., 1995). 
However, in neuronal cell lines, although DEX inhibits ILl-induced adhesion 
molecule upregulation it does not inhibit NFkB activation or induce iKB synthesis 
(Bourke and Moynagh, 1999). Furthermore, there is evidence that glucocorticoid 
receptors can directly interact with the DNA binding site of NFkB and reduce its 
transactivation potential (Liden et al., 1997; Ray et al., 1997). Further analysis is 
required to elucidate the molecular mechanism by which DEX elicits a 
suppressive effect on CD40L-induced expression of IL12 by DC.
Unlike IL4 and DEX, the downregulatory effect of house dust mite (HDM)- 
treated DC on T cell IFNy expression can not be attributed to the inhibition of 
IL l2 expression by DC. Furthermore, the allergen had no effect on the expression 
of co-stimulatory molecules and HDM did not inhibit the ability of DC to 
stimulate allogeneic naive T cell proliferation. HDM-treated DC can be induced 
to express the same levels of IL l2 as control cells but fail to induce the same 
levels of IFNy from responding T cells. This indicates that HDM induces DC to 
express a soluble factor or surface molecule which counteracts the Thl skewing 
effects of ELI2. However, HDM-treated DC with or without CD40L stimulation 
did not express IL4 or ELIO, anti-inflammatory cytokines known to inhibit Thl 
development (O’Garra., 1998). TGFp is an anti-inflammatory cytokine which is 
expressed by DC (de Saint-Bis et al., 1998) although which isotypes are
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expressed have not been reported. It has multiple functions including growth 
regulation of haematopoietic cells, leucocyte recruitment to sites of inflammation, 
activation of resting cells and suppression of activated cells (Wahl, 1994). The 
results of this chapter show that HCP-derived DC expressed mRNA for TGFp3 
but not TGFpl (TGFP2 was not examined). Peyers patch DC express higher 
levels of TGFp mRNA than spleen DC and they induce T cell DL4, IL5 and low 
IFNy expression. This effect can be partially reversed by anti-TGFP antibodies 
(Iwasaki et a l,  1999). TGFp was therefore considered a candidate for IFNy 
inhibition by HDM-treated DC. However, RTPCR results showed that although 
DC expressed mRNA for TGFp3, there was no quantitative difference between 
HDM-treated cells and control cells. Whether DC express TGFp protein remains 
to be shown but if they do, it may have a role in maintaining peripheral tolerance 
or dampening down inflammation.
A variety of allergens have been reported to have protease activity which may 
explain why they induce allergenicity in atopic patients. The dominant allergen of 
the house dust mite Dermatophagoides pteronyssinus is Der y? 1, a 25kDa 
cysteine protease. The allergenicity of Der p  1 has been partly attributed to its 
ability to cleave CD23 (FcsRII) on the surface of B cells (Schultz et al., 1995). 
CD23 is a type 2 lectin expressed by B cells, macrophages, follicular dendritic 
cells (Gordon, 1990) and Langerhans cells (Mudde et a l ,  1994). Der p  1 
proteolytically cleaves CD23 from the cell surface and its soluble form is thought 
to be involved in the regulation of IgE synthesis (Schulz et al., 1995). 
Furthermore, Der p  1 has been shown to cleave CD25, the 55kDa a  subunit of 
the IL2 receptor, on the surface of peripheral T cells (Schulz et al., 1998). This 
resulted in impaired IFNy expression and T cell proliferation following activation 
by anti-CD3 antibodies. Since Thl cells require IL2 for growth whereas Th2 cells 
require IL4 (Constant and Bottomly, 1997), CD25 cleavage is another 
mechanism whereby Der p  1 skews the microenvironment in favour of IgE 
synthesis. In addition, Der p  1 has been shown to induce IL4 secretion from mast 
cells and basophils in the absence of IgE. These actions are also dependent on its 
enzymic activity (Machado et a l,  1996). Der p  1 specific T cell clones express a
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Th2 cytokine profile (Yssel et a l,  1992) and Comoy et al. (1998) showed that 
Der p  1 influences the development of Th2 cells in an in vivo system. They had 
previously found that immunizing mice with the glutathione S-transferase of the 
parasite Schistosoma mansoni (Sm28-GST) plus complete Freund’s adjuvent 
(CFA) induced a non-polarised response of IL4 and IFNy producing cells. 
However, when purified Der p  1 was added to Sm28-GST and CFA, the mice 
consistently produced less IgG2a antibodies and production of IFNy by T cells 
was reduced. Again, it was shown that the enzymatic activity of Der p  1 was 
central to its action since heat treatment or treatment with a specific cysteine 
protease inhibitor reduced the ability of the allergen to inhibit the Thl response. 
Furthermore, mice immunized with Der p  1 produced elevated levels of total and 
Der p  1-specific IgE compared with mice immunized with the allergen plus a 
cysteine protease inhibitor (Gough et ah, 1999)
The proteolytic activity of Der p  1 clearly plays a role in disrupting normal IgE 
regulation. However, other HDM allergens including those with serine protease 
activity may also be important. Der /? 3 is a 24kDa protein which shares 50% 
homology with trypsin (Stewart et ah, 1992; Smith et ah, 1994). Der p  6 has 
similar characteristics to those of chemotrypsin and has a molecular weight of 
25kDa (Yasueda et ah, 1993). Der p  9 is a 30kDa serine protease which is 
distinct fi-om trypsin and chemotrypsin and has been shown to cleave collagen 
(Stewart et ah, 1994; King et ah, 1996). Since Der p  1 has been shown to 
proteolytically cleave cell surface molecules it seems probable that the allergens 
with serine protease activity are also capable of cleaving surface molecules in 
their contribution to IgE dysfunction. One such target may be a newly 
characterised group of G protein-linked receptors which are activated via serine 
proteolysis. So far, four protease activated receptors (PAR) have been described. 
Although they only share about 35% homology, they are all seven transmembrane 
spanning receptors that have a unique method of activation (fig. 5.27).
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Fig. 5.27 Mechanism of PAR activation. Serine proteases cleave 
the receptor at its N-terminal exposing a tethered ligand of a 
specific sequence. The tethered ligand binds to a conserved 
domain on the extracellular region of loop 2 which sends a signal 
to the cell via G proteins.
The extracellular end of the receptor is hydrolysed by a serine protease at a 
specific cleavage point which exposes a N-terminal tethered ligand. This binds to 
a specific domain on loop 2 of the same receptor which activates the signal inside 
the cell. The signal is switched off by either the cell internalising the receptor and 
degrading it or by other inactivating proteins binding to the activation domain and 
sending a negative signal to the cell (Déry et al., 1998; Hollenberg, 1999). PAR 1 
and 3 are cleaved by thrombin, PAR2 is cleaved by trypsin and PAR4 is cleaved 
equally well by both. They are all widely expressed on tissues throughout the 
body and they have a myriad of functions. The most characterised receptor is 
PAR 1 which is expressed by many cell types including platelets, monocytes, 
smooth muscle cells and neurons. PARI activation on platelets is important in the 
coagulation cascade, activation of the receptor on macrophages treated with LPS 
enhances the release of ILl and PARI activation by thrombin on mast cells 
induces degranulation. Cleavage of PARI by thrombin also results in vasodilation 
and vasoconstriction, neutrophil and monocyte extravasation and the production 
of chemotaxins by endothelial cells. PAR2 is abundant in the gastrointestinal tract
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in areas sequestered from luminal trypsin and it may be involved in the regulation 
of gastric smooth muscle contractility. Interestingly, it is expressed by mast cells 
and can be cleaved by mast cell tryptase itself. The only reported physiological 
role of PAR3 is in the regulation of platelet fimction although it is found in a 
variety of tissues. Similarly, PAR4 is widely expressed but its biological function 
is unknown (Déry et al.,199%', Hollenburg, 1999).
It may be possible that serine proteases from HDM are able to cleave some of 
these receptors and contribute to atopy in susceptible individuals. For example, 
PAR2 has been located in the respiratory tract (Cocks et al., 1999) where it 
would come into contact with HDM allergens, such as the trypsin-like Der p  3 
and its activation could result in the dilation of smooth muscle, a symptom of 
asthma (Holt et al, 1999). The results of this chapter showed that HPC-derived 
DC expressed PARI mRNA but not PAR4 mRNA and that treatment with HDM 
did not affect the mRNA expression of either receptor. However, this does not 
rule out the possibility that PARI expressed on the surface of DC is cleaved by 
HDM and downregulated independently of mRNA. In mesangial cells, persistent 
activation of PARI resulted in the downregulation of protein rather than mRNA 
which suggests that receptor internalization and degradation is the principle 
mechanism of downregulation (Déry et a l,  1998). Following this result, it would 
be interesting to find out if DC express PARI on their cell surface and the effect 
of cleavage by thrombin, since it is a known activator of the receptor and a 
protein which DC are likely to come into contact with in vivo. In addition, the 
presence of PAR2 and PAR3 needs to be investigated and, indeed, whether HDM 
serine proteases are able to activate PAR at all. If they are, their ability to activate 
PAR expressed by DC would be a pertinent investigation, given the implications 
of PAR in inflammatory responses. It may also be possible that HDM serine 
proteases are negative regulators of PAR, able to prevent the activation of such 
receptors (Déry et al., 1998). Further enquiries should also involve heat 
inactivating HDM to investigate whether its effects are due to its enzymatic 
properties.
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HDM extract used to treat DC in these experiments was found to inhibit IFNy 
production from T helper cells stimulated by CD40-activated DC. This effect was 
not due to the inhibition of CD40L-induced IL l2 expression by DC. HDM may 
exert its effect via proteolysis of receptors such as PAR resulting in changes in 
the expression of inflammatory genes by DC. Any changes in gene expression 
induced by HDM treatment of DC could be analysed using cDNA arrays. The 
arrays enabled the expression of a large number of genes to be compared with 
relative ease in just one experiment. The inhibitory effects of HDM on IFNy 
production by T cells cannot be attributed to changes in expression of either IL4 
or ILIO by DC, since DC did not express elevated levels of protein or mRNA for 
either of these cytokines when treated with HDM. Changes in gene expression 
induced by HDM were not repeatable in both array experiments so it remains 
unclear whether any of those genes on the arrays are truly affected by HDM 
treatment. However, the arrays have shown that DC express certain genes which 
have never before been reported in this cell type. High levels of mRNA for the 
cytoskeletal protein vimentin were detected on the array. Vimentin is an 
intermediate filament expressed by many cell types including macrophages in 
which it combines with an actin crosslinking protein called fibrim. The two 
proteins co-localise within macrophages at the surface of filapodia at sites of 
cellular adhesion which gives an indication of the role vimentin might play in DC 
(Amos and Amos, 1991; Correia e/ a l,  1999). It is also interesting to report that 
DC expressed mRNA for metalloproteinase 2, a type IV collegenase (Jones et ah, 
1999) which the cells may produce to aid their migration through the cellular 
matrix to the lymph nodes. In addition, the array detected mRNA for thymosine 
p4, a molecule implicated in wound healing and an anti-inflammatory substance 
produced by monocytes.
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Fig. 5.1 Cytokine production by naïve T helper cells stimulated by 
LPS-treated DC. Untreated or LPS-treated DC (lOVwell) were cultured with 
10^  naïve T cells/well for 5 days. T cells were removed, washed and re stimulated 
with PMA and ionomycin for 2 days. Supernatants were analysed for IFNy 
and IL4. Data is presented as single point measurements from one experiment 
representative of three. ND = not detected
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Fig. 5.2 IFNy expression by naïve T helper cells stimulated by DC.
DC (lO'^/well) were treated with or without 10 ng/ml IL4 for 24 h, 
washed and then co-cultured with lOVwell T cells. Some wells also 
contained 10^  CD40L L cells. After 5 days, T cells were removed, 
washed and restimulated with PMA and ionomycin. Pooled supernatants 
were analysed 2 days later for IFNy by ELISA. Three separate experiments 
are shown. ND = not detected
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Fig. 5.3 IL4 expression by naïve T cells stimulated by IL4-treated DC. 
Untreated DC or DC treated with 10 ng/ml IL4 were washed and then 
co-cultured (1 Orwell) for 5 days with lO^T cells/well with or without 
10^  CD40L L cells/well. T cells were removed, washed and restimulated 
with PMA and ionomycin. After 2 days, supernatants were pooled and 
analysed for IL4 by ELISA. Three separate experiments are shown.
ND = not detected
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Fig. 5.4 IFNy expression by T cells stimulated with IL4-treated DC.
DC (lO'^/well) were treated with different concentrations of IL4 for 24 h, 
washed and then co-cultured with 10^  naïve T cells/well for 5 days, with or 
without 10^  CD40L or CD32 L cells/well. T cells were removed, washed and 
restimulated with PMA and ionomycin. After 2 days, supernatants were pooled 
and analysed for IFNy by ELISA.
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Fig. 5.5 IL12p40 expression by IL4-treated DC.
DC were seeded at 10^  cells/well and treated with 
or without 10 ng/ml IL4 for 2 days either in the presence or 
absence of 10"^  CD40L L cells/well. Supernatants were pooled 
and analysed for IL12p40 by ELISA. ND = not detected
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Fig. 5.6 EL12p40 expression by DC treated with different concentrations of 
IL4. DC (lOVwell) were cultured with 10'* CD40L L cells/well in the presence 
of different concentrations of IL4. Supernatants from these cultures and 
cultures containing DC alone or DC plus 10"* CD32 L cells were pooled and 
analysed for IL12p40by ELISA. ND = not detected
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Fig. 5.7 Surface molecule expression by IL4-treated DC. Untreated DC (blue) or 
DC treated with 10 ng/ml IL4 for 24 h (red) were analysed for surface molecule 
expression by flow cytometry. The percentage of cells positive for each molecule 
and its median fluorescent intensity (MFI) is shown. A non-specific isotype matched 
antibody was used as control (black).
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Fig. 5.8 Proliferation of naïve CD4^ T cells stimulated by EL4-treated DC. 
DC were cultured with or without 10 ng/ml IL4 for 24 h.
DC were treated with mitomycin C, washed and then co-cultured 
with 10^  naïve T cells/well. On day 5, 1 jiCi pH]-thymidine was added 
to each well and cells were harvested after 20 hours. Each point represents 
the mean ± SEM of triplicate wells.
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Fig. 5.9 Cytokine expression by naïve CEW T cells stimulated with 
ILIO treated DC. Untreated DC or DC treated with 10 ng/ml ILIO 
for 24 h were washed and co-cultured (10"*/well) with naïve 
T cells (lOVwell) in the absence or presence of 10  ^CD40L L cells/well. 
T cells were removed on day 5, washed and restimulated with PMA and 
ionomycin for 2 days. Supernatants were pooled and analysed for IFNy 
and IL4 by ELISA. IL4 was undetectable in all samples. One 
representative experiment out of two is shown.
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Fig. 5.10 IL12p40 expression by ELlO-treated DC.
Untreated DC or DC treated with 10 ng/ml ILIO for 24 h were 
cultured (lOVwell) with or without CD40L L cells (lO'^/well). 
Supernatants were pooled and analysed 24 hours later for IL12p40 
by ELISA. One representative experimentout of two is shown.
ND = not detected
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Fig. 5.11 IFNy expression by naïve CD4^ T cells stimulated with dexamethasone- 
treated DC. Untreated DC or DC treated with 2.5 x 10'  ^M DEX for 24 h were 
washed and co-cultured (lO'^/well) with naïve T cells (lOVwell) in the absence or 
presence of CD40L L cells (lOVwell). After 5 days, T cells were removed, 
washed and restimulated with PMA and ionomycin. Supernatants were pooled 
and analysed for IFNy by ELISA 2 days later. Two separate experiments are 
shown. ND = not detected
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Fig. 5.12 IL4 expression by naïve CD4^ T cells stimulated with dexamethasone- 
treated DC. Untreated DC or DC treated with 2.5 x 10’^  M DEX for 24 h were 
washed and co-cultured (lO'^/well) with naïve T cells (lOVwell) in the absence or 
presence of CD40L L cells (lOVwell). After 5 days, T cells were removed, washed 
and restimulated with PMA and ionomycin. Supernatants were pooled and analysed 
for IL4 by ELISA 2 days later. Two separate experiments are shown.
ND = not detected
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Fig. 5.13 IL12p40 expression by dexamethasone-treated DC. Untreated DC or 
DC treated with 2.5 x 10'  ^M DEX for 24 h were cultured (lOVwell) for a 
further 24 h with or without CD40L Lcells (10" /^well). Supernatants were pooled 
and analysed for EL12p40 by ELISA. ND = not detected.
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Fig. 5.14 IL12p40 expression by DC treated with different concentrations of 
dexamethasone. DC (lOVwell) were treated with different concentrations of DEX for 
24 h. Cells were washed and then cultured with CD40L L cells (10'* /well) for 24 
hours. Supernatants from these cultures and those containing untreated DC only or 
untreated DC plus CD32 L cells were pooled and analysed for IL12p40 by ELISA. 
ND = not detected.
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Fig. 5.15 Surface molecule expression by dexamethasone-treated DC. Untreated 
DC (blue) or DC treated with 2.5 x 10'  ^M dexamethasone for 24 h (green) were 
analysed for surface molecule expression by flow cytometry. The percentage of 
positive cells expressing each molecule and its median fluorescent intensity 
(MFI) is indicated. A non-specific isotype matched control antibody was used to 
detect background fluorescence (black).
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Fig. 5.16 Proliferation of naïve CD4^ T cells stimulated with dexamethasone- 
treated DC. Untreated DC or DC treated with 2.5 x 10'  ^M dexamethasone 
for 24 h were washed and then co-cultured (lO'^/well) with naïve T cells 
(10^/well). On day 5, 1 |iCi pH]-thymidine was added to each well and after 
20 h the cells were harvested. Each point represents the mean ± SEM of 
tripicate wells.
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Fig. 5.17 IFNy production by naïve CD4^ T cells stimulated by HDM-treated DC. 
Untreated DC or DC treated with 10 pg/ml HDM extract for 24 h were 
washed and co-cultured at 10"^  cells/well with 10  ^naïve T cells/well in the absence 
or presence of L cells (lOVwell). After 5 days, T cells were removed, washed and 
restimulated with PMA and ionomycin. Pooled supernatants were analysed 2 days 
later for IFNy by ELISA. Four separate experiments are shown.
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Fig. 5.18 IL4 production by naïve CD4^ T cells stimulated with HDM-treated DC. 
Untreated DC or DC treated with 10 p,g/ml HDM extract for 24 h were 
washed and co-cultured at 10"^  cells/well with 10  ^naïve T cells/well in the absence 
or presence of L cells (lOVwell). After 5 days, T cells were removed, washed and 
restimulated with PMA and ionomycin. Pooled supernatants were analysed 2 days 
later for IL4 by ELISA. Four separate experiments are shown.
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Fig. 5.19 IL l3 production by naïve CD4^ T cells stimulated with HDM-treated DC. 
Untreated DC or DC treated with 10 (ag/ml HDM extract for 24 h were 
washed and co-cultured at 10"^  cells/well with 10^  naïve T cells/well in the absence 
or presence of L cells (10^/well). After 5 days, T cells were removed, washed and 
restimulated with PMA and ionomycin. Pooled supernatants were analysed 2 days 
later for ILl 3 by ELISA. Three separate experiments are shown.
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Fig. 5.20 ILIO production by naïve CD4^ T cells stimulated by HDM-treated DC. 
Untreated DC or DC treated with 10 pg/ml HDM extract for 24 h were 
washed and co-cultured at 10"^  cells/well with 10  ^naïve T cells/well in the absence 
or presence of L cells (lOVwell). After 5 days, T cells were removed, washed and 
restimulated with PMA and ionomycin. Pooled supernatants were analysed 2 days 
later for ILIO by ELISA. Three separate experiments are shown.
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Fig. 5.21 Proliferation of naïve CD4" T cells stimulated by HDM-treated 
DC. Untreated DC or DC treated with 10 [ag/ml HDM extract for 24 h were 
washed and then co-cultured at 10"^  cells/ml with 10  ^naïve T cells/ml. On 
day 5,1 jaCi pH]-thymidine was added to each well and cells were 
harvested 20 h later. Each point represents the mean ± SEM of triplicate 
wells.
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Fig. 5.22 Surface molecule expression by HDM-treated DC. Untreated DC (blue) or 
DC treated with 10 pg/ml HDM extract for 24 h (pink) were analysed for surface 
molecule expression by flow cytometry. The percentage of positive cells expressing 
each molecule and its median fluorescent intensity (MFI) is indicated. A non-specific 
isotype matched control antibody was used to detect background fluorescence 
(black).
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Fig. 5.23 IL12p40 expression by HDM-treated DC. Untreated DC or DC 
treated with 10 p,g/ml HDM extract for 24 h were cultured at 10^  cells/well 
either with or without lO^L cells/ml. Pooled supernatants were analysed 24 
h later for EL12p40 by ELISA. Two separate experiments are shown.
ND = not detected
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Fig. 5.24 Analysis of G3PDH (A), TOppi (B) and TGFP3 (C) mRNA 
expression using RT-PCR. DC from three individual donors were 
cultured with 10 pg/ml HDM for 24 h. RNA was extracted and 
reverse transcribed. cDNA was cycled 30 times in the PCR reaction 
and then electrophoresed on an agarose gel containing ethidium bromide. 
Bands were visualised by UV light.
TGFpl cDNA product = 745 bp, TGFP3 cDNA product = 601bp.
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Fig. 5.25 Analysis of PARI and PAR4 mRNA expression using 
RT-PCR. DC from three individual donors were cultured with 
10 pg/ml HDM for 24 h. RNA was extracted and reverse 
transcribed. cDNA was cycled 30 times in the PCR reaction and 
then electrophoresed on an agarose gel containing ethidium bromide. 
Bands were visualised by U.V light. PARI cDNA product = 541 bp. 
PAR4 cDNA product = 612 bp
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cDNA spot density on array
Experiment 1
0.52
HDM
0.5
Experipient2
0.81
HDM
0.8
IL10 1.08 0.945 1.255 0.955
IL5 0.585 0.605 0.56 0.57
IL6 1.58 1.865 1.45 1.32
IL8 1.6 1.6 1.6
Endothelial differentiation protein -1 14 47.99 67.45
1.33
59.15
Vi menti n 4.46 37.77 62.96 70.17
Elongation Factor-1 -7 21.83 12.78 5.01
M etallom atrix p ro te in ase- 2 5.1 18.23 36.7
2.22
36.9
HLADRa 19.49 66.1 95.21
HLADRpi 4.29 11.14 28.7
84.3
21.3
HLADRP2 3.7 10.1 26.4 20.1
T hym osin  -p - 4 6.02 4.65 4.18 5.02
T hym osin  -p -10 6.2 14.7 18.6 9.1
P2 microglobulin 1 .67 7.05 9.48 10.6
5 -lip o x y g e n a se  activating protein (FLAP) 11.4 14.64 22.54 32.32
Table 5.1 DC gene expression analysed by cDNA array technology. RNA was 
extracted from untreated DC or DC cultured with HDM for 24 h. RNA was 
reverse transcribed and the resulting cDNA was radiolabelled and used to probe 
the array. Arrays were spotted with 5 pi cDNA from subtraction library clones. 
Both the probes and the arrays were treated to denature the cDNA allowing 
complementary strands to hybridise. Following hybridisation, the density of each 
spot was detected by a phosphoimage screen and computer analysis. The results 
shown in this table are the mean of five spots on a single array. Background 
threshold was <2.
Chapter 6 Summary
Introduction
NFkB is involved in the transcription of a number of genes encoding 
inflammatory factors. Its regulation has been well studied in many cell 
types including macrophages but less is known of its role in the activation 
of dendritic cells. Experiments in this chapter examine the effect of 
inhibiting NFkB on the maturation of DC by EPS.
Methods
Monocyte-derived DC were treated with or without NEkB inhibitor PDTC 
for 1 h prior to the addition of EPS. DC treated with EPS were washed after 
30 min. Translocation of NFkB p65 to the nuclei of DC was visualised by 
fluorescence microscopy. Changes in surface molecule expression were 
measured by flow cytometry. Production of cytokines was analysed by 
EEISA. T cell proliferation was measured by tritiated thymidine uptake in 
allogeneic MER and by IE2 expression measured by EEISA. To examine 
the effect of NFkB inhibited DC on T cell cytokine profiles, treated or 
untreated DC were cultured with naïve allogeneic CD4^ T cells for 5 days. 
T cells were then removed and restimulated with ionomycin and PMA. 
Supernatants were analysed 24h later for the presence of cytokines.
Results and discussion
Inhibition of NFkB by PDTC prevented the functional maturation of DC by 
EPS. Although the upregulation of DC surface molecules by EPS was 
unaffected, PDTC ablated the upregulation of both IE12p40 and IE6 in 
response to EPS. PDTC treated DC were unable to induce high levels of T 
cell proliferation shown by thymidine incorporation and IE2 expression. 
Levels of IFNy produced by T cells stimulated by PDTC treated DC were 
lower than levels produced by T cells stimulated by untreated DC. 
However, PDTC failed to inhibit expression of lE lp  by EPS treated DC 
indicating that IE Ip may be transcribed by additional transcription factors.
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Chapter 6 NFkB Signal Transduction During the Maturation of 
Human DC
6.1 Introduction
Results in Chapter 4 showed that DC mature after treatment with LPS or 
crosslinking surface CD40 molecules. This led to increased levels of co­
stimulatory molecules, inflammatory cytokines and an increased ability to 
stimulate allogeneic T cells. However, little is known about the intracellular 
signalling pathways within DC that are activated during maturation. In this 
chapter, the effects of LPS on the activation of the transcription fector nuclear 
factor K B (NFkB) will be studied in monocyte-derived DC. The anti-oxidant 
pyrollidine dithiocarbamate (PDTC) will be used to inhibit NFkB activation 
by LPS. This will allow investigation of the role of NFkB in the transcription 
of inflammatory genes by LPS-activated DC.
NFkB proteins are ubiquitously expressed by the majority of eukaryotic cells 
and are known to induce transcription of a large number of inflammatory 
genes (Baeuerle and Henkel, 1994). The members of the NFkB family all 
share a conserved N-terminal region called the Rel-homology domain (RDH). 
There are currently five known members of the family: c-Rel, p65, pl05/p50, 
pl00/p52 and RelB. When they are inactive, the molecules reside in the 
cytoplasm of the cell as homo- or heterodimers with p65/p50 being the most 
commonly formed dimer. The proteins pi 05 and p i GO were thought to be the 
precursors of p50 and p52 respectively. However, it has recently been shown 
that they are functional proteins in their own right. The dimérisation site, the 
DNA-binding site and the nuclear localization signal site all lie within the 
RDH of NFkB molecules. In their inactive state within the cytoplasm, NFkB 
proteins are kept under tight control by inhibitory k B proteins (IkB) which 
are coupled to NFkB dimers at their nuclear localisation signal site. This 
prevents NFkB from inappropriately translocating to the nucleus.
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There are also five known IkB proteins: IkB œ, IkBP, IkB s , IkB y and BCL-3. 
They all express either six or seven ankyrin domains which bind to the RHD 
of NFkB molecules, masking the nuclear localisation signal. In addition, 
pl05/p50 and pl00/p52 have ankyrin domains as well as a Rel homology 
domain indicating that they may also have a role in inhibiting other N Fk B 
molecules. BCL-3 is an unusual member of thelKB family because it is 
sequestered in the nucleus rather than in the cytoplasm and can enhance N FkB  
activation.
Activation of NFkB  occurs subsequent to phosphorylation of IkB. This 
induces IkB to dissociate from the N FkB dimer and binding to ubiquitin 
targets it for degradation by the proteosome. Once freed from IkB, the N FkB  
molecule can translocate to the nucleus and initiate transcription. The 
upstream signalling events that precede IkB phosphorylation are complex and 
have yet to be fully elucidated (Fig. 6.1). Stimulation of various receptors for 
molecules such as ILl, TNFa or CD40L results in the activation of N FkB and 
the expression of inflammatory products. Adapter molecules such as TNF 
receptor associated factor (TRAF) and TNF receptor associated death domain 
(TRADD) are activated by ligation of CD40 and TNFa respectively. These 
molecules initiate the phophorylation of IkB probably by activating NFkB  
inducing kinase (NIK). As a consequence, NIK may phosphorylate two 
important and until recently, elusive kinases: IkB kinase-a (IKKa) and IkB  
kinase-p (IKKp). These kinases form a heterodimer within a multiprotein 
complex. Following activation they phosphorylate IkB at serine residues 32 
and 36 inducing its dissociation from NFkB. In addition to binding to DNA 
kB sites on genes encoding inflammatory products, activated N FkB molecules 
also initate the transcription of IkB itself. This control mechanism means that 
NFkB activation can be rapidly switched off l?y an increase in cytoplasmic
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IkB (Baldwin, 1996; May and Ghosh, 1998; Sha, 1998; Scheidereit, 1998; 
Foo and Nolan, 1999).
Dendritic cells grown in vitro from bone marrow precursor cells express high 
levels of all molecules of the NFkB family (Granelli-Pipemo et a l, 1995). In 
situ histochemistry has revealed that p65 and c-rel molecules are ubiquitously 
expressed by lymphoid cells whereas p50, p52 and RelB are selectively 
expressed by DC and macrophages in the T cell regions and follicular 
dendritic cells in the germinal centre of lymph nodes (Feuillard et a l, 1996). 
Furthermore, RelB is essential for the maturation of DC from resting 
precursor cells and for their subsequent antigen presenting ability. Langerhans 
cells, which do not express RelB in normal mice, are present in relB knock out 
mice but an absence of DC in the secondary lymphoid organs indicates that 
RelB is required for the transcription of factors essential for DC 
differentiation. Mice deficient in relB display a variety of inflammatory 
disorders and produce predominantly IgGl in response to influenza A virus, a 
Th2 response rather than a fimctional Thl response. This may be because of 
the lack of mature DC or it may be because B cells deficient in RelB do not 
switch isotype normally (Burkly et a l, 1995).
The role of NFkB molecules in DC development and activation has been 
investigated using factors that inhibit NFkB activation. Human CD34^ 
haemopoietic precursor cells (HPC) were cultured in vitro with vascular 
endothelial growth factor (VEGF), a substance secreted by tumour cells, for 
13 days in the presence of GMCSF and TNFa. The ability of the resulting DC 
to stimulate allogeneic T cells was diminished probably due to the inhibition 
of NFkB by VEGF. To confirm the effect of NFkB inhibition, HPC were 
transfected with a transdominant IkB gene which prevented NFkB from being 
activated. HPC were then cultured in vitro with GMCSF and TNFa for 14 
days to induce DC differentiation and then used as stimulators cells in an 
allogeneic MLR. DC transfected at day 0 and day 3 were unable to stimulate
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allogeneic T cells but those transfected at day 6 induced the same level of 
proliferation as control cells. This indicates that N FkB activation is required 
for the differentiation of precursor cells into functional DC, a process which is 
either complete by day 6 in vitro or doesn’t require further NFkB activation 
(Oyama et ah, 1998).
Similarly, human monocyte-derived DC cultured with N-acetyl-L-cysteine, an 
antioxidant molecule and inhibitor of N FkB activation, failed to stimulate 
allogeneic T cells (Verhasselt et a l, 1999). In addition, cyclosporin A 
inhibited the translocation of NFkB to the nucleus of mouse DC grown in 
vitro from bone marrow precursor cells. As a result, these DC were also 
unable to induce the proliferation of allogeneic T cells (Lee et a l, 1999).
Aims o f chapter 6
The aim of this chapter is to investigate the role of N FkB in DC maturation 
and function. DC derived from adherent peripheral blood mononuclear cells 
cultured for 7 days with GMCSF and IL4 will be stimulated with LPS to 
induce maturation. Activation of p65, a member of the NFkB  femily, by LPS 
will be visualised within DC using fluorescence microscopy. To study the role 
of NFkB in DC maturation, cells will be cultured with PDTC, an anti-oxidant 
known to inhibit N FkB fimction in some cell types (Moynagh et al, 1994; 
Brennan and O’Neill, 1995), for one hour prior to exposure to LPS. The 
effect of PDTC on the translocation of NFkB to the nucleus of LPS-treated 
DC will be visualised. The effect of inhibiting NFkB in DC will be examined 
by measuring maturation factors such as allostimulatory capacity, cytokine 
expression and the levels of co-stimulatory molecules expressed. In addition, 
the effect of inhibiting N FkB activation in mature DC will be investigated in 
relation to the ability of mature DC to induce Thl cytokine production from 
naïve allogeneic T cells.
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Fig. 6.1 Signalling events leading to the activation of NFkB. On ligation of receptors 
such as CD40 and TNF-R, adaptor molecules like TRADD and TRAF activate NIK. 
NIK forms a complex with the kinases IKKct and IKK(3 which phosphorylate IkB. 
IkB dissociates from the NFkB dimer and is targetted by ubiquitin to be degraded by 
the proteosome. NFkB translocates to the nucleus where it binds to kB DNA 
sequences and initiates transcription of inflammatory genes.
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6.2 Results
6.2.1 Effect o f PDTC, a NFkB inhibitor on the LPS-induced activation ofp65 
Activation of NFkB in DC was measured visually using fluorescence 
microscopy. Fluorescent antibodies against the common NFkB subunit p65 
were used to detect activation of the transcription factor. Resting DC were 
dimly fluorescent (fig. 6.2A). However, following treatment with 10 pg/ml of 
LPS for 30 min, fluorescence intensified in the nucleus of DC indicating that 
p65 molecules had migrated from the cytoplasm into the nucleus (fig. 6.2B). 
Intense fluorescence of p65 molecules could be localised to the nucleus using 
propidium iodide staining. Propidium iodide stains the nucleus bright red 
allowing the position of the nucleus in each cell to be visualised. DC which 
had been treated with 100 pM PDTC followed by LPS treatment barely 
displayed any fluorescence (fig. 6.2C). This indicates that PDTC prevents p65 
molecules from translocating from the cytoplasm to the nucleus in response to 
LPS.
6.2.2 Effect o f NFkB  inhibition on the ability o f DC to induce allogeneic 
C D ff T cell proliferation
DC treated with or without 100 pM PDTC for 1 h were cultured with 
allogeneic CD4^ T cells for 5 days. T cell proliferation was measured by 
tritiated thymidine uptake. Treatment with PDTC inhibited the capacity of DC 
cultured at low densities (625-1250 DC/well) to induce T cell proliferation 
(fig.6.3). However, at densities of untreated DC greater than 2500/well (a 
DC/T cell ratio of 1:40), T cell proliferation began to fall. At this density, 
PDTC-treated and untreated DC were equally able to induce T cell 
proliferation. Similarly, T cell proliferation induced by PDTC-treated DC also 
began to tail off when DC/T cell ratios reached 1:10. The decrease in T cell 
proliferation in wells containing higher numbers of DC may be because there
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are too many cells in the well and T cells die due to depletion of nutrients 
from the medium.
The inhibitory effect of PDTC on T cell proliferation induced by DC, at least 
at low DC-T cell ratios was reflected in the secretion of IL2 by T cells (fig.
6.4). DC were either untreated, treated with LPS or PDTC, or treated with 
PDTC washed then cultured with LPS. DC were seeded at lO'^/well with 10  ^
allogeneic CD4^ T cells. After 5 days, T cells were removed, washed and 
restimulated with PMA and ionomycin. Two days later, supernatants were 
measured for IL2. Untreated and PDTC-treated DC induced T cells to secrete 
low or undetectable levels of IL2. In each of two experiments, T cells 
stimulated by LPS-treated DC were induced to express high levels of IL2. 
However, when DC were cultured with the NFkB inhibitor prior to LPS 
treatment they failed to induce high levels of IL2 from responding T cells (fig.
6.4).
Trypan blue excusion showed that PDTC did not affect the viability of DC. In 
addition, propidium iodide staining showed the nuclei of PDTC-treated DC to 
be intact inferring that PDTC does not induce apoptosis. Since, untreated DC 
and PDTC-treated DC were equally viable, the reason why NFkB inhibition 
affects DC stimulatory capacity was investigated.
6.23 Effect o f NFkB inhibition on the upregulation o f DC surface molecules 
induced by LPS
DC were either untreated, treated with LPS or PDTC, or treated with PDTC, 
washed then cultured with LPS. Expression of cell surface molecules was 
analysed by flow cytometry. As expected, LPS induced upregulation of CD40, 
HLA DR (fig. 6.5), CD80, CD54 (fig. 6.6) and CD86 (fig. 6.7). Treatment of 
DC with PDTC prior to LPS stimulation failed to influence the increased 
surface expression levels of CD40, HLA DR (fig. 6.5), CD54 (fig. 6.6) or 
CD86 (fig. 6.7). In the case of CD80, PDTC did inhibit LPS-induced
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expression, seen as a reduced shift to the right of the LPS-induced 
fluorescence profile (fig. 6.6).
6.2.4 Effect o f NFkB inhibition on the upregulation o f cytokines produced by 
DC in response to LPS
Resting DC produced very little detectable IL6 (fig. 6.8), IL12p40 (fig.6.9) or 
IL ip (fig.6.10). In each of three experiments DC increased their production of 
both IL6 and IL12p40 when stimulated by LPS. In two out of three 
experiments ILlp secretion was increased following culture of DC with LPS 
(fig. 6.10). When DC were treated with PDTC prior to LPS exposure the 
induced production of IL6 (fig. 6.8) and IL12p40 (fig.6.9) was blocked. The 
effect of PDTC on IL lp expression by LPS-treated DC was less consistent. In 
two out of three experiments PDTC failed to inhibit LPS-induced upregulation 
of IL lp expression by DC (fig. 6.10).
6.2.5 Effect o f NFkB inhibition on the ability o f LPS-treated DC to induce Thl 
or Th2 cytokines by CD4^ T cells
DC were cultured with allogeneic CD4^ CD45RA^ T cells for 5 days. T cells 
were removed, washed and restimulated with 25 ng/ml PMA and 1.5 pg/ml 
ionomycin. Two days later, supernatants were measured for IFNy and IL4 
content. IL4 production in both experiments was below detectable limits 
(31.25 pg/ml). Untreated control DC induced low levels of IFNy from 
responding T cells (fig. 6.11). DC treated with PDTC were also able to induce 
low levels of IFNy from responding T cells. As shown in Chapter 5, LPS- 
activated DC stimulated T cells to secrete high levels of IFNy. When DC were 
treated with PDTC prior to LPS exposure, the levels of IFNy they induced 
from responding T cells was lower in both experiments. The effect was more 
pronounced in exp.2 than in exp.l.
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6.3 Discussion
LPS-induced signalling events have been studied most extensively in 
macrophages whereas little is known about signalling pathways in general in 
DC. LPS binding proteins (LBP) transfer LPS monomers to CD 14, a 
glycosylphosphatidyl-anchored membrane molecule (Ulevitch and Tobias, 
1995). Since CD14 is not a transmembrane molecule it has to associate with 
another receptor which can deliver signals to the cell. This has recently been 
identified as the Toll-like receptor (TLR). There are five known TLR at present 
and both TLR2 (Yang et a l,  1998) and TLR4 (Chow et a l, 1999) are 
responsive to LPS. However, the Ips gene which is absolutely required for LPS 
responsiveness has been mapped to TLR4 indicating that it is this receptor 
which is the dominant LPS receptor in mammals. TLR activate NFkB which 
has been shown to induce cytokine expression in macrophages and monocytes 
(Baeurle and Henkel, 1994). Although the expression of TLR has yet to be 
reported in DC it is highly probable that these cells express TLR since results 
in this chapter show that LPS induces the activation of NFkB.
When DC were in their resting state, dull staining for p65 could be seen in both 
the cytoplasm and the nucleus indicating that there was low constitutive NFkB 
activity. LPS-treated DC displayed a brightly stained nucleus indicating that 
LPS induced the translocational of cytoplasmic NFkB to the nucleus of the 
cells. However, LPS failed to activate NFkB in cells that had previously been 
exposed to PDTC. Nuclear fluorescence was even lower than control cells, 
suggesting that PDTC inhibited constitutive NFkB activity as well as LPS- 
induced activation.
The mechanism by which PDTC acts to inhibit the activity of NFkB is 
controversial. Various studies have indicated that oxygen radicals within the 
cytoplasm play a role in activating NFkB (for review see Baeurle and Henkel, 
1994) and since PDTC showed antioxidant properties it has been widely used
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in NFkB inhibition studies. Moynagh et al. (1994) showed that PDTC 
inhibited the upregulation of adhesion molecules by lymphocyte cell lines in 
response to ILl but that PDTC had no effect on ILl activation of an astrocyte 
cell line. Furthermore, Brennon and O’Neill (1996) showed that the inhibitory 
effect of PDTC can be reversed by adding a reducing agent to nuclear extracts 
of cells treated with PDTC followed by ILl exposure. This work suggested 
that PDTC acts as a pro-oxidant rather than an anti-oxidant, possibly by 
oxidising a sensitive thiol on the p50 subunit. This does not inhibit the 
activation or nuclear translocation of NFkB but prevents it from binding to kB 
sites in the nucleus. However, the immunofluorescence results presented in this 
chapter show that PDTC inhibits NFkB activity in LPS-treated dendritic cells 
by blocking the translocation of NFkB to the nucleus. Furthermore, PDTC 
clearly blocked the upregulation of IL6 and EL 12 expression by DC in response 
to LPS in three separate experiments but inhibited ILl (3 production in only one 
out of three experiments. This suggests that LPS may utilise another signalling 
pathway to induce secretion of IL lp by DC. Further studies would be needed 
to elucidate whether this signalling pathway is commonly used or whether it is 
used just as a fallback mechanism when NFkB activation is blocked. PDTC 
completely abrogated the upregulation of IL12p40 expression by DC and 
almost totally blocked EL6 upregulation in response to LPS. This indicates that 
NFkB is the only obligatory transcription factor in initiation of transcription of 
these cytokines in DC activated by LPS. Nemeth and co-workers (1998) have 
reported similar effects of PDTC in vivo. When PDTC was administered to 
mice 30 minutes prior to LPS injection, plasma levels of IL l2, M IP-la, TNFa 
and nitrite (a breakdown product of nitric oxide) were reduced. However, IL6 
and ILl a  production was unaffected. Furthermore, IFNy levels were not 
reduced in PDTC-treated mice, indicating that the reduction in IL l2 secretion 
is not enough to inhibit a Thl response. , ILIO plasma levels
were raised in PDTC-treated mice which may have been as a result of the 
inhibition of IL l2 expression.
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PDTC inhibited the ability of low numbers of DC to stimulate allogeneic T 
cells but inhibition was overcome as numbers of DC per well increased. DC 
treated with cyclosporine A (Lee et al., 1999) or N-acetyl-L-cysteine (NAC) 
(Verhasselt et al., 1999), both of which inhibit NFkB, also failed to induce the 
same levels of T cell proliferation as control cells. In these studies, DC surface 
co-stimulatory molecules as well as cytokine expression were also depressed 
by NFkB inhibition. Cyclosporine A reduced the expression of CD40, CD80 
and CD86 but did not affect MHC class II levels whereas levels of CD40, 
CD86 and MHC class II but not CD80 decreased when DC were treated with 
NAC. In the present study, PDTC inhibited LPS-induced upregulation of 
CD80. This may account for the inhibitory effect of PDTC on the 
allostimulatory capacity of LPS-treated DC. PDTC also inhibited LPS-induced 
IL6 and IL l2 secretion by DC and this may also have contributed to inhibition 
of T cell proliferation. Equally, other surface molecules or soluble factors 
secreted by DC that were not tested in these experiments may be responsible.
Despite the total abrogation of IL12p40 expression by DC treated with PDTC 
prior to LPS stimulation, these DC were still able to induce some IFNy 
expression from responding naïve T cells, albeit to a lesser extent than control 
DC. It may be possible that stimulation of CD40 on the surface of DC by 
CD40L expressed by activated T cells is able to induce sufficient IL12 to 
induce IFNy production. This hypothesis depends on whether PDTC can block 
NFkB activation and IL l2 expression by DC in response to CD40 stimulation.
The results of this chapter are similar to those of Rescigno et al., (1998). They 
showed that LPS failed to induce the maturation of murine spleen DC that had 
been pre-treated with a compound that prevents the degradation of IxBa. 
However, in contrast to results in this chapter, inhibition of NFkB prevented 
DC from increasing their surface levels of MHC class II and CD86. However, 
the authors did not report whether cytokiné expression was inhibited or
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whether DC function was affected. Interestingly, this report showed that LPS 
prevented DC apoptosis and, as well as activating NFkB in DC, LPS also 
activated extracellular signal-regulated kinase (ERK). When the kinase that 
activates ERK was inhibited, LPS lost its ability to protect DC from apoptosis.
The activation of NFkB is critical for the generation of DC in vitro and for 
their maturation into effective antigen presenting cells. The results of this 
chapter show that PDTC inhibits LPS-induced nuclear translocation of NFkB 
in DC. Inhibition of NFkB activity in DC by PDTC results in a lower capacity 
to stimulate allogeneic T cells which may be due to the downregulation of 
CD80 or because PDTC inhibits the upregulation of IL12 and IL6 by DC in 
response to LPS.
160
B
Fig. 6.2 Effect of PDTC, a NFkB inhibitor, on the LPS-induced activation 
of p65 in DC Monocyte-derived DC at day 5 were either untreated (A) or 
incubated with 10 pg/ml LPS for 30 min. (B) or incubated with 100 pM 
PDTC for 1 h, washed then cultured with LPS for 30 min. (C). DC were 
fixed, permeabilised and non-specific sites blocked with BSA. DC were 
labelled with a rabbit anti-human NFkB p65 primary antibody followed by 
a goat anti-rabbit IgG antibody conjugated to fluorescein. Cells were 
visualised under a fluorescence microscope (x 400).
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Fig. 6.3 Effects of PDTC, a NFkB inhibitor, on the allostimulatory 
capacity of DC. DC were treated with or without 100 pM PDTC and 
washed after 1 h. DC were seeded into plates at various concentrations 
and 10  ^allogeneic CD4^ T cells were added to each well. After 5 days, 1 pCi 
[^H]-thymidine was added to each well. Isotope incorporation was measured 
20 h later. Errors bars represent the S.E.M. of three wells.
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Fig. 6.4 Effect of PDTC, a NFkB inhibitor, on the ability of LPS- 
treated DC to induce IL2 expression by CD4^ T cells. DC were treated 
with or without 100 pM PDTC. Cells were washed after 1 h then 
treated with or without 10 pg LPS. DC were washed again after 24 h 
then 104 DC/well were co-cultured with 10  ^CD4^ T cells/well. After 
5 days, T cells were removed, washed, replated and then restimulated 
with 25 ngPMA and 1.5 pM ionomycin. After 2 days, supernatants were 
measured for IL2 by ELISA. Two separate experiments are shown. Bars 
represent results from 4 pooled wells. ND = not detected
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Fig. 6.5 Effect of PDTC, a NFkB inhibitor, on upregulation of CD40 and 
HLA DR by LPS-treated DC. DC were cultured with or without 100 pM PDTC 
for 1 h. Cells were washed and then treated with 10 pg/ml LPS (broken line) or 
without LPS (black line). After 24 h, CD40 and HLA DR expression on the 
surface of DC was analysed by flow cytometry. A non-specific matched isotype 
was used as a negative control (black, filled in).
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Fig. 6.6 Effect of PDTC, a NFkB inhibitor, on upregulation of CD80 and CD54 
by LPS-treated DC. DC were cultured with or without 100 pM PDTC for 1 h.
Cells were washed and then treated with 10 pg/ml LPS (broken line) or without 
LPS (black line). After 24 h, CD80 and CD54 expression on the surface of DC was 
analysed by flow cytometry. A non-specific matched isotype was used as a negative 
control (black, filled in).
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Fig. 6.7 Effect of PDTC, a NFkB inhibitor, on upregulation of CD86 by 
LPS-treated DC. DC were cultured with or without 100 pM PDTC for 1 h. 
Cells were washed and then treated with 10 pg/ml EPS (broken line) or 
without EPS (black line). After 24 h, CD86 expression on the surface of 
DC was analysed by flow cytometry. A non-specific matched isotype 
was used as a negative control (black, filled in).
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Fig. 6.8 Effect of PDTC, a NFkB inhibitor, on LPS-induced 
expression of IL6 by DC. DC were treated with or without 100 pM 
PDTC. Cells were washed after 1 h then cultured with or without 
10 pg LPS for 24 h. Levels of IL6 in the supernatants were 
measured by ELISA. Three separate experiments are shown.
ND = not detected
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Fig. 6.9 Effect of PDTC, a NFkB inhibitor, on the LPS-induced 
expression of IL12p40 by DC. DC were treated with or without 100 pM 
PDTC. Cells were washed after 1 h then cultured with or without 
10 pg LPS for 24 h. Levels of IL12p40 in the supernatants were 
measured by ELISA. Three separate experiments are shown.
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Fig. 6.10 Effect of PDTC, a NFkB inhibitor, on LPS-induced 
expression of IL ip by DC. DC were treated with or without 100 pM 
PDTC. Cells were washed after 1 h then cultured with or without 
10 pg of LPS for 24 h. Levels of IL ip in the supernatants were 
measured by ELISA. Three separate experiments are shown.
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Fig. 6.11 Effect of PDTC, a NFkB inhibitor, on the ability of LPS- 
treated DC to induce IFNy expression by CD4^ T cells. DC were treated 
with or without 100 pM PDTC. Cells were washed after 1 h then 
treated with or without 10 pg LPS. DC were washed again after 24 h 
and 10"^  DC/well were then co-cultured with 10  ^CD4^ T cells/well. After 
5 days, T cells were removed, washed, replated and then restimulated 
with 25 ng/ml PMA and 1.5 pM ionomycin. After 2 days, supernatants were 
measured for IFNy by ELISA. Two separate experiments are shown.
Results are from samples pooled from 4 wells.
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Chapter 7 Conclusions
In this study dendritic cells were generated in vitro from CD34^ HPC using 
GMCSF and TNFa or from adherent PBMC by culture in GMCSF and IL4. 
Both types of DC displayed a characteristic morphology and phenotype, 
expressing co-stimulatory molecules CD80, CD86, CD40, adhesion molecules 
CD54, CD44 and MHC class II molecules. They were also able to stimulate 
proliferation of naïve allogeneic T cells. Following activation of DC by LPS 
or via crosslinking of membrane CD40 molecules, cell surface levels of MHC 
class II and co-stimulatory molecules were increased. Activated DC also 
showed increased ability to stimulate naïve CD4^ T cell proliferation and 
produced high levels of inflammatory cytokines but not the inflammatory 
mediator nitric oxide. DC activated by either CD40 or LPS induced secretion 
of IL12p40 and ILip. However, only LPS induced production of IL6.
I have shown in this study that DC maturation by LPS is regulated by the 
transcription factor NFkB. The anti-oxidant PDTC prevented the translocation 
of NFkB from the cytoplasm to the nucleus of LPS-activated DC. This 
reduced the ability of DC to stimulate naïve allogeneic T cells and prevented 
LPS-induced upregulation of IL12p40 and IL6. However, IL ip  upregulation 
was unaffected by NFkB inhibition.
The main objective of this study was to explore treatments that induced DC to 
modulate CD4^ T cell cytokine expression. When DC were treated with LPS, 
or agents which crosslinked membrane CD40 they produced high levels of 
IL12. This stimulated the production of high levels of IFNy from responding 
naïve CD4^ T cells. IFNy production was inhibited when DC were treated 
with glucocorticoids, IL4 or house dust mite extract prior to CD40L 
stimulation. The effects of dexamethasone and IL4 could be explained by their 
observed inhibitory effect on IL12 expression by DC. However, despite the 
ability of HDM-treated DC to upregulate IL12 production in response to
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CD40 activation, they failed to induce high levels of IFNy from responding T 
cells. The reason for this remains unclear. HDM extracts did not induce DC to 
produce any Th2- inducing or Thl inhibitory cytokines such as EL4, TGFg or 
ILIO. In addition, HDM extracts did not influence DC surface molecule 
expression or the ability of CD40-activated DC to stimulate the proliferation 
of T cells. Furthermore, a comparison of genes between DC treated with or 
without HDM extracts using cDNA arrays did not highlight any changes in 
•mRNA expression that could be attributed to HDM treatment. An interesting 
observation was the expression of PARI on the surface of DC. HDM cleavage 
of PAR expressed by DC may induce changes in expression of soluble 
mediators which could be a component of asthma.
Another possible explanation for the inhibitory effect of HDM-treated DC on 
IFNy production by T cells lies with IL18. This cytokine can induce high 
levels of IFNy from established T cell clones and potentiates IL12-induced 
IFNy secretion by T cells (Okamura et aL, 1998). Human DC are known to 
express BL18 mRNA (de Saint-Vis et al., 1998) and protein (Stoll et al., 1998) 
which synergises with IL12 to induce IFNy production from T cells. Studies 
using IL12 deficient mice, however, have shown that DC-derived IL18, 
cannot initiate Thl developmeiit. It would be interesting to investigate 
whether HDM has an inhibitory effect on IL18 expression by DC. This might 
explain why IFNy secretion is inhibited when CD4^ T cells are stimulated by 
activated HDM-treated DC despite the high levels of IL12 present.
The effect of HDM on DC clearly requires fiirther investigation and it would 
be pertinent to examine the effect of HDM on DC isolated from the 
respiratory tract. DC form a contiguous network throughout the respiratory 
tract epithelium and also line the lung. They have a rapid turnover consistent 
with their function as sentinels of this area which is in constant contact with 
foreign antigen. These DC are highly endocytic, have an immature phenotype, 
and under steady state conditions induce Th2 cell development. This may be a
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default mechanism preventing inflammatory responses to innocuous 
substances which could unnecessarily damage self tissue. However, when 
respiratory tract DC are exposed to maturation factors they can induce a Thl 
response. There are factors released in the respiratory tract, including NO or 
PGE2 produced by epithelial cells, that may enable DC to maintain their Th2- 
inducing status. Furthermore, DC isolated fl'om the bronchial epithelium of 
asthmatic patients were shown to promote Th2 cell development (Hance et a l, 
1993).
The results in this thesis have shown that HDM prevents activated DC fi*om 
inducing high levels of IFNy production by responding T cells. What are the 
implications of this effect in vivol One explanation may be as follows: when 
an individual inhales HDM, the allergen is picked up by DC resident in the 
respiratory tract or the lung. Migration of these DC to the draining lymph 
nodes allows them to come into contact with HDM-speciflc T cells. In a non­
asthmatic individual, it does not matter if  HDM prevents DC flrom inducing 
HDM-speciflc Thl cells because they do not produce HDM-speciflc Th2 cells 
either. Asthmatic individuals, on the other hand, are in danger because they 
require HDM-speciflc Thl cells to counteract their HDM-speciflc Th2 cells. 
In the absence of IFNy, HDM-speciflc Th2 cells are free to secrete IL4 and 
induce the production of IgE.
Different subtypes of DC may exist in vivo which fulfil different 
immunological roles but this phenomenum has not yet been fully elucidated in 
mice or humans. In mice lymphoid derived DC express high levels of IL12 
and can induce Thl responses whereas DC of a myloid origin do not express 
IL12 and are believed to influence Th2 development (Maldonado-Lopez et al., 
1999). The reverse has been shown in humans; myloid DC induce Thl type 
cytokines whereas DC derived fl-om lymphoid cells in the tonsil stimulate Th2 
cell differentiation (Rissoan et a l, 1999). However, the results presented in 
this thesis indicate that the way in which DC influence the phenotype of
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responding T helper cells depends on their cytokine environment or on the 
type of antigen they encounter. During a bacterial or viral infection DC 
initiate innate responses by producing IL12 which induces IFNy production by 
NK cells, activating macrophages. IL12 also acts in an autocrine manner 
inducing further IL12 secretion from DC initiating adaptive immunity by 
inducing Thl cell development in secondary lymphoid organs. DC are unique 
in their ability to activate naïve T cells which means that in addition to Thl 
type antigens, DC must be able to initiate primary immune responses to Th2 
inducing antigens including allergens and helminth antigens. These antigens 
may have properties that modulate DC thereby triggering Th2 cell 
development. Subsequent IL4 production acts on DC to prevent IL12 
secretion thus inhibiting a Thl response.
The results presented in this study add to the growing knowledge of DC 
physiology. DC are pivotal players in immunity since they make decisions as 
to whether an immune response should be immunogenic or tolerogenic. Their 
capacity to influence the cytokine profile of T helper cells and possibly 
cytotoxic T cells means that DC are an opportune cell type to use in the 
development of therapeutic interventions.
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